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Clinical pathways (CPWs) are tools used by healthcare professionals to guide evidence-based 
practice by improving multidisciplinary communication, teamwork, and care planning to 
optimize patient outcomes. CPWs are continually developed and implemented in several 
healthcare settings; however, the evidence of their effectiveness in hospitals is debatable to 
date. There is no coherent theory that explains how CPWs work in different healthcare 
settings. 
 
The overall objective of this thesis is to investigate the effects of CPWs implemented in 
hospitals. The first part (study 1) of this thesis described a statistical method to refine an 
operational definition for CPWs that is useful for conducting CPWs research in healthcare. 
The refined operational definition was used to synthesize evidence from CPW literature. The 
second part (study 2) of the thesis investigated the effects of CPWs in hospitals following the 
Cochrane systematic review methodology. The key finding in this review was that stand-
alone CPWs may reduce in-hospital complications and hospital costs compared to usual care 
(low-certainty evidence) and it is uncertain whether stand-alone CPWs reduces the length of 
hospital stay or improve adherence to recommended practice by healthcare providers (very 
low-certainty evidence). The final section of the thesis (study 3) is a realist review protocol 
following the realist methodology to describe an evidence-based approach for developing a 
realist program theory with the aim of filling the theoretical void on how clinical pathways 
work in hospitals to generate intended outcomes. 
 
Taken together, these studies make a valuable addition to the growing body of research on 
clinical pathways implemented in hospitals. There is an urgent need to develop an 
internationally agreed definition for clinical pathways that can inform the development of 
plausible theories on how they work in hospital environments. 
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CHAPTER 1: GENERAL INTRODUCTION 
1.1 Problem Statement 
Due to the global call for improvement in the quality of healthcare services delivered in 
hospitals, clinical pathways have emerged as an intervention to help address quality gaps 
during the delivery of patient-centered care [1, 2]. However, there is conflicting evidence and 
an ongoing international debate on the effects of clinical pathways in hospitals [3]. While 
some studies evaluating clinical pathways effects in hospitals reported beneficial outcomes, 
others found no effect or unwanted outcomes [3]. Scarce healthcare resources are continually 
expended for the development, implementation and evaluation of clinical pathways in 
hospitals. To date, there is weak evidence to support the impact of clinical pathways on 
patient and health system outcomes. It is therefore timely to investigate the true effects of 
clinical pathways in hospitals and further strengthen the evidence base for health planning 
and decision making purposes. 
1.2 Clinical pathways and their potential to improve quality of healthcare  
Globally, health systems are continuously searching for effective and efficient ways to 
provide patient care without comprising quality [4]. The Institute of Medicine (IOM) defines 
quality as “the degree to which health services for individuals and populations, increase the 
likelihood of desired health outcomes and are consistent with current professional 
knowledge” [5]. About two decades ago, the IOM released two landmark reports on safety 
and quality in healthcare; To Err is Human and Crossing the Quality Chasm [1, 6]. Both 
reports from the IOM aimed at sensitizing healthcare stakeholders to prioritize the reduction 
of adverse events and preventable medical errors associated with patient care. Ever since, 
health systems, healthcare professions and healthcare institutions have focused on the need to 
improve the quality of health care delivery to deliver optimum value. 
The incorporation of new evidence into clinical setting or practice is a daunting task for many 
healthcare managers and care providers. The enormity associated with sorting and 
prioritizing clinical evidence to improve patient care presents challenges to many healthcare 
systems to date [7, 8]. The slow uptake of updated clinical evidence into practice predisposes 
patients to harm, poor outcomes and increased healthcare costs [8]. This problem is referred 
to as the “evidence-practice gap” which contributes to undesired variation in patient 
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outcomes, e.g. morbidity and mortality rates. James Brent, a renowned physician in clinical 
quality improvement and patient safety referred to the three most common causes of 
undesired variation in healthcare as “the complexity of clinical practice, a lack of valid 
information identifying best care across a range of choices, and physicians’ continued 
reliance upon subjective recall in making clinical judgments” [9]. Collectively, these factors 
contribute to errors and unintended patient outcomes in healthcare settings. 
Over the years, quality improvement initiatives such as Lean, Six-sigma, Continuous Quality 
Improvement, etc., and tools such as surgical checklists, clinical pathways, etc., have been 
implemented in different healthcare contexts to reduce variation and achieve health system 
goals [10-13]. Clinical pathways (CPWs) are developed in healthcare as a strategy for 
improving care processes by translating guideline recommendations into a local context to 
provide state-of-the-art care [14]. Also, CPWs are often implemented as knowledge 
translation tools that recommend the best available evidence for a clinical condition or 
practice area during an episode of care [14-16]. Since their evolution in the 1980s, CPWs 
have been widely implemented in hospital care and gradually implemented in primary care 
settings [15].  
With the continuous rise in the global burden of chronic diseases, variation in clinical 
practices and increased costs associated with poor quality patient care, [17] CPWs have 
emerged as an improvement tool in many health systems to help address these issues [18]. 
When implemented appropriately, CPWs have the potential to support clinical decision-
making processes to improve the quality of patient care. Several studies have demonstrated 
the potential of CPWs to streamline care processes, contain cost, foster patient-centered care 
and promote teamwork in hospital environments [19-21]. While some studies found 
improvement in patient outcomes [22], reduced length of hospital stay [23] and hospital costs 
[24], others reported no difference or worsened outcomes [25, 26] after using a clinical 
pathway for patient management. Despite the number of resources and time dedicated to the 
development and implementation of CPWs in hospitals, their effects are debatable to date. 
Therefore, it is timely to investigate how CPWs work and to further assess their effectiveness 
in hospital environments. The literature synthesis on effects of CPWs in hospitals will inform 
future governmental and organizational effort to bridge quality gaps in patient care provided 
in hospitals.  
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1.3 Evidence base for clinical pathways in healthcare 
To date, useful evidence of complex healthcare interventions is limited and varied [27]. 
CPWs are complex interventions with different interacting components that are developed as 
paper or electronic-based documents [14]. The widespread use of CPWs in hospitals has been 
reported in the USA, Australia, Canada, Europe, and Asia [14]. With the enormous resources 
committed to the development and implementation of CPWs in healthcare to reduce practice 
gaps across health systems and improve care coordination, the evidence on their effectiveness 
in healthcare settings is inconclusive to date [14, 28].  
Different types of evaluation designs, specifically observational methods are frequently used 
to assess the effects of complex interventions in healthcare including CPWs [29]. This notion 
may be due to the cost-effectiveness associated with implementing observational designs 
compared to experimental trials that may be impractical to carry out in real-world settings. 
However, variation in the evaluation approaches also contributes to the differences in the 
outcomes observed when examining effects from similar contexts [30]. Observational study 
designs have been purported to have the propensity for bias that distorts effect estimates and 
are often excluded in quantitative evidence synthesis, e.g. Cochrane systematic reviews of 
complex health interventions [31].  
Randomized trials are traditionally referred to as the gold standard for conducting 
quantitative-systematic reviews [32]. A Cochrane systematic review on effects of CPWs in 
hospitals care by Rotter et al. (2010) identified studies that reported positive effects on patient 
outcomes such as reduced in-hospital complications, after the implementation of CPWs in 
hospital settings [14]. However, the review also found undesired results such as increased 
mortality, increased re-hospitalization rates, reduced provider satisfaction among others, in 
similar hospital settings [14].  
Building on the systematic review by Rotter et al. (2010) and to align with the 
Methodological Expectations for Cochrane Intervention Reviews (MECIR) standards for 
conducting systematic reviews [33], this thesis similarly followed the Cochrane Effective 
Practice of Care (EPOC) care group [34] approach to update the evidence base on the effects 
of CPWs in hospitals.  
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1.4 Clinical pathways for hospital care 
CPWs have been implemented in hospitals since the 1980s and their use is continually on the 
rise in many health systems [35]. In 2006, Vanhaect and colleagues reported on the 
prevalence of CPWs in 23 countries via an international survey [36]. The total number of 
individual patients on a pathway was used to estimate the overall prevalence reported in the 
study. The study showed that there was substantial variation in the use of CPWs across the 
countries surveyed [36]. Although modest increases in the utilization and uptake of CPWs 
were reported in Wales, Scotland and the United Kingdom, the overall usage was rated as 
“low” [36]. The survey did not provide information on the type of clinical conditions 
assessed.  
The updated version of the survey published in 2014 included data from 163 countries with a 
25% response rate [37]. In line with the previous study, the survey found significant 
differences in the use of pathways and suboptimal involvement of patients in pathway 
development [37]. Both studies called for the creation of an evidence base for CPWs and a 
call for better understanding of CPWs to support clinicians, patients and health policymakers 
during decision-making processes.  
As noted in the previous section, hospitals are complex healthcare environment with several 
interacting components complimenting each other to deliver quality patient care [38]. 
Contextual factors such as collaboration, team relationships, organizational priorities, patient 
and staff engagement among others are important factors that can influence the successful 
implementation, uptake and sustainability of CPWs in healthcare settings [39]. Due to the 
quality of reporting of the included studies in the Cochrane review by Rotter et al. in 2010, it 
was challenging to identify contextual elements associated with successful CPW 
implementation. While statistical pooling as done by Rotter et al. (2010) showed limited 
evidence that CPWs have the potential to decrease the number of in-hospital complications 
and improve professional documentation among healthcare professionals, a realist approach 
may better suited to address these complex contextual factors [14].  
1.5 Issues with clinical pathways research 
Like other complex interventions, integration of CPWs in healthcare environments is faced 
with issues regarding conceptualization, implementation, evaluation and sustainability in 
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healthcare environments. A literature review on definitions for CPWs by De Blesser et al. 
(2006) identified 37 concepts used to describe CPWs [40]. Examples of the CPW definitions 
identified include critical pathway, care maps, algorithm, protocol, etc. [40]. This variation in 
the definition of a CPW implies that there is no internationally agreed-on definition or a 
commonly used language for CPWs. The difference in definition of CPWs makes it difficult 
to synthesize, appraise and collate evidence to assess their effects in different healthcare 
settings.  
Owing to the variation in the number of resources committed to the development and 
implementation of CPWs, their effectiveness in practice settings varies [14]. When pathways 
are implemented top-down in a healthcare setting, they may be viewed as “cookbook 
medicine,” and their uptake may be suboptimal with little or no effect. However, in 
environments where there is a shared vision with organizational support, they are more likely 
to be embedded with little chaos [41]. It is probable that the ongoing confusion regarding 
CPWs effects in healthcare is related to challenges in the conceptualization of this quality 
improvement tool. This confusion makes the identification, cataloging, synthesizing and 
development of an evidence base for CPWs effectiveness difficult. 
Kinsman et al. (2010) developed a four-criteria checklist to assist researchers in the objective 
identification of CPWs studies from the literature and advanced the methodological direction 
towards the development of an evidence base for CPWs [16]. The research undertook a four-
stage process to create the first operational definition for conducting the first Cochrane 
systematic review on the effects of CPWs in healthcare published in 2010. This thesis aims to 
update the evidence base for the effects of using CPWs in healthcare with a focus on 
hospitals. 
1.6 Systematic Reviews and Clinical pathways 
Over the years, researchers have called for the judicious use of evidence-based medicine in 
healthcare settings [42]. They argued that the use of weak or outdated evidence during patient 
care increases the risk of significant harm to patients and increased costs to the health system. 
With the enormous volume of literature published daily about new knowledge, diagnostic 
tests or medical procedures, it is challenging for clinicians to be up to date with current 
evidence in their practice area [43]. It is frequently stated that an average of 17 years is 
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required for research evidence to reach clinical practice [43]. This time lag is unacceptable 
due to the potential for a significant level of harm for patients, especially those who are 
critically ill. The gap in translating research knowledge into practice settings is the focus of 
many organizations such as the Cochrane Collaboration and the Joanna Briggs Institute 
which develop, disseminate and support efficient ways to present evidence in a rigorous, 
reliable, portable and useful format [44, 45].          
A systematic review was initially used to answer the questions asked by this thesis because it 
was purported to be an unbiased and cost-effective option to rigorously and broadly appraise 
the international literature on the true effects of clinical pathways in hospitals. A systematic 
review (SR) is defined as a methodical approach to identify, assess and synthesize published 
primary studies to investigate a specific research question [46]. “It attempts to gather all 
empirical evidence that fits pre-specified eligibility criteria into answering a specific research 
question” [47]. When conducted appropriately, SRs may provide reliable findings from 
which valuable conclusions can be drawn and policy decision made. In contrast to a 
traditional narrative review (NR) that aim to provide an overview of a research topic, a SR 
applies rigorous strategies to systematically gather evidence around a focused research 
question [48].  
 
A systematic review protocol is usually written to describe the systematic process and 
guidelines to be followed in answering the research questions. The protocols are typically 
registered in a database, e.g. PROSPERO [49] and the aim is to permit objective reporting 
and increase the replicability of the review. Where applicable, meta-analysis is an add-on to 
systematic reviews. It is a statistical pooling of similar underpowered studies to examine 
intervention effects. The five necessary steps of conducting of a systematic review include 
(1) identifying the research question; (2) literature search (3) study quality assessment; (4) 
synthesizing and summarizing the evidence and (5) interpret findings [50]. With a positivist 
lens to quantify the effects of clinical pathways in hospitals, this thesis follows the systematic 
review methodology.  
1.7 The Cochrane Effective Practice and Organisation of Care Group (EPOC)  
For 20 years, Cochrane has produced systematic reviews of primary research on human 
health and health policy, and these have been internationally recognized as the highest 
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standards in evidence-based recommendations [51]. A sub-group of Cochrane, EPOC, 
focuses on reviews of interventions that are designed to influence or improve professional 
practice and the delivery of effective health services in healthcare organizations [34]. This 
thesis follows the evidence synthesis approach recommended by the Cochrane EPOC group 
for conducting systematic reviews of complex interventions. Table 1-1 lists the types of study 
designs included in Cochrane EPOC reviews to evaluate complex interventions such as 
clinical pathways [52]. 
Table 1–1. Cochrane EPOC study designs 
Type of study Study characteristics 
Randomised controlled trial (RCT) OR 
randomised trial 
An experimental study in which people are allocated to a 
control and an experimental group using random assignment 
to prevent bias. Cluster randomised studies are experimental 
studies where a group of subjects (as opposed to individuals) 
are randomised. Cluster randomised studies reduce or 
eliminate the contamination of care providers during clinical 
trials.  
Non-randomised controlled trial (NRCT) OR 
non-randomised trial 
An experimental study in which people are allocated to 
different interventions using methods that are not random. 
Controlled before-after study (CBA) A study in which observations are made before and after the 
implementation of an intervention, both in a group that receives 
the intervention and in a control group that does not. 
Interrupted-time-series study (ITS) 
 
A study that uses observations at multiple time points before 
and after an intervention (‘the interruption’). The design 
attempts to detect whether the intervention has had an effect 
significantly greater than any underlying trend over time. 
Source: Cochrane website: https://epoc.cochrane.org/sites/epoc.cochrane.org/files/public/uploads/EPOC Study 
Designs About.pdf   
The preliminary results of the systematic review update conducted by this thesis likewise 
showed inconclusive evidence on the effects of clinical pathways in hospitals. During the 
review of the meta-analytic summaries for all the multiple comparisons assessed by the 
systematic review, it became apparent that the systematic review methodology was not 
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ideally suited for evaluating complex health interventions such as CPWs and might be a key 
reason for the dearth of quality evidence generated on this topic so far.  
With the aim of informing future researchers, this thesis described another methodological 
approach (realist synthesis) developed by Ray Pawson to evaluate complex health 
interventions including CPWs [53]. In contrast to systematic reviews, realist methods utilize 
multiple sources of data including qualitative studies to elicit theoretical accounts of how an 
intervention works or not. Also, the realist analytical framework ensures the incorporation of 
contextual factors that contribute to the successful implementation of CPWs in different 
hospital environments. This approach is in stark contrast to systematic reviews where 
contextual factors are disentangled from the other intervention components resulting in 
difficulty in identifying recipe for intervention success, equivocal results, and limited use for 
policy [54].  
1.8 Realist Reviews 
The use of theory is vital to the field of implementation science because they help us to 
understand how interventions work and achieve their intended outcomes [55]. Apart from the 
use of systematic reviews for evaluating complex interventions, realist synthesis is another 
viable approach to generate evidence on complex interventions for policy and decision 
making in healthcare [56]. “Realist synthesis focuses more explaining “why,” “how,” “for 
whom” and “to what extent” interventions work” [56]. The goal of a realist synthesis is to 
develop a program theory that explains how interventions or programs work. In contrast to 
systematic reviews, the purpose of a realist review is to develop a program theory that 
describes how interventions or programs work [57]. Realist reviews are theory building 
exercises that attempt to understand multiple layers of causality and the associated 
mechanisms that generate multiple impacts in different contexts. Since healthcare 
interventions are theory incarnate [58], realist approaches are more suited in answering key 
policy questions that involve social interactions between multiple actors in different health 
contexts such as CPWs.  
Initially developed by Ray Pawson, realist reviews follow realist philosophy which is 
grounded in social science and assumes that the world is real and humans interact with reality 
which limits or constructs our interpretation [57]. Realist approaches acknowledge the role of 
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contextual factors in modulating mechanisms that account for multiple outcomes observed at 
the micro, meso and macro level [57]. In contrast to traditional systematic reviews, realist 
reviews utilize numerus sources of information (published and grey) and study designs 
(qualitative and quantitative) related to the program theory to answer its research questions 
[59]. The analysis in a realist review focuses on eliciting the contexts-mechanisms-outcome 
(CMO) configurations that are used to develop, refute or refine the intervention program 
theory [60]. Because realist review identifies critical elements and mechanisms that can 
explain causality patterns in different contexts, they are crucial for implementation science 
[61]. Following a realist approach, this thesis also attempts to describe in depth the steps 
required to create a program theory for CPWs in hospitals. 
1.9 Thesis objectives  
The objectives of this thesis are to: 
1. Develop a working definition for clinical pathway research 
2. Assess the effects of clinical pathways in hospitals  
3. Propose a method for developing a realist program theory for clinical pathways in 
hospitals. 
1.10 Ethics approval  
This research was deemed ethics exempt by the University of Saskatchewan Behavioural 
Research Ethics Board (BEH 13-255).  
1.11 Thesis structure 
The research is presented in a manuscript-style thesis format, which consists of three parts, 
each prepared as a stand-alone manuscript. Collectively, the papers contribute to the 
overarching research purpose to investigate the effects of CPWs in hospital care and to 
propose an alternative research method for developing a theory for CPWs in hospitals. 
Manuscripts are presented as single thesis chapters with their corresponding methods 
following this general introduction section (Chapter 1).  
Based on the lack of agreement for the definition of a clinical pathway and following the 
Cochrane systematic review approach to investigate CPW effects, this thesis began by 
refining an exisiting operational definition for a clinical pathway that is sensitive enough to 
capture relevant studies in broader healthcare contexts. This methodological approach is 
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necessary to easily permit the objective identification of relevant CPW studies for conducting 
the systematic review. This process will ensure only studies considered as CPWs studies 
were considered for analysis attempt to reduce confounfing bias that can impact the findings 
of the systematic review.  
The first manuscript (Chapter 2), “What is a clinical pathway? Refinement of an operational 
definition to identify clinical pathway studies for a Cochrane systematic review” contributes 
to the evidence base for methods and describes the process of identifying relevant literature 
for CPWs research. The manuscript focuses on the process of refining an operational 
definition for CPW research and proposes the use of the refined definition for the future 
synthesis of CPWs literature. The refined definition for a CPW was used to conduct the 
systematic review update to assess the effects of clinical pathways in hospitals in this thesis. 
The second manuscript (Chapter 3), “Clinical pathways for secondary care and the effects on 
professional practice, patient outcomes, length of hospital stay and costs” contributes to the 
evidence base on the effects of clinical pathways in hospital settings. Following the EPOC 
methods for conducting systematic reviews, the manuscript updates and adds to the body of 
evidence on the effects of clinical pathways implemented in hospitals on patient outcomes, 
professional practice, length of stay and costs. 
Upon completion of the systematic review update on the effects of CPWs in hospitals 
following the Cochrane EPOC methodology, it was apparent that a different approach was 
needed to answer the research questions asked by this thesis. This was because majority of 
the qualitative studies that could have better inform the evidence generated by the systematic 
review have been excluded and it was difficult to attribute clinical pathway success or failure 
to intervention effects alone. This prompted an alternative way to investigate the effects of 
clinical pathways in hospitals and a realist approach was proposed by this thesis. 
The third manuscript (Chapter 4), “Development of a program theory for clinical pathways in 
hospitals: protocol for a realist review” contributes to the evidence base on theoretical 
methods for implementing clinical pathways in hospitals. The manuscript describes a process 
for developing a program theory for implementing clinical pathways in hospitals. 
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The final thesis section is the “Discussion and Conclusion” (Chapter 5), which summarizes 
the research results from all the independent research and provide general conclusions and 
recommendations based on the findings from the entire thesis.  
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CHAPTER 2: WHAT IS A CLINICAL PATHWAY? REFINEMENT OF AN 
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FOR A COCHRANE SYSTEMATIC REVIEW (MANUSCRIPT 1) 
 
Authors: Adegboyega K Lawal1*, MPH, Thomas Rotter1, PhD, Leigh Kinsman2, PhD, 
Andreas Machotta3, MD, Ulrich Ronellenfitsch4, MD, Shannon D Scott5, PhD, Donna 
Goodridge6, PhD, Christopher Plishka1, MPH, Gary Groot6, PhD 
 
Affiliations:  
1 College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Canada 
2 University of Tasmania and Tasmanian Health Organisation (North), Launceston, 
Tasmania, Australia 
3 Department of Anesthesiology, Sophia Children’s Hospital, Erasmus-MC Rotterdam, The 
Netherlands  
4 University Medical Center Mannheim, Medical Faculty Mannheim of the University of 
Heidelberg, Department of Surgery, Mannheim, Germany 
5 Faculty of Nursing, University of Alberta, Edmonton, AB 
6 College of Medicine, University of Saskatchewan, Saskatoon, Canada  
 





Clinical pathways (CPWs) are a common component in the quest to improve the quality of 
health. CPWs are used to reduce variation, improve quality of care, and maximize the 
outcomes for specific groups of patients. An ongoing challenge is the operationalization of a 
definition of CPW in healthcare. This may be attributable to both the differences in definition 
and a lack of conceptualization in the field of clinical pathways. This correspondence article 
describes a process of refinement of an operational definition for CPW research and proposes 
an operational definition for the future syntheses of CPWs literature. Following the approach 
proposed by Kinsman et al. (BMC Medicine 8(1):31, 2010) and Wieland et al. (Alternative 
Therapies in Health and Medicine 17(2):50, 2011), we used a four-stage process to generate a 
five criteria checklist for the definition of CPWs. We refined the operational definition, 
through consensus, merging two of the checklist’s criteria, leading to a more inclusive 
criterion for accommodating CPW studies conducted in various healthcare settings. The 
following four criteria for CPW operational definition, derived from the refinement process 
described above, are (1) the intervention was a structured multidisciplinary plan of care; (2) 
the intervention was used to translate guidelines or evidence into local structures; (3) the 
intervention detailed the steps in a course of treatment or care in a plan, pathway, algorithm, 
guideline, protocol or other ‘inventory of actions’ (i.e. the intervention had time-frames or 
criteria-based progression); and (4) the intervention aimed to standardize care for a specific 
population. An intervention meeting all four criteria was considered a CPW. The 
development of operational definitions for complex interventions is a useful approach to 
appraise and synthesize evidence for policy development and quality improvement. This step 
was pivotal to permit the objective identification of CPW studies required to conduct the 
Cochrane systematic review on effects of CPWs in hospitals. 
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The optimization of patient safety and quality in healthcare remains the primary focus of 
quality improvement initiatives [1]. The health quality improvement movement has 
stimulated researchers and managers in healthcare to be innovative in developing new ideas 
to address issues relating to patient safety and sub-standard care [2, 3]. Several quality 
improvement concepts, such as Lean, Plan-Do-Study-Act cycles, Continuous quality 
improvement, etc., and tools such as clinical pathways (CPWs), surgical checklists, etc., have 
been implemented in a variety of healthcare settings to sustain and support these continuous 
quality improvement concepts. 
CPWs are a common component of these improvement initiatives. They aim to organize and 
standardize care processes, thus maximizing patient outcomes and improving organization 
efficiency [4, 5]. Originating in the USA, CPWs have been used in healthcare since the 
1980’s. Their goal is to improve patient outcomes, such as mortality rate and others, while 
containing costs and without compromising quality [6, 7]. Different terms, including care 
maps, critical pathways, local protocols or algorithms are used to describe the construct of 
CPWs and may be developed as paper-based or electronic documents [8]. The widespread 
use and prevalence of CPWs in hospitals is reported in the USA, Australia, Canada, Europe, 
and Asia [5, 9]. In Canada, CPWs are viewed as a patient-informed knowledge translation 
tool to ensure clients receive the best available care [10, 11]. The myriad of terms used to 
describe a CPW has led to conceptual confusion in the field of pathway research. 
2.3 Aim and purpose of this paper 
The present paper aims to (1) describe the process of refinement and rigorous testing used to 
obtain an ‘operational definition’ for CPW research, and to (2) propose an operational 
definition for future syntheses of CPWs literature. 
This paper builds on the initial evidence, appraised by Kinsman et al. (2010) [7], where a 
team of Cochrane review authors developed a set of criteria for the practical operational 




2.4 Purpose and conceptualization of CPWs 
CPWs are mainly implemented for specific groups of patients meeting a pre-specified 
criterion. The implementation of CPWs may be driven by a variation in the quality of care 
and outcomes for patients with similar health conditions: cardiovascular, respiratory, surgical, 
cancer, etc. Usually, the aim of the implementation is to reduce a pre-identified variation in 
patient outcomes and costs and, more recently, to keep patients and families informed about 
their course of treatment or care. 
There are several challenges to CPW research, similar to other complex health service 
implementation efforts such as conceptualization, implementation, evaluation, and 
sustainability [8, 12]. De Blesser et al. (2006) [13] identified 37 primary definitions for 
CPWs used in the literature and various terms have been used to describe CPWs in different 
health settings. There is not a standard definition to identify CPW studies. This paper aims to 
fill that gap, by proposing a method for the development and refinement of an operational 
definition for CPW research in healthcare. Clarity of the CPW concept, especially for 
research, is pivotal to the development of an evidence base; a base that policymakers, 
healthcare professionals, patients, and other front-line users can refer to for rational decision-
making. 
2.5 Working definition on CPWs 
In 2010, a team of Cochrane authors developed an operational definition for CPWs. The 
definition can be used to appraise and synthesize international literature on CPWs in hospitals 
[7]. From three seminal articles [13, 14, 15] on CPWs, five operational criteria for CPW 
definition were rigorously developed [5, 7]. The criteria were subsequently tested on 10 
CPWs articles among the review team in a two-stage process. After achieving 100 % 
agreement, they were applied in the identification of relevant articles for a Cochrane 
systematic review on CPWs in hospitals published in 2010 [5].  
Recent attempts to apply the criteria to CPWs studies conducted in primary care was 
problematic due to poor reporting of the CPW intervention in the literature. A modification of 
the original five operational criteria was proposed and agreed by all review authors. This 
change increased the sensitivity of the operational definition to accommodate relevant 
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literature on CPWs, spanning across a broader context of healthcare settings, including 
primary care. 
2.6 Methods 
Developmental process and refinement of an operational definition for CPWs 
In 2010, a team of Cochrane review authors undertook a four-stage process to develop a list 
of criteria to generate an operational definition for CPWs in hospitals. This followed a 
methodology proposed by Kinsman et al. (2010) [7] and Wieland et al. (2011) [16]. The 
process required (1) identification of articles exploring the scope and definition of CPWs (or 
similar terms); (2) synthesis of previously suggested components and generation of draft 
criteria for testing; (3) pilot testing the level of agreement between review authors when 
applying criteria to identified studies; and (4) modification of the criteria to maximize 
agreement between review authors [7]. 
The rigorous testing of the criteria with 10 CPW articles, and with 100 % agreement among 
review authors, led to the development of a practical operational definition for CPWs: (1) the 
intervention was a structured multidisciplinary plan of care; (2) the intervention was used to 
channel the translation of guidelines or evidence into local structures; (3) the intervention 
detailed the steps in a course of treatment or care in a plan, pathway, algorithm, guideline, 
protocol or other ‘inventory of actions’; (4) the intervention had timeframes or criteria-based 
progression (that is, steps were taken if designated criteria were met); and (5) the intervention 
aimed to standardize care for a specific clinical problem, procedure or episode of healthcare 
in a specific population [7]. 
An intervention was a CPW if it met the first criterion together with three of the other four 
criteria. The operational definition further supported the identification of relevant full text 
studies that were eventually used in finalizing the first systematic review on CPWs in 
hospital care in 2010 [7]. 
2.7 Rationale for refinement of the operational definition for CPWs 
A recent attempt by the review team to conduct a systematic review on CPWs in primary care 
was hampered by the challenge of applying the above operational definition in a primary care 
setting, with the major problem during the protocol development for the systematic review 
[17] being the identification of relevant CPW studies in a primary care context. 
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This is due to the requirements of criteria numbers 3 and 4. The application of these two 
criteria is problematic, because several articles explicitly met criterion 3 but not criterion 4, 
or vice versa, and thus had to be excluded. 
TR and LK pilot tested the new criteria on five CPWs studies [18, 19, 20, 21, 22] in primary 
care identified during the protocol development for a systematic review on CPWs in primary 
care [17]. Consensus was reached among review authors that, by merging the two criteria, the 
definition would be more inclusive. Thus, the new operational definition for CPWs was 
narrowed to a four criteria checklist. 
2.8 Results 
Pilot test of the new operational definition for consistency 
Two review authors (CP and AB) independently pilot-tested the refined operational definition 
containing the four criteria-checklist, with LA serving as an arbitrator to resolve any 
disagreement during the process. The two review authors had no contact during the pilot test. 
The pilot test was conducted on 20 articles selected randomly from the 27 included articles 
from the 2010 Cochrane systematic review on CPWs in hospitals. The aim of the pilot-test 
was to ensure that the number of articles retrieved for the full text extraction phase in 2010 
remained unchanged when using the modified criteria. The results of the pilot-test were 
collated and a reliability analysis for qualitative variables was estimated using the kappa 
statistic [23]. Statistical analysis was conducted using SPSS V. 22 (SPSS, Chicago, IL). See 
table 2-1 for data layout. 
Table 2–1. Observed and expected percentage agreement; data layout 
 
                                                      




Legend: (a) and (d) represent the number of times the two observers agree while (b) and (c) represent the number of times the two observers 
disagree, m1 = row total number for inclusions, m0 = row total number of exclusions, n1 = column total for inclusions, n0 = column total for 
exclusions 
  CP 
AB Include Pending Totals 
Include 17a 0b 17m1 
Exclude 0c 3d 3m0 
Totals 17n1 3n0 20n 
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Observed agreement =17/20 = 85% 
Expected agreement (pe) = [(n1 /n) ∗ (m1 /n)] + [(no /n) ∗ (mo /n)] 
Pe = [(17/20) ∗ (17/20)] + [(3/20) ∗ (3/20)] = 0.722 + 0.023 = 0.75 
The first independent pilot testing, applying the new criteria to the previously published CPW 
articles described above, generated 85 % observed and 75 % expected agreement, 
respectively (Table 2-2). For the reliability analysis, the kappa test statistic was 0.99 with 
a P value <0.001, implying perfect agreement between the two reviewers (Table 2-3). 
Table 2–2. Inter-rater reliability analysis of 20 articles on clinical pathways in hospital care; data layout 
AB * CP   Cross-tabulation     
Count 
    CP Total 
    1.00 0.00   
AB 
1.00 17 0 17 
0.00 0 3 3 
Total 17 3 20 
AB, reviewer 1; CP, reviewer 2; 1.00, Included; 0.00, Pending 
Table 2–3. SPSS output for Kappa statistic 
Symmetric measures 






Agreement Kappa 1.000 0.000 4.472 0.000 
N of Valid Cases 20       
Approx. Sig. = P value 
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Refined criteria for CPW operational definition 
The four criteria derived from the refinement process described above are (1) Is it a 
structured multidisciplinary care plan? (2) Is it used to channel the translation of guidelines or 
evidence into local structures? (3) Does it detail the steps in a course of treatment or care in a 
plan, pathway, algorithm, guideline, protocol or other ‘inventory of actions’ (i.e. the 
intervention had time frames or criteria based progression)? (4) Does it aim to standardize 
care for a specific clinical problem, procedure or episode of care in a specific population? 
Henceforth, an intervention was considered a CPW if it contained all the four criteria in the 
new operational definition. Subsequently, the new definition will be applied to identify (1) 
relevant titles and abstracts for an on-going update of a Cochrane systematic review on 
CPWs in hospitals, and (2) a new Cochrane systematic review on CPWs in primary care. 
Prospectively, the systematic review will follow the validated Cochrane Effective Practice 
and Organization of Care (EPOC) methodology for complex interventions, and will consider 
randomized controlled trials, non-randomized controlled trials, controlled before and after, 
and interrupted time series study designs [18]. 
2.10 Discussion 
This article describes the process of development, refinement, and testing of a practical 
working definition for CPWs. It also supports the inclusion of relevant primary research 
articles only in our Cochrane systematic review update on CPW effectiveness in hospital and 
primary care. The initial criteria, rigorously developed in 2010 using the Kinsman et al. 
(2010) [7] and Wieland et al. (2011) [16] approach for a Cochrane systematic review, is a 
milestone in the field of CPW research. The first proposed operational definition of a CPW 
ultimately led to the successful completion of the first Cochrane EPOC review on CPWs in 
hospitals. 
It is imperative to understand that we created an operational definition for CPWs in hospital 
and primary care settings, rather than undergoing a scientific concept analysis [24]. We 
propose the development of minimum inclusion criteria and an operational definition for 
systematic reviews of complex interventions such as CPWs. This is due to the high level of 
resources required of Walker and Avant’s gold standard concept analysis process and the 
likelihood that the required expertise and time required may not be feasible for healthcare 
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decision makers or implementers. Our belief is that this approach serves as a preliminary step 
to ensure all-important studies are catalogued while simultaneously including only the 
relevant evidence. Future work will be conducted to ascertain the sensitivity of the refined 
criteria in identifying pathway studies in primary care. 
Although it has been established in previous literature that CPWs are complex interventions, 
this information is not sufficient and useful for the development of an evidence base for 
CPWs in the international literature. There is variation in the terms used to depict a CPW, 
therefore referring to a CPW as a complex intervention without standardizing its elements 
only adds to complexity and confusion towards the attainment of a standard definition. The 
pilot test for the operational criteria and reliability analysis shows a significant high level of 
agreement among reviewers. This demonstrates that the resulting criteria have the potential to 
be clear and objective enough to permit further research relevant to the field of CPWs. This 
methodology may be refined and applied to similar fields also challenged with the issue of 
cataloguing and reviewing the evidence for complex health service interventions. 
Refining the working definition for a clinical pathway to encompass broader healthcare 
contexts can help generate and advance a positive discourse towards an internationally agreed 
definition for CPWs in healthcare. An internationally agreed definition for CPWs in 
healthcare can benefit researchers by ensuring the identification and inclusion of relevant 
literature for future CPWs syntheses. This step will also strengthen the internal and external 
validity of findings from future research and make appropriate policy recommendations that 
benefit patients and the health system. From a healthcare providers’ perspective, an 
internationally agreed definition for CPWs will alleviate the confusion among care providers 
on the components of a CPW. Also, this move will improve the shared understanding and 
goals of CPWs which is vital for care decision making processes to maximize clinical 
outcomes for patients.  
2.11 Conclusion 
Worldwide CPW implementation and usage in healthcare is on the rise. The lack of an 
agreed-upon definition of a CPW and what is not a CPW remains a significant challenge for 
many CPW researchers and clinicians. This paper describes the process of developing, 
refining, and pilot testing a set of criteria to be used for a practical operational definition for 
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CPWs in healthcare, following the Kinsman et al. (2010) [7] and Wieland et al. (2011) [16] 
approach. 
Future researchers considering the development, implementation, and evaluation of CPWs 
should adopt the developed definition or modify them to fit into their future research. This 
step will advance the discourse towards an internationally agreed-upon definition of what 
constitutes a CPW in healthcare and create a practical impact from a research, healthcare 
provider and patient standpoint.  
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 TRANSITION FROM CHAPTER 2 TO CHAPTER 3 
The refined operational definition for a clinical pathway provides a working definition to 
identify, catalog and appraise the clinical pathway literature. The following four criteria for 
an operational definition for a CPW includes:  
1. the intervention was a structured multidisciplinary plan of care;  
2. the intervention was used to translate guidelines or evidence into local structures;  
3. the intervention detailed the steps in the course of treatment or care in a plan, 
pathway, algorithm, guideline, protocol or other ‘inventory of actions’ (i.e., the 
intervention had time-frames or criteria-based progression);  
4. the intervention aimed to standardize care for a specific population. An intervention 
meeting all four-criteria was considered a CPW 
The next manuscript will use the refined operational definition to update a Cochrane 
systematic review and examine the effects of CPWs in hospitals.  
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CHAPTER 3: CLINICAL PATHWAYS FOR SECONDARY CARE AND THEIR 
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3.1 Abstract  
Background  
Clinical pathways are structured, multidisciplinary care plans used by health services to detail 
essential steps in the care of patients with a specific clinical problem. They aim to translate 
evidence into practice and optimize clinical outcomes, whilst maximizing clinical efficiency. 
This is the first update of the original Cochrane review by Rotter et al. (2010) guided by the 
study protocol from Rotter et al. (2007). 
Objectives  
To investigate the effect of clinical pathways (CPWs) on professional practice, patient 
outcomes, length of hospital stay, and costs in hospital settings, as compared to usual care. 
Search methods  
For this update, we searched the following databases from 7 August 2014 to 1 March 2017: 
Cochrane Central Register of Controlled Trials (CENTRAL) and bibliographic databases 
including MEDLINE, Embase, CINAHL, Amed, PsycINFO, HMIC, Cochrane-HTA, 
ClinicalTrials.gov, WHO ICTRP, Cochrane-NHS EED and Global Health. We also searched 
the reference lists of relevant articles. 
Selection criteria  
We included randomised trials, non-randomised trials, interrupted time series studies and 
controlled before-after studies. 
Data collection and analysis  
Two review authors independently screened all titles, abstracts and full text manuscripts to 
assess eligibility and methodological quality. We grouped and assessed studies according to 
those comparing clinical pathways with usual care and those comparing clinical pathways as 




Main results  
We identified 12 additional studies from the updated searches. Overall, 39 studies involving 
15,911 participants met the study inclusion criteria for final analysis. Thirty-two studies 
compared stand-alone clinical pathway intervention with usual care, and seven studies 
compared clinical pathways (as part of a multifaceted intervention) with usual care. Twenty-
eight studies focused on non-invasive clinical conditions. 
Stand-alone clinical pathway interventions 
Stand-alone CPWs interventions may reduce 90-day mortality in hospitals (odds ratio (OR) 
0.83, 95% confidence interval (CI) 0.62 to 1.12; 6 studies, 3828 participants; low-certainty 
evidence). Stand-alone CPWs interventions may reduce hospital readmissions up to six 
months (OR 0.74, 95% CI 0.48 to 1.15; 7 studies, 1391 participants; low-certainty evidence). 
Stand-alone CPWs may reduce in-hospital complications (OR 0.46, 95% CI 0.33 to 0.64; 7 
studies, 2012 participants; low-certainty evidence). Overall, it is uncertain if stand-alone 
CPW interventions reduce length of hospital stay (Mean difference (MD) -0.83 days 95% CI 
-1.21 to -0.45, 20 studies, 5782 participants; very-low certainty evidence). Stand-alone CPWs 
interventions may reduce hospital cost (MD USD -1171.52, 95% CI -1835.86 to -507.18; 7 
studies, 1264 participants; low-certainty evidence). Overall, it is uncertain if stand-alone 
CPW interventions improves adherence to recommended practice in hospitals (studies were 
not combined; very-low certainty evidence). 
Multifaceted clinical pathway interventions 
Statistical meta-analysis was not feasible for all the outcomes examined under this 
comparison group due to insufficient number of primary studies. Overall, it is uncertain if 
multifaceted CPW interventions reduce 90-day mortality (studies were not combined; very-
low certainty evidence). It is uncertain if multifaceted CPW interventions reduce hospital 
readmissions (studies were not combined; very-low certainty evidence). Multifaceted CPW 
interventions may reduce length of hospital stay (studies were not combined; low-certainty 
evidence). Finally, it is uncertain if multifaceted CPW interventions reduce hospital costs 
(studies were not combined; very-low certainty evidence) 
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Authors' conclusions  
The findings suggest that stand-alone clinical pathways may reduce in-hospital complications 
and hospital costs compared to usual care (low-certainty evidence). It is uncertain whether 
stand-alone clinical pathways reduce length of hospital stay because the certainty of evidence 
is very-low. Multifaceted clinical pathway interventions implemented in hospitals compared 
to usual care make little or no difference on hospital readmissions and length of stay (low-
certainty evidence). It is uncertain if multifaceted clinical pathway interventions reduce 90-
day mortality and hospital costs because the certainty of evidence is very-low. Future 
research should ensure the use of rigorous evaluation designs and report on implementation 
factors used during the pathway development. Also, economic evaluations of clinical 
pathways are needed to help healthcare mangers and policy makers make important decisions 
on the timing and level of implementation of clinical pathways. 
How up-to-date is this review? 




3.2.1 Description of the condition  
With continuous advocacy for patient-centered care by the public, health systems are 
continually faced with the task of delivering safe and high quality services to patients [62]. 
The adoption of clinical pathways worldwide is gradually on the increase and substantial 
resources have been expended on pathway development, implementation, and sustenance in 
hospitals [63]. However, individual studies investigating the impact of clinical pathways 
(CPWs) have reported conflicting outcomes [14]. Some studies found that the introduction of 
CPWs for different types of clinical conditions such as deep vein thrombosis [64], 
community acquired pneumonia [65] and septic shock [66] can reduce the length of hospital 
stay, while others such as Trombetti et al. (2013) [67] and Bernard et al. (2011) [68] found 
increased or no benefit regarding length of hospital stay for malnourished and diabetic 
patients respectively.  
Rigorous evaluation of the effectiveness of CPWs in hospitals and improved understanding 
of the reasons behind their success or failure, are necessary before additional resources are 
expended on developing and implementing more CPWs. There is limited research on theories 
underpinning how CPWs work in different healthcare contexts. Furthermore, there is paucity 
of information reported on successful implementation strategies for CPWs in different 
hospital settings. This information is needed to attribute the success or failure of a CPW to 
the implementation process used in the study [41]. 
3.2.2 Description of the intervention  
CPWs aim to link evidence to practice for specific health conditions and, therefore, optimize 
patient outcomes and maximize clinical efficiency [69].  For this review, CPWs are defined 
as structured multidisciplinary care plans which detail essential steps in the care of patients 
with a specific clinical problem [14]. They support the translation of clinical guidelines into 
local protocols and clinical practice [70]. Whilst clinical guidelines provide generic 
recommendations, CPWs detail the local structures, systems and time-frames to address these 
recommendations. With the myriad of terms used to describe a CPW, they are also referred to 
as 'integrated care pathways', 'critical pathways', 'care plans', 'care paths', 'algorithms' and 
'care maps' [15]. In addition to the support of evidence-based practice, CPWs have been 
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proposed as a strategy to optimize resource allocation in a climate of rising healthcare costs 
[71] as they may improve organizational efficiency [15]. 
3.2.3 Clinical pathway definition 
A three-stage process was undertaken to develop an operational (working) definition for a 
CPW. This process was described in the previous version of this review Rotter et al. (2010) 
[14]. Recently, the operational definition was refined following the rigorous approach 
suggested by Kinsman et al. (2010) [16] and Wieland et al. (2011) [72] to accommodate 
relevant literature on CPWs, spanning across a broader context of healthcare settings, 
including primary care [15]. Two review team members independently pilot-tested the new 
definition on 20 studies, randomly selected from the 26 included studies from the first version 
of this review [14]. LA served as an arbitrator to resolve any disagreement during this 
process.  
The pilot test generated 85% observed and 75% expected agreement, respectively, with a 
kappa statistic of 0.99 (P < 0.001), implying perfect agreement between the two review 
authors. The following four criteria for a CPW operational definition, derived from the 
refinement process described above, are (1) the intervention was a structured 
multidisciplinary plan of care; (2) the intervention was used to translate guidelines or 
evidence into local structures; (3) the intervention detailed the steps in a course of treatment 
or care in a plan, pathway, algorithm, guideline, protocol or other ‘inventory of actions’ (i.e. 
the intervention had time-frames or criteria-based progression); and (4) the intervention 
aimed to standardize care for a specific population. We considered an intervention meeting 
all four criteria to be a CPW [15]. 
3.2.4 How the intervention might work  
CPWs may serve as strategies to reduce variation in hospital practice by providing evidence-
based care recommendations. CPWs have the potential to reduce in-hospital complications, 
improve patient outcomes and enhance efficiency in the health system [14]. They are most 
commonly developed locally via consensus or adapting clinical practice guidelines and they 
interact with other contextual and behavioural factors to achieve desirable outcomes [73]. 
Even though CPWs are used as knowledge translation tools to provide best available 
evidence during an episode of care, there seems to be no coherent theory that adequately 
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explain how they work in practice settings [74, 75]. To date, there has been limited research 
focused on understanding the mechanisms through which CPWs work [76]. Because CPWs 
are multidisciplinary and have multifaceted components, contextual factors must be 
considered during their implementation [77]. Several theories to explain the normalization of 
new knowledge into practice have been identified in the literature [75, 78]. These theories are 
broadly classified into (1) individual related theories: cognitive theories [79], educational 
theories [79], and motivational theories [79]; and (2) social interaction and context theories: 
theories of communication [79], social learning theory [79], team work theories [79], 
leadership theories [79], theory of organizational learning and culture [79], complexity theory 
[79], and economic theories [79].  
Behavioural change theories emphasizes the incorporation of patient and healthcare 
professionals' perspectives about existing care standards to facilitate optimum adherence of 
the pathways [79]. The outcomes of CPW implementation may be most easily detected when 
prior compliance to clinical standards has been poor, as this leaves potential for substantial 
improvements. In contrast, CPW implementation in settings demonstrating already highly 
compliance have detected little or no improvement [39]. CPWs may help to overcome the 
barrier of updating clinical standards in a practice area that is not feasible for individual 
healthcare professionals. Organizational theories may provide insights into critical elements 
from a macro health systems perspective that are required for change and sustainability 
processes (e.g. barriers to change, organizational culture, vision, and focus). 
3.2.5 Why it is important to do this review  
This review is part of a series of Cochrane systematic reviews of CPWs, to investigate their 
effects on professional practice, patient outcomes, length of hospital stay, and hospital costs. 
This review focuses on the effects of CPWs in hospitals and updates a previous Cochrane 
Review [14]. The conduct of this update was supported by the Saskatchewan Health 
Research Foundation. The previous version of this Cochrane Review included 26 studies that 
met the inclusion criteria at that time from eight countries (Australia, Canada, Japan, Norway, 
Taiwan, Thailand, UK, and USA). Despite the limitations, the systematic review by Rotter et 
al. (2010) concluded that clinical pathways are associated with reduced in-hospital 
complications and improved adherence to recommended practice without negatively 
impacting on length of hospital stay and hospital costs. 
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In recent years, there has been a gradual rise in the uptake of CPWs in healthcare contexts, 
but the evidence regarding their effects are remains inconclusive [37]. In addition to the 
absence of a standardized definition, heterogeneity in CPW implementation strategies, 
evaluation approaches, selected outcomes and study design contribute to equivocal findings 
on effectiveness [15]. A thorough understanding of the implementation process is critical to 
the success or failure of CPWs in the healthcare environment. This updated Cochrane 
systematic review aims to rigorously investigate the effects of clinical pathways in hospital 
settings, especially on professional practice, patient outcomes, length of hospital stay, and 
hospital costs. It also aims to improve our understanding of implementation strategies that 
may contribute to the effectiveness of CPWs in various practice settings. 
3.3 Objectives  
To investigate the effect of clinical pathways on professional practice, patient outcomes, 
length of hospital stay, and costs in hospital settings compared to usual care. 
3.4 Methods  
Criteria for considering studies for this review  
3.4.1 Types of studies  
Following the Effective Practice and Organisation of Care (EPOC) methodological design 
criteria, we included randomised trials, cluster-randomised trials, non-randomised trials, 
controlled before-after studies, and interrupted time series studies [52]. 
Controlled before-after studies are experimental studies with at least two intervention sites 
and two control sites without randomization during the allocation process [52]. Data are 
collected from the control and intervention groups before the intervention is introduced and 
then further data are collected after the intervention has been introduced. We reassessed all 
controlled before-after studies from the 2010 review to ensure they met the current EPOC 
standards for controlled before-after studies for this updated review. 
For non-randomised trials, participants are allocated to different groups by investigators in a 
non-random fashion. They may pose a greater risk of bias compared to the randomised trials 
[52]. We reassessed the non-randomised trials from the 2010 review to ensure they included 
at least two intervention sites and two control sites in this updated version. 
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Interrupted time series studies represent a robust method of measuring the effect of an 
intervention as a trend over time; it is a useful design when recruitment of a control cohort is 
impractical, for example, change in hospital policy. Three or more data points are collected 
before and after the intervention as a minimum standard and the intervention effect is 
measured against the pre-intervention trend [52].  
3.4.2 Types of participants  
We considered two groups of participants relevant for this review. 
• Health professionals, including doctors, nurses, physiotherapists, pharmacists, 
occupational therapists, social workers, dietitians, psychologists, psychiatrists, speech 
pathologists, and dentists involved in CPW utilization in the hospital setting. 
• Hospitalized patients (inpatient and outpatient settings) with clinical conditions managed 
using a CPW, irrespective of diagnosis. 
 
3.4.3 Setting 
We included studies conducted in hospitals evaluating the impact of CPWs. 
 
3.4.4 Types of interventions  
The interventions included in this review are clinical pathway interventions that met the 
working definition described earlier under the section “clinical pathway definition”. We 
included clinical practice guidelines that were tailored to a local context. For analysis, we 
included two comparisons: 
• Stand-alone clinical pathway versus usual care. 
• Multifaceted interventions including a clinical pathway versus usual care. 
We expected that most studies would compare a clinical pathway intervention with usual care 
in the same setting. We included studies of multifaceted interventions if the clinical pathway 
aspect could be separately assessed from other elements of the intervention. For example, a 
multifaceted intervention that included the introduction of a case management model, 
professional education, introduction of a clinical pathway and structural change, such as the 
introduction of information technology support with the aim being to enhance evidence-based 
practice. In such an instance, we included studies in which a multifaceted intervention 
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incorporating a clinical pathway was compared to the same intervention without a clinical 
pathway element. 
3.4.5 Types of outcome measures  
Based on our experience with the previous review by Rotter et al. (2010) [14], we expect to 
find variation in the range of follow-up and criteria used for assessing outcomes in the 
included studies. Thus, we included all objectively measured outcomes. 
Primary outcomes:  
• 90-day mortality 
• Hospital readmission (up to 6 months) 
• In-hospital complications 
Secondary outcomes:  
Patient outcomes 
• Length of hospital stay 
• Hospital costs and charges 
• Adherence to recommended practice 
For this review, we define invasive procedures as medical procedure that penetrates the body, 
usually by puncturing the skin or inserting instruments into the body [80].  
3.5 Search methods for identification of studies 
Electronic searches  
We searched the following databases with no language restrictions from August 2008 to 
March 2017: 
1. The Cochrane Central Register of Controlled Trials (CENTRAL). 
2. Bibliographic databases, including MEDLINE, Embase, CINAHL, HMIC, Amed, 
Cochrane-NHS EED, and Cochrane-HTA. 
3. Cochrane Database of Abstracts of Reviews of Effectiveness (DARE) was searched for 
related reviews. 
We searched electronic sources using a strategy developed incorporating the methodological 
component of the EPOC search strategy combined with selected MeSH terms and free text 
terms relating to clinical or critical pathways. This search strategy was translated into the 
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other databases using the appropriate controlled vocabulary as applicable. The MEDLINE 
search strategy is provided in Appendix 1. 
Searching other resources  
Grey literature 
• Web of Science (www.webofknowledge.com). 
• OpenGrey (www.opengrey.eu). 
Trial registries 
• The Word Health Organization (WHO) International Clinical Trials Registry Platform 
(ICTRP) search portal (apps.who.int/trialsearch). 
• ClinicalTrials.gov (clinicaltrials.gov) 
In addition to databases, we searched other resources for published and unpublished studies. 
1. We hand searched high-yield journals and conference proceedings which had not already 
been hand searched on behalf of the Cochrane Collaboration. 
2. We reviewed reference lists of all papers and relevant reviews identified. 
3. We contacted authors of relevant articles regarding any further published or unpublished 
work. 
4. We contacted researchers with expertise relevant to the review topic for other studies. 
3.6 Data collection and analysis  
Selection of studies  
We imported the search results into our reference management software and removed 
duplicate records. Three pairs of review authors (SS and CP), (LK and PW), and (AM and 
UR) independently screened all titles and abstracts for manuscripts eligible for full-text 
assessment. We resolved any disagreement by discussion or with a third author who served as 
an arbitrator (TR). Two review authors (AL and CP) independently assessed all full text 
studies with the review inclusion criteria and resolved disagreements by discussion or with 
the use of an arbitrator (TR). 
Data extraction and management  
We extracted data using a modified standardized data extraction form based on the Cochrane 
EPOC Group's data collection checklist [81], created with Microsoft Access and extracted 
directly from trial reports. We retrieved the full text copies of all potentially relevant papers 
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identified during the titles and abstract phase. We sent non-English studies for translation 
through the EPOC editorial base to examine eligibility for inclusion in the final review. Two 
review authors (AL and CP) independently extracted information. When necessary, we 
sought additional information on study characteristics, study design, intervention types and 
outcomes reported from the authors of primary studies. We recorded details on the number of 
retrieved references, the number of obtained full text papers and the number of included and 
excluded studies (Figure 3-1). We managed this data in Clarivate Analytics Endnote [82]. We 
imported all extracted data into Review Manager 5 for further analysis [83]. 
Assessment of risk of bias in included studies  
Two review authors (AL and CP) independently assessed the risk of bias of included studies, 
any disagreements were referred to a third review author (TR). We used the nine-point 
criteria from the Cochrane EPOC group for assessing risk of bias in randomised trials, non-
randomised trials, and controlled before-after studies: allocation sequence generation; 
allocation concealment; baseline outcome measurements; baseline characteristics; incomplete 
outcome data; knowledge of allocated interventions; protection against contamination, 
selective outcome reporting; other risks of bias [84]. For interrupted time series studies, there 
are seven criteria: intervention independent of other changes; pre-specified effect shape; 
intervention unlikely to affect data collection; blinding; incomplete outcome data; selective 
outcome reporting; other bias [84]. We rated each component and categorized it in a 'Risk of 
bias' table as 'low risk', 'unclear risk', or 'high risk', as described in the Cochrane Handbook 
for Systematic Reviews of Interventions [85]. We did not exclude any study based on risk of 
bias. We earmarked studies given an overall rating of "high risk" and "unclear risk" for 
sensitivity analysis order to examine their influence on the pooled effect estimates. 
Measures of treatment effect  
We reported all data in natural units. In the case of missing standard deviations, we undertook 
the appropriate transformation. For continuous outcome measures, we reported a summary 
effect size and the weighted mean difference (WMD) with corresponding 95% confidence 
intervals (CIs). Additionally, we estimated a standardized mean difference (SMD) and 
summary effect size for outcomes with different scales. For dichotomous data, we calculated 
an absolute crude event rate (risk difference, RD) or odds ratio (OR). Where applicable, we 
calculated the crude event rate (risk ratio, RR) for all outcomes and included the P-values as 
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reported by the study authors. We performed all analyses using Review Manager 5 [83]. To 
assess the effects of CPWs based on the type of hospital intervention provided to the patient, 
we defined and categorized invasive procedures as hospital interventions that require an 
opening of the skin tissue, for example surgery and vice versa for non-invasive procedures. 
Unit of analysis issues  
To avoid unit of analysis error in cluster-randomised trials, we applied an intracluster 
correlation coefficient (ICC) to calculate the effective sample size and account for the impact 
of clustering on the statistical power of the study [86]. We re-calculated cluster-randomised 
trials that did not account for clustering with respect to the number of participants per group 
also called “computing an effective sample size” with an estimate of an ICC taken from a 
ICC database of the University of Aberdeen [87]. Where possible, we selected a similar 
intervention with comparable study characteristics reporting an ICC.  
Dealing with missing data  
If a primary study did not provide information about standard deviation and P values, we 
used the approximate or direct algebraic connection between the stated confidence intervals, 
or P values, and the standard deviation and calculated the inverse transformation to the 
individual or pooled standard deviation [85]. In other instances, we attempted to contact the 
primary author for additional information. 
Assessment of heterogeneity  
Owing to the variation in practice settings, clinical conditions examined, and the focus of the 
CPW intervention, we envisaged clinical, statistical and methodological heterogeneity. We 
assessed statistical heterogeneity using the Chi² test using P < 0.10 and quantified statistical 
heterogeneity using the I² statistic. The review team decided that pooled estimates with an I² 
statistic value greater than 60% would be considered to have substantial statistical 
heterogeneity [85]. We also assessed statistical heterogeneity in the results of each meta-
analysis by visual inspection of the forest plots [85]. 
Assessment of reporting biases  
We assessed potential publication bias in the results of each meta-analysis by visual 
inspection of funnel plots and for individual studies [85]. 
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Data synthesis  
Previous studies (including EPOC reviews) have demonstrated that implementation of 
interventions to improve professional practice benefit from being multifaceted and including 
the following features: 1) evidence-based content; 2) adaption for local use; 3) clinician 
involvement in CPW development; 4) use of an implementation team; 5) evidence-practice 
gap identification prior to implementation; 6) identification of potential barriers to change; 7) 
incorporation of reminder systems; 8) incorporation of audit and feedback into 
implementation; 9) use of education sessions, and 10) use of local opinions leaders as part of 
the process [88-92]. 
For this update review, we applied this 10-criteria checklist for implementation strategies of 
complex interventions to all included studies. We extracted relevant information on the 
implementation strategies for implementing CPWs, as reported in the primary studies. 
Further, we ranked each study based on an overall implementation score with an equal weight 
applied to each criterion on the checklist. A study ranked 'high' if seven or more 
implementation strategies were used, 'medium' if four to six implementation strategies were 
used and 'low' for up to three implementation strategies reported in the primary study.  
We followed the EPOC recommendation regarding re-analysis of individual studies and data 
synthesis. We presented the description of included studies and the certainty of evidence in a 
tabular format for each type of outcome using Summary of findings table 1, Summary of 
findings table 2 and assessed the effects of the included studies, based on the quality, size 
and direction of effect observed. We used a random-effects model meta-analysis to 
statistically combine similar studies. Where meta-analysis was not applicable due to 
dissimilar measures reported by individual studies, we reported the average effect size using 
plain language summaries as appropriate. 
We considered reported hospital cost data as indirect costs, as full costing approaches and 
hospital charges. There was insufficient reported data to synthesize full economic 
evaluations. We updated the cost/charges effects of CPWs (cost/charges analysis), but not the 
cost-effectiveness, for all studies that report on cost measures. Cost/charges data is presented 
in USD for the common price year 2016 by using the "CCEMG-EPPI-Centre Cost 
Converter" (Version 1.5), a web-based tool that can be used to adjust an estimate of cost 
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expressed in one currency and price year to a target currency and, or price year, or both [93]. 
We adjusted costs/charges for inflation by applying Gross Domestic Product deflators 
('GDPD values') or using government recommended rates [94]. Additionally, we have 
provided the costing method and the undiscounted cost data to allow readers to recalculate 
the results using any discount rate (Appendix 2). 
Three studies utilized interrupted time series design [95-97]. All three met minimum criteria 
including number of points pre- and post-intervention, and the utilization of appropriate 
models. Owing to the disparate nature of outcomes reported by the interrupted time series 
studies, we presented the results from individual studies in a narrative format. For interrupted 
time series data presented in a graphical format, we extracted data using the plotdigitizer 
software recommended by EPOC [98]. We saved each graph as a JPEG file and opened via 
the plotdigitizer software and the raw data was extracted by dragging the cursor over each 
data point. 
Summary of findings 
Two review authors (AL and CP) independently assessed the certainty of the evidence (high, 
moderate, low and very-low) using the five GRADE considerations (risk of bias, consistency 
of effect, imprecision, indirectness, and publication bias) as described in Guyatt et al. (2008) 
[99]. We created two 'Summary of findings' tables for the two main comparisons examined in 
this review (Summary of findings table 1 and Summary of findings table 2) and, included the 
primary outcomes and all patient important outcomes: 90-day mortality, hospital readmission 
up to six months, in-hospital complications, length of hospital stay, hospital costs, adherence 
to recommended practice. 
Subgroup analysis and investigation of heterogeneity  
To explore trends that may explain the observed variation in the pooled estimates of the 
included studies, we conducted subgroup analysis and reinvestigated heterogeneity based on 
the country where the studies were conducted, the conditions for which the pathway was 
designed, study year and settings where the CPWs were implemented. 
Sensitivity analysis  
We conducted sensitivity analysis, where feasible, based on the risk of bias inherent in the 
included studies. To examine the robustness of the pooled estimates, we compared the 
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computed effect estimates of the pooled outcomes when we retained studies rated at high and 
unclear risk of bias in the meta-analysis plots, with pooled estimates generated by only 
including studies rated at low risk of bias alone. 
3.7 Results  
Description of studies  
See: table 3-1 for Characteristics of included studies. 
3.7.1 Results of the search  
The search from 2008 up to March 1, 2017 yielded 14,888 records. We excluded 14,764 
records upon review of the titles and abstracts. We screened the remaining records by 
reviewing 100 full text papers and included 12 studies. Two articles [25, 100] from the 
published 2010 review were reported in duplicate and have been combined into one [25] for a 
total of 26 studies. Overall 39 studies are included in this review update. See Figure 3-1 for 
PRISMA flow chart.   
 
Figure 3-1: PRISMA study flow chart 
 
 39 
3.7.2 Included studies  
In total, thirty-nine studies met the inclusion criteria for the definition of a CPW and 
methodological quality for this update. Twenty-seven studies had been included in the 
previous version of the review [14]. See table 3-1 below for characteristics of included 
studies. 













type  Country 
Overall 
risk of bias 
Comparison 1: single CPW intervention versus usual care 
Aizawa 2002 TURP Surgical / Urology unit Acute 69 P-RCT Japan 
Unclear 
risk 
Brook 1999 Mechanical ventilation Medical ICU ICU 321 P-RCT USA Low risk 
Bernard 2011 Type 2 Diabetes Mellitus Emergency Department ED 176 P-RCT USA Unclear risk 
Bittinger 1995 Heart Failure ICCU and Medical unit Acute 30 P-CRT USA High risk 
Carratala 2012 Community Acquired Pneumonia Emergency Department ED 401 P-RCT Spain High risk 
Chadha 2000 
Menorrhagia and urinary 
incontinence 
Gynaecological 
unit Acute 946 CBA UK High risk 
Choong 2000 Femural neck fracture Orthopaedic unit Acute 111 NRCT AUS 
Unclear 
risk 
Costantini 2014 End of life care End of life ward Extended care 308 C-RCT Italy High risk 
Cunningham 
2008 Asthma Emergency Department ED 251 C-RCT UK High risk 
Delaney 2003 
Laparotomy and Intestinal 
Resection Rehabilitation 
Extended 
care 64 P-RCT USA High risk 
Doherty 2006a Asthma care 
Medical units of the 
hospitals Acute 187 CBA AUS High risk 
Dowsey 1999 Hip and knee arthroplasty Orthopaedic unit Acute 163 P-RCT AUS 
Unclear 
risk 
Doig 2008 Malnutrition ICU ICU 1118 C-RCT AUS/NZ Low risk 
Falconer 1993 Stroke Rehabilitation Stroke Rehabilitation 
Extended 
care 121 P-RCT USA 
Unclear 
risk 
Gomez 1996 Suspected MI 
Coronary Care unit/ 
Chest pain evaluation 
unit Acute 100 P-RCT USA High risk 
Johnson 2000 Asthmatic children 
Emergency and 
Paediatric wards Acute 110 P-RCT USA High 
Kim 2002 Atrial fibrillation Emergency Department ED 18 P-RCT USA 
Unclear 
risk 
Kinsman 2012 MI Emergency Department ED 115 C-RCT AUS Low risk 
Kiyama 2003a Gastrectomy Surgical ward Acute 85 P-RCT Japan 
Unclear 
risk 
Kollef 1997 Mechanical ventilation Medical & Surgical ICU ICU 357 P-RCT USA Low risk 
Marelich 2000 Mechanical ventilation Medical ICU ICU 253 P-RCT USA Low risk 
Marrie 2000 Pneumonia Emergency Department Acute 1743 C-RCT Canada 
Unclear 
risk 
Panella 2009 Heart Failure Medical Unit Acute 429 C-RCT Italy Unclear risk 
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ProCess 2014 Septic shock Emergency Department ED 895 P-RCT USA Low risk 
Roberts 1997 CPW Chest Pain/ possible MI 
Emergency/ telemetry 
observational units ED 165 P-RCT USA 
Unclear 
risk 
Rotter 2014 Radical laparoscopy prostatectomy Surgical ward Acute 254 ITS Germany Low risk 
Smith 2004 CPW COPD Medical Units Acute 1230 CBA AUS High risk 
Sulch 2002 Stroke Rehabilitation Stroke Rehabilitation 
Extended 




Identification of battered 
woman Emergency Department ED 892 ITS USA High risk 
Trombetti 2013 Malnutrition Medical Unit Acute 694 P-RCT Switzerland Unclear risk 
Usui 2004 Pneumonia 
Medical Units/ 
respiratory medicine Acute 61 NRCT Japan High risk 
Verdu 2009 DVT Medical Unit Acute 88 NRCT Spain High risk 
Comparison 2: Multifaceted intervention including a CPW versus usual care 
Bauer 2006 Bipolar disorder 
Mental health outpatient 
clinic VAMC Other 306 P-RCT USA Low risk 
Bookbinder 
2005 Palliative care Palliative Care 
Extended 
care 267 CBA USA High risk 
Brattebø 2002 Mechanical ventilation Surgical ICU ICU 285 ITS Norway Low risk 




Care of delirium in older 
medical patients Medical units Acute 227 P-RCT Canada Low risk 
Kampan 2006 
Diabetic patients admitted 
with hypoglycaemia Medical unit Acute 65 P-RCT Thailand 
Unclear 
risk 
Philbin 2000 Patients with heart failure Medical Units Acute 2906 C-RCT USA 
Unclear 
risk 
P-RCT = patient randomised clinical trial; C-RCT = cluster randomised clinical trial; NRCT = non-randomized controlled trial; CBA = 
controlled before-after study; ITS = interrupted time series; USA = United States of America; UK = United Kingdom; AUS = Australia; 
NZ =New Zealand; DVT= deep vein thrombosis; TURP = transurethral resection of the prostate; MI = myocardial infarction; COPD = 
chronic obstructive pulmonary disease; Acute = General acute hospital; ICU = Intensive care unit; ED = Emergency department; 
Extended care = Rehabilitation or palliative facilities; Other = Psychiatric or mental health clinic/ hospital; ICCU = intensive coronary 
care unit 
 
3.7.3 Study designs 
From the 2010 review, nineteen of the included studies were randomised trials [23, 25, 26, 
101-115] four were controlled before-after [116-119], two were non-randomised trials [120, 
121] and two were interrupted time series studies [95, 96]. Out of the nineteen randomised 
trials, two were cluster-randomised trials [113, 114]. The review update resulted in the 
inclusion of twelve additional studies with ten randomised trials [65-68, 122-127] in which 
five were C-RCT [122-126], one non-randomised trial [64] and interrupted time series study 
[97] each. 
 
3.7.4 Clinical conditions 
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Included studies targeted a wide range of conditions. Across the 39 studies, there were 25 
(64%) different conditions targeted. Chest pain [23], mechanical ventilation [102, 111, 112], 
stroke rehabilitation [25, 26], asthma [107, 118, 123]), congestive heart failure [125, 127] and 
pneumonia [65, 113, 121] was examined in more than one study. See Appendix 2 for 
information on all included pathway conditions or clinical indications. 
3.7.5 Country 
Sixteen studies (41%) were conducted in the United States [23, 26, 66, 68, 96, 102, 104, 106, 
107, 109, 112, 114-116, 127], five (13%) in Australia [105, 118, 120, 126, 128], three (8%) 
in Japan [101, 110, 121], three (8%) in the United Kingdom [25, 117, 123]), two (5%) in each 
of: Canada [113, 129], Italy [125, 130] and Spain [64, 65].  One (3%) study each in Germany 
[97], Thailand [108], Taiwan [103], Norway [95] and Switzerland [67]. One (3%) study [124] 
was conducted in two countries (New Zealand and Australia). 
3.7.6 Setting 
The settings of the studies were extracted and recorded into one of five categories 
representing various areas of the hospital. Nineteen studies (49%) were conducted in a 
general acute ward (for example medical, surgical, pediatrics, gynecology) [23, 64, 97, 101, 
103, 105, 107, 108, 110, 113, 114, 117-121, 125, 129], five (13%) in an extended stay facility 
(for example rehabilitation or palliative care, end of life) [25, 26, 104, 116, 122], Six (15%) 
in an ICU [95, 102, 111, 112, 124, 127], eight (21%) studies were conducted in the 
emergency department (ED) [65, 66, 68, 96, 109, 115, 123, 126], and one (3%) [106] in 
another area (mental health outpatient clinic). 
In ten (26%) studies, the CPW was designed for an invasive procedure [95, 97, 101, 102, 
104, 105, 110-112, 120]. Twenty seven (69%) studies [24-26, 64-68, 96, 103, 106-109, 113-
116, 118, 121-124, 126-129] described CPWs for a non-invasive diagnosis (for example 
diabetes, stroke, asthma, deep vein thrombosis, sepsis) and two (5%) studies [23, 117] 
described CPWs for combined invasive / non-invasive procedures (for example, suspected 
myocardial infarction with or without percutaneous transluminal coronary angioplasty). 
To improve comparability, we categorized the studies into two groups: 
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(1) Those describing patients managed with a CPW compared to usual care. 
(2) Those describing patients managed within a multifaceted intervention including a CPW 
compared to usual care. 
For this review update, all twelve additional studies identified compared stand-alone CPW to 
usual care. Overall, thirty two (82%) studies compared a stand-alone CPW to usual care [23, 
25, 26, 64-68, 96, 97, 101, 102, 104, 105, 107, 109-113, 115, 117, 118, 120-126, 128] and 
seven (18%) studies [95, 103, 106, 108, 114, 116, 129] compared a multifaceted intervention 
(including a CPW) to usual care. We did not identify further studies which combined the 
CPW with other interventions (multifaceted interventions). Multifaceted pathway 
interventions were combined with case management elements [103, 106, 108, 116, 129] or 
with complex quality improvement programs [114, 116]. Other investigators used single 
pathway interventions together with counselling methods [106, 108, 114, 116] or in 
conjunction with external providers such as primary care or extended care agencies [106, 
114]. Further multifaceted strategies include posters [95], physician order sheets [116] and 
reminders by the study nurse [129]. 
3.8 Outcomes 
3.8.1 Patient outcomes 
Objectively measured patient outcomes reported by included studies comprised of 90-day 
mortality [25, 65-67, 102, 111, 124, 128], hospital readmissions up to six months [23, 65, 
101, 115, 120, 125], and in-hospital complications [65, 66, 101, 104, 105, 110, 112, 120]. 
3.8.2 Utilization, coverage and access: Length of stay (LOS) 
LOS was calculated and reported as total length of hospital stay in hours or in days from 
admission until discharge. However, one study calculated LOS from the day of surgery to the 
day of discharge [110]. Most of the included studies predefined LOS as an outcome indicator 
and a surrogate for hospital costs. We present the length of hospital stay data in days. 
3.8.3 Resources use: Hospital costs 
Hospital costs data were reported as direct or indirect hospital costs in USD, Japanese JEN, 
EUROS, and Thailand’s BAHT. Hospital charges were reported in USD or country specific 
insurance points (See 'types of outcome measures' section for a brief description of the 
differences between costs, charges, and insurance data). Within this highly variable set of 
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cost measures reported, a direct costing approach (e.g., treatment costs as direct costs were 
included in the cost estimates; time cost or lost wages and other indirect costs were not) was 
used by two studies [106, 109], excluding professional fees in both USA settings. One study 
[110] included direct costs and professional fees. For this update, hospital cost was reported 
by two studies [131, 132]. Panella et. al (2009) reported on direct hospital costs and Verdu et. 
al (2009) used cost estimates (cost-efficiency indicators) to assess the effects of CPWs on 
hospital cost. Direct and indirect cost were included in the cost estimates reported in two 
studies [115, 133] although it was unclear which costing method was used and which costs 
were included (i.e. professional costs) in the Kampan et al (2006) study. Hospital charges in 
USD was reported as median hospital charges by Falconer et al. (1993) [26] and as mean 
hospital charges by three studies [23, 107, 114]. A surrogate for hospital charges in the form 
of insurance points was reported in two Japanese investigations [101, 121]. Because of the 
different methods used for generating hospital costs and the highly differing cost outcomes 
included in this review update (hospital costs, charges and insurance data), we presented an 
overview of the costing method used and which costs/charges were in- and excluded from the 
calculations in tabular form (Appendix 2). 
3.8.4 Quality of care: Adherence to recommended practice 
The only quality of care measure is adherence to recommended practice by healthcare 
professionals using a clinical pathway for the management of patient's clinical condition. For 
this review, we measured adherence to recommended practice by the proportion of 
documentation performed by healthcare professionals while using CPWs for patient 
management in hospital settings. 
3.8.5 Other outcomes 
We did not find any study reporting on other planned outcomes such as ICU admissions, 
discharge destination, staff satisfaction and time to mobilization post-surgery.  
See Appendix 2 for tabular description of all outcomes reported by the primary studies. 
3.9 Implementation Process 
The process for developing and implementing the CPW was extracted and recorded 
according to whether evidence-informed strategies had been utilized. Overall six (15%) 
studies [95, 103, 106, 116, 124, 126] were scored as having a "high" implementation score, 
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20 (51%) studies [24-26, 64, 68, 96, 97, 101, 104, 105, 107, 111, 112, 114, 117, 118, 122, 
123, 128, 129] were scored as having a "medium" implementation score and 12 (31%) 
studies [23, 65-67, 102, 108-110, 113, 115, 120, 121] were scored as having a "low" 
implementation score. The most frequent implementation strategy utilized was clinician 
involvement during the CPW development (31 studies). The use of an implementation team, 
identification of evidence-practice gaps prior to implementation and the use of educational 
sessions were each reported in 23 (59%) studies. Audit and feedback was reported in 15 
(38%) studies, use of local opinion leaders was reported in 14 (36%) studies, incorporation of 
reminder systems was reported in 12 (31%) studies and the identification of potential barriers 
to change was reported in eight studies. Full details of all Implementation strategies reported 
in all included studies are presented in Table 3-2. 
Table 3–2. Implementation strategies reported in included studies 
































Y Y - - - Y - N Low 
Bauer 2006 Y Y Y Y Y Y Y Y High 
Bernard 
2011 
Y Y Y N N N Y N Moderate 
Bittinger 
1995 
Y Y - N N N Y Y Moderate 
Bookbinder 
2005 
Y Y Y Y Y Y Y - High 
Brattebø 
2002 
Y Y Y Y Y Y Y - High 
Brook 1999 Y - Y - - - - - Low 
Carratala 
2012 
- N N N N N Y N Low 
Chadha 
2000 
Y Y - - Y N Y Y Moderate 
Chen 2004 Y Y Y Y - Y Y Y High 
Choong 
2000 
Y - - - - - - - Low 
Cole 2002 Y Y Y - - Y Y - Moderate 
Costantini 
2014 
Y Y Y N N N Y Y Moderate 
Cunningham 
2008 
Y - Y N - Y Y Y Moderate 
Delaney 
2003 
Y Y - Y - Y - - Low 
Doherty 
2006a 
Y Y Y Y Y N - - Moderate 
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Doig 2008 Y Y Y N Y Y Y Y High 
Dowsey 
1999 
Y - - - Y Y - Y Moderate 
Falconer 
1993 
Y Y N - - Y Y - Moderate 
Gomez 1996 Y - Y - - - - - Low 
Johnson 
2000 
Y Y - - N N Y Y Moderate 
Kampan 
2006 
- Y - - - Y - - Low 
Kim 2002 - - Y - - - - - Low 
Kinsman 
2012 
Y Y Y N Y Y Y Y High 
Kiyama 
2003a 
- - Y - - - - - Low 
Kollef 1997 N - - - Y N Y Y Low 
Marelich 
2000 
Y Y - - Y - - - Low 
Marrie 2000 - - - - Y - - - Low 
Panella 2009 Y Y Y N N N Y Y Moderate 
Philbin 2000 Y Y - - - Y Y - Moderate 
ProCess 
2014 
Y Y - N N N N N Low 
Roberts 
1997 
Y - Y - - - - - Low 
Rotter 2014 Y N Y N N N Y Y Moderate 
Smith 2004 Y Y Y - - Y Y - Moderate 
Sulch 2002 Y - Y Y - - Y Y Moderate 
Tilden 1987 - Y Y - Y - Y - Moderate 
Trombetti 
2013 
- - - N N N N N Low 
Usui 2004 Y - - - - - - - Low 
Verdu 2009 Y Y Y N N N Y N Moderate 
 
3.10 Excluded studies  
57 excluded studies did not meet the Cochrane EPOC minimal inclusion criteria for study 
designs; the controlled before-after study and non-randomised trials lacked two control and 
two intervention groups respectively. 19 excluded studies did not meet the CPW content 
criteria used in this review (see types of interventions for additional information) and 10 
studies were not conducted in hospital settings. 
3.11 Risk of bias in included studies  
3.11.1 Allocation (selection bias)  
17 of the 39 studies (44%) adequately described the random sequence generation during 
intervention allocation and were at low risk of bias. Random sequence generation was not 
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used in seven studies [64, 110, 116, 117, 120, 121, 128] and was considered unclear in 15 
studies (39%). 
Allocation concealment was undertaken in 14 studies (36%), unclear in 20 studies (49%) and 
was not present in six studies [64, 116, 117, 121, 123, 128]. 
3.11.2 Baseline outcome measurements 
Baseline outcomes were similar between the CPW group and usual care in 14 studies [65, 67, 
68, 107, 111, 113, 114, 117, 123, 125, 127, 128], it was unclear whether measurements were 
similar in 27 studies (64%). 
3.11.3 Baseline characteristics 
Baseline characteristics for the CPW and usual care groups were similar in 31 studies (80%) 
and unclear in four studies (13%). There were differences in the baseline characteristics 
between the CPW group and usual care group in three studies [104, 117, 121]. 
3.11.4 Intervention independent of other changes 
The implementation of a CPW in the hospital was independent of other changes in one study 
[97] and unclear in one study [95]. Due to the presence of other factors (media regarding 
topic, hospital push for improved charting), the intervention was not independent of other 
changes in one study [96]. 
3.11.5 Shape of intervention effect prespecified 
Prespecification of the intervention effect was provided in one study [97] and unclear in the 
remaining two studies [95, 96]. 
3.11.6 Intervention unlikely to affect data collection 
Sources and methods of data collection were the same before and after the intervention in all 
the three interrupted time series studies [95-97]. 
3.11.7 Incomplete outcome data (attrition bias)  
Outcome data was complete in 27 studies (69%), and unclear in nine studies (26%). Loss to 
follow up of more than 20% occurred in two studies [64, 127]. 
3.11.8 Knowledge of the allocated intervention prevention 
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The use of objective outcomes or blinding of the assessment of the primary outcome 
variables was achieved in 23 studies of the 39 studies. Blinding of the primary outcome 
variables was not present in nine studies [24, 25, 104, 114, 116, 117, 122, 123, 126] and 
unclear in six studies (18%).  
3.11.9 Protection against contamination 
There was a low risk of contamination of the intervention between the CPW and usual care 
group in 17 studies (45%). Eight studies [23, 66, 68, 101, 102, 106, 116, 123] were judged as 
having a high risk from contamination of health professionals and contamination was unclear 
in 13 studies (36%). 
3.11.10 Selective reporting  
The risk of selective reporting was low in most studies (add number of studies and 
references). In eight studies [96, 103, 110, 113, 115, 116, 118, 121] some outcomes listed in 
the methods section were missing in the results or incompletely reported in the study. 
3.7.11 Other potential sources of bias  
Six studies [23, 96, 107, 113, 116, 127] reported the influence of extraneous variables such as 
cultural and leadership styles, exposure to other educational offerings, healthy worker effect 
and data entry errors. Other potential source of bias was unclear in 11 studies (31%). Figure 
3-2 depicts the risk of bias across included studies. 
Figure 3-2: Risk of bias graph: review authors' judgements about each risk of bias item 
presented as percentages across all included studies. 
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3.12 Effects of interventions  
See below for Summary of findings table 1 and Summary of findings table 2 for the main 
comparisons; patient outcomes (90-day mortality, hospital readmissions up to six months, in-
hospital complications), LOS, hospital costs and adherence to recommended practice. See 
Appendix 3 for all data analysis and meta-analyses on comparable studies reporting on the 
primary and secondary outcomes. We also provided the data collection form used for this 
review update in Appendix 4. 
Table 3–3. Summary of findings table 1 
Stand-alone clinical pathways compared to usual care 
Patient or population: hospitalised patients 
Setting: hospitals 
Intervention: stand-alone clinical pathway 
Comparison: usual care 
Outcomes Anticipated absolute 


























analysis: OR 0.83 
(95% CI 0.62 to 
1.12) 
217 per 1000 187 per 1000 
(146 to 237) 
Hospital 
readmission (up 
to 6 months) 








analysis: OR 0.74 
(95% CI 0.48 to 
1.15) 
97 per 1000 7464 per 
1000 
(49 to 110) 
In-hospital 
complications 








analysis: OR 0.46 
(95% CI 0.33 to 
0.64) 
125 per 1000 62 per 1000 






was 12.5 days 
MD 0.83 days 
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Very low2, 3, 
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Random-effects 
analysis: MD -0.83 

















1171.52 (95% CI -
1835.86 to -507.1) 
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the 
comparison group and the relative effect of the intervention (and its 95% CI). 
CI: confidence interval; MD: mean difference; OR: odds ratio; RT: randomised trial; USD: US dollar 
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GRADE Working Group grades of evidence 
High-certainty: we are very confident that the true effect lies close to that of the estimate of the effect 
Moderate-certainty: we are moderately confident in the effect estimate: The true effect is likely to be close to 
the estimate of the effect, but there is a possibility that it is substantially different 
Low-certainty: our confidence in the effect estimate is limited: The true effect may be substantially different 
from the estimate of the effect 
Very low-certainty: we have very little confidence in the effect estimate: The true effect is likely to be 
substantially different from the estimate of effect 
1Downgraded one level due to imprecision (confidence interval contains harm and benefit). 
2Downgraded one level due to publication bias (funnel plot strongly implies publication bias). 
3Downgraded one level due to serious risk of bias (high risk of concealment, randomisation, performance bias). 
4Downgraded one level due to indirectness (variation in type of complications assessed). 
5Downgraded one level due to inconsistent results (substantial heterogeneity was found). 
 
3.12.1 90-day mortality 
Within the category of stand-alone pathway interventions, six studies [65, 66, 102, 111, 124, 
128] with 3828 patients were combined because they were comparable and reported on in-
hospital mortality up to 90 days after the use of a CPW. Two studies [66, 124] found 
increased mortality within a 90-day period after the use of a CPW. The result showed an odds 
ratio (OR) favouring the CPW group compared to usual care with OR 0.83 (95% CI 0.62 to 
1.12; P = 0.22; Analysis 1.1.1). There was low-certainty of evidence (Summary of findings 
table 1). We explored further by conducting sensitivity analysis by excluding studies with 
high and unclear risk of bias from the analysis, the resulting effect estimate was OR 1.04 
(95% CI 0.87 to 1.24; P = 0.66; Analysis 1.1.2). 
3.12.2 Hospital readmissions (up to 6 months) 
Seven studies (1391 participants) reported on hospital readmissions for all causes, and 
characterized with follow up periods up to six months. Aizawa et al. (2002) reported one 
readmission event from 32 patients on the CPW versus no readmissions from 37 patients in 
the usual care group within six months [101]. Choong et al (2000) reported a follow up 
period of 28 days and two events for 55 patients in the CPW group versus six events from 56 
usual care patients [120]. Carratala et. al (2012) reported 18 events from 200 patients in the 
CPW group versus 15 events from 201 usual care patients [65]. Panella et al (2009) found 17 
rehospitalization events from 214 patients following a CPW compared to 30 events for 215 
patients managed with usual care (P = 0.053).  
In the study from Dowsey et al (1999) [105], four out of 92 CPW patients were readmitted 
within a follow up period of three months versus nine out of 71 patients following usual care 
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(P = 0.06). Delaney et al. (2003) found 3 readmissions for the CPW group versus six 
readmissions for usual care while managing patients with laparotomy and intestinal resection 
[104]. In a period of 30 days, Gomez et al. (1996) reported three readmissions for both 50 
intervention pathway patients as well as for 50 patients in the usual care group [23]. Roberts 
et al. (1997) observed five re-hospitalizations for 82 pathway patients versus four 
readmission events from 83 individuals managed with usual care within an eight-week period 
[115]. When combined, the effect estimate showed an OR favouring CPW group of OR 0.74 
(95% CI 0.48 to 1.15; P = 0.18; Analysis 1.2) with low heterogeneity, I² = 13%. There was 
low-certainty of evidence (Summary of findings table 1). 
3.12.3 In-hospital complications 
In-hospital complications were assessed by eight studies [65, 66, 101, 104, 105, 110, 112, 
120]. There was variation in the type of complications assessed following the use of a CPW. 
All studies reported improvements associated with use of a CPW. Choong et al. (2000) listed 
postoperative confusion, infection and deep vein thrombosis as complications for patients 
with a fractured neck of femur and reported 10 events for 55 patients in the CPW group 
versus 14 events for 56 patients in the usual care (P = 0.40) [120]. Delaney et al. (2003) listed 
postoperative infection and uncontrolled bleeding as complications for patients following 
intestinal resection and reported 7 events for 31 patients in the CPW group versus 10 events 
for 33 patients in the usual care group (P = 0.58) [104].  
With respect to adverse drug reactions, Carratala et al. (2012) reported 9 events in 200 
patients managed with a CPW versus 32 events out of 201 patients following usual care (P < 
0.001) [65]. Kiyama et al. (2003) listed surgery-site problems as complications for patients 
following gastrectomy and reported 3 events for 47 patients in the intervention group versus 
5 events for 38 patients in the control group [110]. Marelich et al. (2000) listed ventilator-
associated pneumonia as a complication for patients requiring mechanical ventilation and 
reported 11 events for 166 patients in the CPW group versus 20 events for 169 patients in the 
usual group (P = 0.06) [112]. Process et al. (2014) found 23 adverse events out of 439 
patients following a CPW versus 37 events out of 456 patients in the usual care group (P = 
0.32) [66]. Aizawa et al. (2002) did not describe specific complications for patients following 
transurethral resection of the prostate and reported 1 event for 32 patients in the intervention 
group versus 2 events in 37 patients in the control group [101]. Dowsey et al. (1999) listed 
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wound infection, chest infection, deep vein thrombosis, joint dislocation, pressure areas, 
failure to cope at home and decreased range of motion post discharge as complications for 
patients following knee or hip arthroplasty up to three months’ post-surgery and reported 10 
events for 92 patients in the intervention group, versus 20 events for 71 patients in the control 
group (P = 0.01) [105]. The combined odds ratio showed an effect estimate favouring the 
CPW group OR 0.46 (95% CI 0.33 to 0.64; P < 0.0001; Analysis 1.3). There was low-
certainty of evidence (Summary of findings table 1). 
3.12.4 Length of hospital stay 
Length of stay (LOS) was the most commonly reported secondary outcome and majority of 
[120] studies reporting reduced LOS following the use of CPW. Out of the 32 studies 
categorized as single pathway interventions, 22 (56.4%) randomised trials examined the 
effect of CPWs on LOS [23, 25, 26, 64-68, 97, 101, 102, 104, 105, 107, 109, 110, 113, 115, 
120, 121, 123-125, 128], 14 studies reported on reductions in LOS [24, 64, 65, 101, 102, 105, 
107, 109, 110, 113, 115, 120, 121] while three studies [66, 123, 124] found no difference in 
LOS between the groups after the use of a CPW. Using an ITS approach, Rotter et al. (2014) 
reported no change in the LOS after the use of a CPW for prostate patients undergoing RLP 
[97]. Conversely, Falconer et (1993); Bernard et al. (2011); Trombetti et al (2013). and Sulch 
et al. (2002) reported increased LOS associated with CPWs in the management of type 2 
diabetes, management of malnourished elderly patients and stroke rehabilitation [25, 26, 67, 
68]. Due to poor reporting, all the LOS data was missing in one study [128] and the 
investigators did not provide sufficient information on the uncertainty measures. The MD for 
the combined studies was -0.83 days (95% CI -1.21 to -0.45; P < 0.00001; Analysis 1.4.1). 
There was substantial heterogeneity, I² = 81% and we found very low-certainty of evidence 
(Summary of findings table 1).  
3.12.4.1 Subgroup analyses 
Length of hospital stay: study design 
Using a random effects model, we compared randomized studies and non-randomized studies 
to examine the effects of CPW on LOS based on the study designs used in the primary 
studies. We observed further reduction in LOS for non-randomized studies group with an 
effect estimate of MD of -1.85 days (95% CI of -2.74, -0.95; P < 0.0001; Analysis 1.4.2) with 
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I² of 0% compared to randomized studies MD of -0.84 days (95% CI of -1.21, -0.47; P < 
0.00001) with I² of 79% (Analysis 1.4.3).  
Length of hospital stay: country 
We examined the effects of market forces from countries where the studies were conducted, 
on the effect of hospital LOS. A larger reduction in LOS was found among Japanese studies 
and studies conducted in Spain with a pooled reduction in LOS by approximately three and 
two days respectively (MD of -3.01 days (95% CI -5.35, -0.67; P = 0.01; Analysis 1.4.4) and 
-2.09 days (95% CI -3.06 to -1.11; P < 0.0001; Analysis 1.4.5), followed by studies 
conducted in Australia with a MD -1.45 days (P = 0.0005; 95% CI -2.02 to -0.56; P = 0.0005; 
Analysis 1.4.6). Studies conducted in the USA constituted majority of the studies included in 
this update, but those studies combined, led to LOS with a MD of -0.60 days (95% CI -1.08 
to -0.11; P = 0.02; Analysis 1.4.7). An increase in LOS was observed for pooled studies 
conducted in UK, MD of 1.29 days (95% CI -3.22, 5.81; P = 0.57; Analysis 1.4.8). 
Length of hospital stay: setting 
Emergency department 
Seven studies [65, 66, 68, 109, 113, 115, 123] conducted in the emergency department 
reported on the LOS for 2117 patients managed with a CPW. Only one study [68], focusing 
on management of diabetes mellitus reported no differences between the CPW group and 
those following usual care; (5.4 hours (SD 1.8) for the CPW group versus 4.9 hours (SD 1.9) 
for usual care, P = 0.06). When statistically combined, the MD for the combined LOS was -
0.66 days (95% CI -1.12 to -0.20; P < 0.005; Analysis 1.4.9) 
Acute care 
Eleven studies with 2090 patients [23, 64, 67, 101, 105, 107, 110, 113, 120, 121, 125] 
reporting on the LOS were conducted in acute care settings with the use of a CPW compared 
to usual care. Only one study [67] reported an increase in the LOS after the use of a CPW for 
malnourished elderly patients. When all eleven studies were statistically combined, we 
observed a reduction in the LOS with an effect estimate of MD equal to -1.37 days (95% CI 





Three studies [25, 26, 104] with 337 patients were conducted in extended sections 
(rehabilitation units) of the hospital. Delaney et al. (2003) reported no differences in the LOS 
for patients undergoing surgical rehabilitation with the use of a CPW (5.2 days (SD 2.5) for 
CPW group versus 5.8 days (SD 3) for usual care (P = 0.12). After statistical pooling, we 
observed an increase in the effect estimate with a MD of 1.46 days (95% CI -2.14 to 5.05; P 
= 0.43; Analysis 1.4.11). 
Intensive care unit 
Two studies [102, 124] with 1440 participants were conducted in the intensive care unit 
(ICU) hospital. Brook et al. (1999) found a reduction in the LOS after using a CPW for 
managing sedation during mechanical ventilation (5.7 days (SD 5.9) for CPW group versus 
7.5 (SD 6.5) for usual care, P = 0.013). Doig et al. (2008) reported an eight-hour reduction in 
LOS after using a CPW for the management of malnourished patients in the ICU ward (9.1 
days (SD 11.5) for CPW group versus 9.9 (13.3) for usual care, P = 0.42). The combined 
effect for length of stay for the two studies revealed no difference between the CPW group 
and usual care group; MD -5.18 days (95% CI -12.94 to 2.57; P = 0.19; Analysis 1.4.12) 
Surgical unit 
Two studies[101, 110] with 154 participants were conducted in the surgical unit of a hospital. 
Aizawa et al. (2003) reported a two-day reduction in LOS when a CPW was used in the 
management of patients with benign prostatic hyperplasia (12.7 days (SD 2.8) for CPW 
group versus 14.7 (SD 5.2) for usual care, P = 0.04). Kiyama et al. (2003) reported a 10-day 
reduction in LOS after a CPW was used in the management of patients undergoing 
gastrectomy in the surgical ward (18.1 days (SD 9.5) for CPW group versus 28.2 (22.3) for 
usual care, P = 0.009). The combined effect for length of stay for the two studies revealed no 
difference between the CPW group and usual care group; MD -2.86 days (95% CI -7.77 to 
2.04; P = 0.25; Analysis 1.4.13) 
Study year 
22 studies (3001 patients) were published in years ranging from 1993 to 2014, and reported 
on LOS, were ordered in forest plots by year of publication. The combined effect resulted in 
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a MD of -0.98 days (95% CI -1.35 to -0.60; P < 0.00001; Analysis 1.4.14). Association with 
the impact of CPW on LOS or other outcomes and the study year could not be identified. 
Length of hospital stay: clinical condition 
There were five conditions which were addressed by more than one study. Three studies [65, 
113, 121] evaluated pathway management for pneumonia, two studies each for stroke 
rehabilitation [25, 26], suspected myocardial infarction [23, 115], malnutrition [67, 124], 
asthma care in children [107, 123]. Further conditions within this subgroup of single pathway 
interventions were transurethral resection of the prostate [101], deep vein thrombosis [64], 
septic shock [66], type 2 diabetes mellitus [68], heart failure [125], menorrhagia and urinary 
incontinency [117], femoral neck fracture [120], laparotomy and intestinal resection [104], 
asthma care [118], hip and knee arthroplasty [105], atrial fibrillation [109], gastrectomy 
[110], chronic obstructive pulmonary disease or COPD [128] and a pathway instrument 
designed for the better identification of female victims of domestic violence [96]. Due to the 
variation in the clinical conditions targeted by the various clinical pathways, we report on 
subgroup analysis per pathway condition.   
Pediatric asthma care 
Cunningham et al. (2008) reported no differences in reduction of LOS for pediatric patients 
with asthma (1.6 days (SD 1.1) in the CPW group versus 1.7 days (SD 1.1) in the usual care 
group, P = 0.83). also found a decrease in the LOS for hospitalized asthmatic pediatric 
patients when managed with a CPW (1.6 days (SD 1.1) for CPW group vs 2.2 days (SD 1.1) 
for usual care group, P < 0.01), The combined effect for LOS for these studies (351 patients) 
revealed no differences between the CPW group and usual care group, MD of -0.31 days, 
(95% CI -0.72 to 0.09; P = 0.13; Analysis 1.4.15). 
Stroke rehabilitation 
Falconer et al. (1993) and Sulch et al. (2002) both reported increased LOS associated with 
CPWs used for stroke rehabilitation units [25, 26]. Falconer et al. (1993) reported a LOS of 
35.6 (SD 15.5) days in the CPWs group versus 32.3 (SD 15.4) days in the control group (OR 
3.30; 95% CI -2.25 to 8.85). Sulch et al. (2002) reported a LOS of 50 (SD 19) days in the 
CPWs group versus 45 (SD 23) days in the control group (OR 5.00; 95% CI -1.71 to 11.71). 
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The combined odds ratio for the two studies was OR 3.99 (95% CI -0.29 to 8.27; P =0.07; 
Analysis 1.4.16).  
Pneumonia 
Marrie et al. (2002) and Usui et al. (2004) both reported reductions in LOS and duration of 
intravenous antibiotic infusion when CPWs was implemented for inpatient management of 
pneumonia [113, 121]. Marrie et al. (2002) reported a LOS of 8.2 days (SD 1.9) in the CPWs 
group versus 9.6 days (SD 2.1) in the control group (MD -1.40 days; 95% CI -1.94 to -0.86) 
whilst duration of intravenous antibiotic infusion was also significantly less in the CPWs 
group, 4.6 days (SD 0.9) versus 6.3 days (SD 1.4); (MD -1.70 days; 95% CI -2.01 to -1.39). 
Usui et al. (2004) reported a LOS of 8.0 days (SD 4.2) in the CPWs group versus 10.8 (SD 
4.2) days in the control group (MD -2.74 days; 95% CI -4.84 to -0.64), whilst duration of 
intravenous antibiotic infusion was also significantly less in the CPWs group, 6.5 days (SD 
3.5) versus 8.2 days (SD 3.5); (MD -1.75 days; 95% CI -3.52 to 0.02) [121]. Similarly, 
Carratala et al. (2012) reported reduction in the LOS during the management of hospitalized 
adults with community acquired pneumonia (3.9 days (SD 6.3)) for CPW group versus 6.3 
(SD) for usual care; (MD of -2.10 days; 95% CI -3.33, -0.87) [65]. When the three studies 
were combined, the LOS decreased with a MD of -1.64 days (95% CI -2.24, -1.05; P < 
0.00001; Analysis 1.4.17). 
Malnutrition 
Doig et al. (2008) reported reductions in LOS for malnourished hospitalized elderly patients 
managed with the use of CPW, (9.1 days (SD 11.5) for CPW group versus 9.9 (SD 13.3) for 
the usual care group, P = 0.24) [124]. Conversely, Trombetti et al. (2013) found an increase 
in the LOS for malnourished patients after the use of a clinical pathway (38 days (SD 34) for 
CPW group versus 37 days (SD 32) for usual care, P = 0.613) [67]. The combined effect 
resulted in no differences between both groups with a MD of -0.67 days (95% CI -2.07 to 
0.74; Analysis 1.4.18). 
Suspected myocardial infarction 
Gomez et al (1996) [23] and Roberts et al. (1997) [115] both reported reductions in LOS for 
CPWs implemented in emergency departments for suspected myocardial infarction. Gomez 
1996 reported a reduced LOS in the CPW group (0.64 days (SD 0.51) versus 2.28 days (SD 
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5.25); P = 0.0001). Roberts et al. (1997) reported a LOS of 1.38 days (SD 1.18) in the CPWs 
group versus 1.84 days (SD 1.33; P = 0.08) in the control group (MD -0.49 days; -0.87, -
0.11). The combined LOS for the Gomez et al. (1996) and Roberts et al. (1997) studies was 
MD -0.90 days (95% CI -1.98 to 0.18; P = 0.10; Analysis 1.4.19). 
Length of hospital stay: invasive versus non-invasive conditions 
Fourteen primary studies [24-26, 64-68, 107, 109, 113, 121, 123, 124] reporting on LOS 
focused on the use of a CPW for non-invasive procedures and eight studies [23, 101, 102, 
104, 105, 110, 115, 120] used a CPW for invasive procedures (surgery, mechanical 
ventilation, coronary angiography). According to health economic theories, invasive 
procedures should be standardized more easily than non-invasive procedures due to variation 
during treatment [134]. However, the combined effect estimate showed a minimal reduction 
in the overall length of hospital stay for invasive conditions versus non-invasive conditions 
respectively (MD -1.39 days, 95% CI -2.17 to -0.60; P = 0.0006 (Analysis 1.4.20) versus MD 
-0.81 days, 95% CI -1.25 to -0.37; P < 0.00001, Analysis 1.4.21). 
Length of hospital stay: implementation strategies 
(≤ 3 evidence-based implementation strategies) 
Seven studies [65-67, 102, 109, 115, 121] employed less than four implementation strategies 
(Table 3) during the implementation of a CPW. After combining the seven primary studies 
based on LOS, we observed a reduction in the LOS with a MD of -1.42 days (95% CI -2.40 - 
0.43; P = 0.005; Analysis 1.4.22) with high variation among the pooled studies; I² = 66%. 
Sensitivity analysis excluding studies at high risk and unclear risk of bias from the analysis 
shows a reduction with a MD of -2.61 days (95% CI -8.13 to 2.91; P = 0.35; Analysis 
1.4.23). 
(4 to 6 evidence-based implementation strategies) 
Twelve studies [23, 26, 64, 68, 101, 104, 105, 110, 113, 120, 123, 125] employed four to six 
implementation strategies. The combined effect estimate resulted in reduction in the LOS 





(≥ 7 evidence-based implementation strategies) 
Two studies [25, 107] reported the use of seven or more implementation strategies. The 
combined effect resulted in no real increase in LOS with a MD 1.17 days (95% CI -3.87 to 
6.22; P = 0.65; Analysis 1.4.25). 
3.12.5 Oncology Pathways 
With regards to the implications of using a CPW that directly related to oncology care, only 
one study [135] was found; therefore, statistical pooling was unable to be conducted. 
Costantini et al. (2014) examined the effectiveness of a CPW on the quality of end-of-life 
care for patients with cancer in hospitals and for their family members in an Italian medical 
context [135]. A post intervention assessment involved interviews with 232 family members 
of patients who had died from cancer approximately 107 days after death. No significant 
difference for the overall quality of care was determined between wards in which the CPW 
program was implemented and the control wards. 
 
By comparison, one study [110] conducted in a Japanese medical context that indirectly 
related to oncology care found several positive implications of using a CPW. Kiyama et al. 
(2003) examined gastrectomy patients with either gastric cancer or gastrointestinal stromal 
tumors (malignant or benign tumor not specified) to determine the clinical and cost-
effectiveness of a standardized CPW in comparison to traditional consultations [110]. 
Regarding patient outcomes, the target achievement at 24 hours (P < 0.005), 4 days (P < 
0.05), 7 days (P < 0.05), and 14 days (P < 0.001) were significantly improved for the CPW 
group in comparison to the control. In terms of the length of time in hospital, preoperative 
stays were significantly reduced (P < 0.001) in the CPW group (MD 9 days, SD 3.2) versus 
control group (MD 12.6 days, SD 6.0). A reduction was also reported for postoperative stays 
(P < 0.01) in the CPW group (MD 18.1 days, SD 9.5) in comparison to the control group 
(MD 28.2 days, SD 22.3). However, the length of postoperative stay did not differ between 
groups for patients with postoperative complications (MD 25.5 days, SD 4.8 for CPW group 
versus MD 33.9, SD 10.2 for control group). The reduction in length of hospital stay for 




3.12.6 Hospital costs and charges 
Out of 32 primary investigations grouped as single pathway interventions, eight of the 
included studies (1264 patients) reported on a highly varying set of cost/ charge measures. 
All eight studies [23, 24, 101, 107, 110, 115, 121, 132] found lower hospitalization costs/ 
charges or insurance points for CPW groups. We reported all hospital charges and cost in US 
dollars.  
Five studies reported on hospital costs [109-111, 115, 132]. While professional fees were 
included in the hospital costs reported by Kiyama et al. (2003) and Roberts et al. (1997), Kim 
et al. (2002) excluded them from the cost estimates. Three [109-111] out of the four studies 
used indirect hospital costs and only one study [115] reported on direct and indirect hospital 
costs. Only two studies [110, 115] reported on reductions in hospital costs; Kiyama et al. 
(2003) reported full hospital cost (direct and indirect costs) of USD 13069.36 (SD 1822) for 
CPW group vs USD 16,806 (SD 5072), P<0.001, for patients undergoing gastrectomy at a 
medical school hospital. Roberts et al. (1997) also reported full hospital cost of USD 2,344 
(SD 1145) for patients managed on a CPW vs USD 3,214 (SD 919) for patients following 
usual care (P<0.01). Verdu et al. (2009) reported an estimated cost savings of around EUR 
21,393.18 (EUR 60,391.90 - EUR 38,998.72) in 2004 in comparison cost incurred in 2002 
after the implementation of a clinical pathway to manage patients with lower deep vein 
thrombosis in an academic tertiary Spanish hospital [132].  
Within the subgroup of hospital charges, three studies [23, 107, 125] reported hospital 
charges associated with the use of CPWs for patients with varying clinical conditions. All 
three studies [23, 107, 125] reported reductions in the hospital charges for patients managed 
via CPW as compared to usual care and one study found difference between both groups. 
Gomez et al. (1996) reported 30 day-hospital charge of USD 1,424 (SD 1,735) for 
myocardial ischemic patients following a CPW vs USD 5,860 (SD 14,638) for the usual care 
group (P = 0.0001) [23]. Johnson et al. (2000) reported hospital routine charges (room 
charge) of USD 2407 (SD 1151.9) for asthmatic patients following a CPW vs USD 3116 (SD 
1151.9) for those following usual care (P<0.001) [107]. Panella et al. (2009) reported hospital 
charges for patients hospitalized with heart failure following a CPW to be Euros 2125 (SD 
843.52) while Euros 2211 (SD 917) was estimated for patients following usual care (P = 
0.11) [125].  
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Types of hospital costs and charges reported in included studies are provided in Appendix 2. 
Table 3 provides data as reported whereas Table 4 provides price data adjusted to US dollars 
standardized to the year 2016. Two studies [101, 121] used surrogate cost outcomes in form 
of the Japanese insurance points and they reported reductions in charges and surrogates for 
the pathway groups. Aizawa et al. (2002) reported 48424.2 insurance points for patients (n = 
32) managed with a CPW and 55365.5 insurance points for patients (n= 37) managed with 
usual care, Usui et al. (2004) reported 24.338 insurance points for patients (n = 30) managed 
with a CPW and 34.048 insurance points for patients (n= 31) managed with usual care, P = 
0.0031. Taken together, the MD was USD 1171.52 (95% CI -1835.86 to 507.1; P < 0.00001; 
Analysis 1.5). There was substantial heterogeneity, I² = 88% and we found very low-certainty 
of evidence (Summary of findings table 1). 
3.12.7 Adherence to recommended practice 
Three studies [25, 89, 96] measured the impact of CPWs on the adherence to recommended 
practice by healthcare professionals using a CPW, and all three reported positive findings for 
the use of CPWs. Adherence to recommended practice was measured by the quantity of 
documentation conducted by healthcare professionals while managing patients on a CPW. 
Doherty et al. (2006a) reported a 54% improvement in documentation of severity of asthma 
in the study hospitals compared to a 3% improvement in the control hospitals. Sulch et al. 
(2002) measured documentation of team goals for stroke patients and reported compliance in 
75 of 76 cases in the intervention versus 56 of 76 cases in the control group (OR 26.79, 95% 
CI 3.49 to 205.58).  
Tilden et al. (1987) measured documented identification of female victims of domestic 
violence in the emergency department and found no change when time series analysis was 
utilized. Due to insufficient number of comparable studies, we did not conduct any meta-
analysis for this outcome.  
Other professional practice outcomes reported by three studies [25, 117, 123] include: 
provider knowledge, patient contact, and provider-patient communication (Table 4; Table 7; 
Table 10; Table 11) reported a reduction in the number of inappropriate uses of urodynamics 
for urological patients managed with a CPW (43% for the CPW group and 45% for usual 
care) and increase in the compliance score regarding recommendations for initial hospital 
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assessment for urinary incontinence (3.5 points for CPW and 3.0 for usual care).  
Cunningham et al. (2008) reported: an increase in the number of medical contacts with 
asthmatic patients during the first 12 hours of care (6 contacts for the CPW group versus 5.5 
contacts for usual care, P = 0.04); increase in the number of nursing contacts with patients 
(22 contacts for the CPW group versus 19.2 contacts for usual care, P = 0.001); and increase 
in the number of clinician contacts with all patients (16 contacts for the CPW group versus 
13.8 contacts for usual care, P = 0.001). Sulch et al. (2002) found an increase in the 
proportion of communications with general practitioners following death/discharge within a 
24-hour time (80% for the CPW group and 45% for usual care, P < 0.001). However, Chadha 
et al. (2000) found a 2% reduction in the percentage of appropriate first-line treatments for 
urological patients (81% for the CPW group and 83% for usual care). 
3.13 ITS studies 
Three ITS studies [95-97] are included in this review. 
Brattebo et al. (2002) investigated the effect of a scoring system and protocol for sedation on 
duration of patients' need for ventilator support in a surgical intensive care unit. Measures 
(LOS and ventilator time) were taken 11 months before and after the introduction of the 
sedation protocol at the ICU department of the hospital. Using a time series analysis, 
Brattebo et al. (2002) found a 2.1-day (95% CI 0.65 to 3.55) reduction in mean ventilator 
time, demonstrated by a decrease from 7.4 days to 5.3 days after the implementation of the 
sedation protocol for ventilating ICU patients. Brattebo 2002 also reported a 1 day (95% CI -
0.89 to 2.89) reduction in mean LOS demonstrated by a reduction from 9.3 days to 8.3 days 
after the introduction of the intervention. 
Rotter et al. (2014) reported on the effects of a CPW for 254 prostate patients undergoing 
radical laparoscopic prostatectomy at a surgical ward of medical facility. Data was collected 
using at six time points every 4-week before (n = 123) and after (n = 131) the implementation 
of the intervention. Mixed results were reported from this study. Rotter et al. (2014) reported 
no change when comparing LOS before (9 days) and after (9 days) CPW implementation. 
There was no difference in slope (P = 0.472) or change in mean (P = 0.910). Rotter et al. 
(2014) also reported a reduction in the number of admissions to ICU with 11 admissions pre-
intervention and 4 admissions post intervention (P =0.041). Further, Rotter et al. (2014) 
found an increase in the number of re-operations after pathway implementation (n = 4 pre-
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pathway and n = 5 post-pathway P = 0.539) and a decrease in the number of transfusions of 
blood products after pathway implementation (n= 4 pre-pathway and 3 post-pathway, P = 
0.465). Finally, Rotter et al. (2014) reported an increase in the number of patients requiring 
readmissions within 30 days (n= 8 pre-pathway vs n = 23 post pathway implementation, P= 
0.006). 
Tilden et al. (1987) investigated the effect of a nursing protocol in identifying battered 
women receiving care in the ED of a hospital. The goal of the protocol is to increase the rate 
of identification of battered women presenting to the ED of the hospital. The intervention was 
introduced in May 1984 and data was collected at four time points prior to (n = 72) and after 
(n = 74) the implementation of the intervention (June to September 1983 and June to 
September 1984). Tilden et al. (1987) found an increase in the post treatment rate of positive 
battering during the study period (7 cases pre-intervention vs 17 cases post-intervention, P = 
0.03).  
 
Table 3–4. Summary of findings table 2 
Multifaceted clinical pathway compared to usual care 
Patient or population: hospitalised patients 
Setting: hospital 
Intervention: multifaceted intervention (including clinical pathway) 
Comparison: usual care 






















90-day mortality Study population - 227 
(2 RCTs) 
⊕⊝⊝⊝ 
Very low1, 2, 
3 
Statistical pooling 
was not conducted 
due to insufficient 






to six months 





was not conducted 








Not reported - - - Outcome not 
reported 
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analysis: MD -0.71 






See comment - 371 
(2 RCTs) 
⊕⊝⊝⊝ 
Very low1, 4, 
5 
Statistical pooling 
was not conducted 






Not reported - - - Outcome not 
reported 
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the 
comparison group and the relative effect of the intervention (and its 95% CI). 
 
CI: Confidence interval; MD: mean difference; RT: randomised trial 
GRADE Working Group grades of evidence 
High-certainty: we are very confident that the true effect lies close to that of the estimate of the effect 
Moderate-certainty: we are moderately confident in the effect estimate: The true effect is likely to be close to 
the estimate of the effect, but there is a possibility that it is substantially different 
Low-certainty: our confidence in the effect estimate is limited: The true effect may be substantially different 
from the estimate of the effect 
Very low-certainty: we have very little confidence in the effect estimate: The true effect is likely to be 
substantially different from the estimate of effect 
1Downgraded one level due to risk of bias (concealment, randomisation, contamination, dissimilar baseline 
characteristics). 
2Downgraded one level due to imprecision (small sample size). 
3Downgraded one level due to publication bias (difficult to assess owing to insufficient studies). 
4Downgraded one level due to imprecision (confidence interval contains benefit and harm). 
5Downgraded one level due to inconsistency (excluding the outlier study, visual inspection suggests 
inconsistency). 
3.14.1 90-day mortality 
Two studies [114, 129] measured in-hospital mortality up to 90 days and reported no 
evidence of a reduction in mortality after the use of a CPW. The time to follow-up was not 
documented by Cole et al. (2002) who found no difference in mortality between intervention 
and control groups (22.1% versus 19.3%). Philbin et al. (2000) reported no difference in heart 
failure-related or all-cause mortality at six months. Due to insufficient number of comparable 
studies, we did not pool the effect estimates. There was very low-certainty of evidence 
(Summary of findings table 2). 
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3.14.2 Hospital readmissions up to six months 
The effect of a CPW on hospital re-admission up to six months was investigated in two 
studies [108, 114], which looked at the use of a CPW for children with asthma and elderly 
patients with heart failure respectively. Philbin et al. (2000) reported 169 readmission events 
for heart failure up to six months for 840 experimental patients vs. 141 readmissions for 664 
patients in the control group (P = 0.97) during the management of heart failure patients with a 
CPW. Readmissions for all causes up to six months were 363 events for 840 patients in the 
experimental group vs. 293 events for 664 control patients (P = 0.93). Kampan 2006 reported 
a reduction in six month readmissions for hypoglycemia in patients with diabetes (6% for 
CPW group versus 34% for usual care; P = 0.04). Studies were not combined due to 
differences in patient characteristics and insufficient number of studies. There was low-
certainty of evidence (Summary of findings table 2). 
3.14.3 Length of hospital stay 
Out of the seven primary studies categorized as multifaceted interventions including a CPW 
element, three studies [108, 114, 129] reported LOS measures. All studies reported no 
difference between CPW and usual care groups and Kampan et al. (2006) employed a small 
sample size. Studies were not combined due to differences in insufficient number of 
comparable studies. There was low-certainty of evidence (Summary of findings table 2). 
Subgroup analyses 
3.14.3.1 Length of hospital stay- country 
There was an insufficient number of studies to examine country effect on multifaceted 
intervention including a CPW. 
3.14.3.2 Length of hospital stay- condition or intervention 
Seven disparate conditions were reported by seven primary studies in this group thus 
subgroup analysis was not feasible. The different pathway conditions (Table 2) were bipolar 
disorder [106], palliative care [116], mechanical ventilation [95], asthma in children [103], 
delirium in older medical patients [129], diabetic patients admitted with hypoglycemia [108] 




3.14.4 Hospital costs and charges 
Three [106, 108, 114] out of seven studies grouped as multifaceted interventions including a 
CPW element reported on hospital costs/charges. Bauer et al. (2006) reported on a set of cost 
measures stratified on several criteria: three year mean intervention costs, variable outpatient 
costs, hospital inpatient costs, psychiatric inpatient costs and medical / surgical inpatient 
costs. None of these three studies reported on differences between the groups in terms of 
cost/ charge outcomes whilst Kampan et al. (2006) employed only a very small sample size 
available for analysis. Both studies compared the same sort of variable hospital costs 
included for each study in the pooled analysis, although it remains unclear if the term "mean 
costs" used in the Kampan et al. (2006) study refers only to variable costs as further 
information was not able to be elicited from the chief investigator. Studies were not 
combined due to insufficient number of comparable studies. There was very low-certainty of 
evidence due to risk of bias, imprecision and inconsistency (Summary of findings table 2). 
3.8 Discussion  
3.8.1 Summary of main results  
Clinical pathways are implemented in various hospital settings for the management of 
different clinical conditions. After applying the inclusion criteria to approximately 13,000 
search hits, thirty-nine studies with 15911 patients from thirteen countries were included in 
the final analysis and synthesis. This review included a broad range of clinical conditions 
using invasive and non-invasive procedures, for which a clinical pathway was implemented 
in a specific setting of a hospital in addressing the medical condition. Overall, mixed results 
were reported on the effects of CPWs on patient, professional, length of stay and cost 
outcomes. The high level of heterogeneity in the clinical conditions and settings examined 
precluded meaningful meta-analysis of many outcomes and therefore limited our certainty in 
some of the pooled estimates. Despite the limitations in this review, some of the findings may 
be valuable to policy makers, managers, researchers, teams and clinicians working with 
clinical pathways in hospital settings. 
The overall findings show that stand-alone clinical pathways implemented in hospitals may 
reduce in-hospital complications and hospital costs (low certainty evidence). It is uncertain 
whether stand-alone clinical pathways reduce the length of stay in hospitals or improve the 
adherence to recommended practice among health care providers in hospital settings because 
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the certainty of evidence is very low. For multifaceted interventions including a CPW, the 
use of a CPW may make little or no difference to the hospital length of stay (low certainty 
evidence) and it is uncertain whether the use multifaceted interventions including a CPW 
reduce hospital costs because of the certainty of evidence is very low. However, the results 
must be interpreted with caution, recognizing the variation in hospital settings and clinical 
conditions, as well as clinical outcomes examined within the studies included in this review. 
We found a limited number of well-designed study designs evaluating the effects of hospital 
clinical pathways on other outcomes. 
3.8.2 Patient outcomes 
Several patient groups were included in this synthesis reflecting the breadth of the review. 
90-day mortality, hospital readmissions up to six months and In-hospital complications were 
reported as direct patient outcomes examined by more than one study. Stand-alone and 
multifaceted CPW interventions implemented in hospitals make little or no difference in 
hospital readmissions up to six months (low certainty evidence). A significant reduction in 
the in-hospital complications assessed was found in the CPW group compared to usual care 
and the evidence was rated at low certainty implying that stand-alone CPWs may reduce in-
hospital complications in hospitals (low certainty evidence). The meta-analytic comparison 
includes about 1007 patients in the experimental, as well as 1005 patients in the control 
groups and we observed a reduced effect with an odds ratio of 0.46 (CI 95% 0.33 to 0.64). 
The results are not unexpected owing to the different clinical conditions examined in the 
meta-analysis summary. Examining mortality among hospitalized patients on a clinical 
pathway should likewise be interpreted with caution as other meaningful indicators such as 
LOS, re-admissions should be considered. 
3.8.3 Length of hospital stay 
Majority of the studies (27) examining the effects of clinical pathways on hospital length of 
stay reported beneficial effects while four studies reported increased LOS after CPW 
implementation. Lack of study power may be responsible for the beneficial effects on LOS 
without achieving statistical significance. Overall, the variation in the effects of clinical 
pathways on length of hospital stay may be due to different clinical conditions examined by 
the individual studies reporting on the length of stay. Patients with comorbidity may require 
longer hospitalization compared to those without comorbidities. Hence, it is worth noting that 
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longer LOS does not automatically imply bad care or failed clinical pathway implementation, 
but provides room for further investigation and suggested changes to the pathway design if 
necessary. Other important indicators such as re-hospitalization or re-admission rates, 
mortality rate or rate of complications may be may need to be evaluated in conjunction with 
LOS to investigate the effect of CPWs thoroughly.  
In this review, there was significant reduction in LOS when looking at single clinical 
pathway interventions compared to multifaceted interventions. The results from the 
multifaceted intervention showed that there were no differences between groups. The lack of 
difference between study groups may be due to the number and sample size of the included 
studies investigating the effects of multifaceted CPW interventions on length of stay. Based 
on the results, it is uncertain whether stand-alone CPWs reduce length of hospital stay, 
because the certainty of this evidence is very low. In addition, multifaceted CPW 
interventions may reduce length of hospital stay (low-certainty evidence). However, the 
results should be interpreted with caution, and associated factors such as clinical condition, 
comorbidity, hospital policies, and healthcare systems should be considered. 
3.8.4 Hospital costs 
Majority of the included studies reporting on cost outcomes or indicators found reductions in 
hospital cost for patients managed on a CPW compared to usual care. These costs include 
hospital charges, variable and fixed cost associated with patient hospitalization. Studies 
utilizing insurance points as cost surrogates also reported reductions due to the use of a 
clinical pathway in patient management. We found that stand-alone clinical pathways may 
reduce hospital costs compared to usual care (low certainty evidence), while multifaceted 
CPW interventions may make little or no difference to hospital costs (low certainty 
evidence). It is also imperative to examine other factors (e.g., the effect of case mix or 
Diagnostic related groupings reimbursement systems) that may influence cost outcomes for 
hospitalized patients but this was beyond the scope of this review. 
3.8.5 Professional practice outcomes: adherence to recommended practice 
All three included studies reporting on adherence to recommended practice were conducted 
in stand-alone CPW hospital settings. The three studies reported improvement in the quantity 
of documentation by healthcare providers using a clinical pathway for patient management as 
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compared to usual care. However, owing to the risk of bias inherent in the included studies, it 
is uncertain whether stand-alone CPWs improve the quantity of documentation by healthcare 
providers in the hospital because the certainty of this evidence is very low. Improved 
professional documentation may not be directly associated with favorable patient outcomes, 
but it may increase patient safety because of improved team functioning and communication 
during care delivery. 
There were insufficient numbers of comparable studies to draw other meaningful conclusions 
to examine the effects of CPWs in hospitals for other primary and secondary outcomes. 
3.8.6 CPW Implementation strategies 
Several strategies used for implementing CPWs were identified by this review (Table 3-2). 
All included studies reported the use of a multifaceted approach for clinical pathway 
implementation in different sections of the hospital. Out of the 39 included studies, clinician 
involvement was the most common implementation strategy (31 studies) reported by all 
included studies while few studies (8 studies) reported on the identification of barriers to 
change before CPW implementation. Based on LOS data and after examining seven studies 
utilizing less than three implementation strategies, we observed minimal reductions in the 
pooled effects on LOS. The result was not consistent after conducting a sensitivity analysis. 
Interestingly, studies utilizing four to six number of implementation strategies did not result 
in further reductions in hospital LOS. The pooled estimates for studies that used seven or 
more implementation strategies did not show differences between the CPW group and usual 
care. Our overall finding of no difference between multifaceted and single intervention 
strategies to implement CPWs in hospital contexts conforms with the conclusion of a recent 
systematic review by Squires et al. (2014) [136]. Overall, the high level of variation in all the 
pooled estimates and the insufficient number of studies reporting on the use of seven or more 
implementation strategies probably accounted for differences between the groups and further 
limited meaningful conclusions on the relationship between using clinical pathways and 
improvement in LOS. For this review, we only evaluated the number of implementation 




3.8.7 Overall completeness and applicability of evidence  
This review update included 39 studies and was limited to single and multifaceted clinical 
pathways mostly implemented in urban hospital settings. We investigated the effects of single 
and multifaceted CPWs interventions on the patient outcomes, length of stay, cost and 
professional practice outcomes. Due to the broad scope of the review questions and certainty 
of evidence of the results, we are unable to draw firm conclusions on any of the results. Thus, 
the applicability and generalization of the review findings are a concern. Apart from the 
statistical pooling of similar studies to answer specific review questions, we conducted 
subgroup analyses where feasible to further explore heterogeneity in the pooled estimates. To 
further investigate heterogeneity in the combined effects, where possible, we examined the 
context and disease-specific variances that may explain our results and meaningful to the 
review conclusions. 
For single CPW interventions implemented in emergency departments, seven studies were 
sufficiently similar and used for meta-analysis to investigate the impact of CPWs on 
emergency department LOS. Initially, we observed a reduction in LOS, but the results were 
invalidated upon conducting a sensitivity analysis by excluding studies with high and unclear 
risk of bias. Hence, preliminary analysis suggests that CPW implementation may lead to 
reduced LOS in emergency departments. However further research tailored to this hospital 
setting with an increased number of similar studies may be required to answer this specific 
question.  
For general acute hospital admissions, eleven studies were comparable and valid results 
favoring a reduction in LOS was observed from the pooled estimates. However, a sensitivity 
analysis was not feasible to examine the robustness of our findings thus limiting the 
applicability of our evidence in this practice setting. A similar approach with three studies for 
extended hospital care and two studies for intensive care units did not point to any difference 
between both groups. 
One of the recommendations from the previous version of this review Rotter et al. (2010) is 
the exploration of disease-specific pathways with the hope of reducing heterogeneity after 
grouping studies by disease conditions. Based on three similar studies from the sub-group 
analysis, we observed a reduction in the LOS with the use of a CPW for pneumonia 
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management in the hospital. However, the external validity of this finding was limited 
because of the risk of bias inherent in the pooled studies thus requiring further investigation 
with a sufficient number of studies. There was insufficient number of studies focused on 
other clinical conditions or procedures (asthma, mechanical ventilation, myocardial 
infarction, malnutrition and stroke rehabilitation). The combined estimates for these 
investigations also yielded different effect sizes and statistical significance. 
With the notion of clinical pathways' potential to reduce variation in care delivery by 
standardization of care processes, we also explored the effects of CPWs on invasive and non-
invasive hospital procedures using twelve and eight similar studies respectively. Based on 
LOS data, we found reductions in LOS for both categories of hospital procedures with 
minimal difference between both groups (non-invasive vs invasive procedures) in absolute 
effect (1.39 days vs 0.81 days respectively). The results were not robust enough to draw 
meaningful conclusions for non-invasive and invasive procedures due to methodological bias 
in the primary studies. This interesting although limited finding warrants further investigation 
that may be meaningful to future use of hospital resources. Such investigations will also be 
useful for hospital managers to prioritize future areas of clinical pathway development and 
implementation while balancing patient and health system goals. 
3.8.8 Certainty of the evidence 
3.8.8.1 Stand-alone CPWs 
Most studies had methodological issues with study designs and protocol implementation, 
resulting in high or unclear risk of bias which affected the certainty of evidence. Also, the 
high level of statistical (I2 value) and clinical variation in the different conditions and practice 
settings examined affected the degree of inconsistency and imprecision in the overall results. 
We evaluated the certainty of the seven reported outcomes (90-day mortality, hospital 
readmissions up to six months, in-hospital complications, LOS, hospital costs and adherence 
to recommended practice) using the GRADE system. For stand-alone CPW interventions 
compared to usual care, we found low and very-low levels of certainty evidence for mortality 
rates reported up to 90 days due to imprecision and publication bias.  
We also graded the certainty of evidence for hospital readmissions up to six months for 
stand-alone CPW interventions as low due to concerns over the risk of bias and imprecise 
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estimates. We ranked the certainty of evidence for in-hospital complications as low due to 
concerns about the risk of bias and imprecise estimates. We graded the certainty of evidence 
for LOS as very low due to considerations of risk of bias and high-level inconsistency 
inherent in the pooled studies. Finally, we found very-low level certainty of evidence for 
adherence to recommended practice due to concerns about the risk of bias and imprecision. 
3.8.8.2 Multifaceted CPWs 
We found low and very-low levels of certainty of evidence for 90-day mortality in 
multifaceted CPW interventions compared to usual care due to concerns about imprecision 
and publication bias. We downgraded the certainty of evidence for six-month hospital re-
admissions for multifaceted CPW intervention from high to low due to concerns over the risk 
of bias and imprecise estimates. In-hospital complications and adherence to recommended 
practice were not reported by multifaceted CPW interventions. Also, we found low certainty 
of evidence for LOS for multifaceted CPW interventions due to concern with the risk of bias 
and imprecision of study results. We graded the certainty of evidence for hospital costs for 
multifaceted CPW interventions as very-low due to issues around inconsistency, risk of bias 
and imprecision in the pooled estimates. The certainty of the body of evidence suggests that 
specific outcomes may be improved by the implementation of CPWs in different hospital 
settings. 
3.8.9 Potential biases in the review process  
To avoid publication bias, we employed an extensive and highly sensitive search strategy for 
study identification owing to the complex nature of clinical pathways and the broad review 
questions investigated in this review. We developed and used our refined working definition 
on CPWs due to the high variation in the terminologies used to describe a clinical pathway. 
The validated checklist on what constitutes a clinical pathway helped to include CPW 
interventions irrespective of the terminology used in the study. Two people independently 
screened all search results in the screening and full-text stage. We used imputation techniques 
to approximate missing data where applicable and for non-respondent primary authors during 
the contact process. Although imputation was conducted for a low number of studies, there is 
a likelihood of this procedure distorting the overall clinical and or statistical significance. 
 
 71 
3.8.10 Agreements and disagreements with other studies or reviews  
To date, this review remains the only comprehensive systematic review investigating the 
effects of clinical pathways on length of stay, professional practice outcomes, patient 
outcomes and costs in hospitals. This review update adds new data to the previous Cochrane 
systematic review on this topic by Rotter et al. (2010). The conclusions from this systematic 
review update are in line with the first version published. However there is a low certainty of 
evidence found for most of the primary outcomes examined in this update. Following the 
Cochrane EPOC review methods, Rotter 2010 included 11,398 participants from 26 studies 
and reported that clinical pathways are associated with a decrease in in-hospital 
complications and an increase in documentation by healthcare professionals in the hospitals. 
Rotter 2010 did not examine the certainty of evidence. 
We found a very-low level certainty of evidence for an increase in adherence to 
recommended practice following the use of stand-alone clinical pathways in hospitals. Rotter 
2010 also saw a decrease in the in-hospital complications after examining five studies using 
stand-alone clinical pathways in hospital settings. We similarly observed a reduction in the 
in-hospital complications after combining seven studies. We found low certainty of evidence 
for in-hospital complications using stand-alone CPW compared to usual care. ALso, for 
stand-alone CPWs compared to usual care, we found very-low and low levels of certainty of 
evidence in the reduction of hospital length of stay and hospital costs respectively. These 
additional findings are consistent with a non-Cochrane systematic review investigating the 
impact of clinical pathways on hospital length of stay and hospital costs [137].  
Conversely, multifaceted CPW intervention may make little or no difference to the length of 
stay in hospitals (low certainty evidence). Finally, it was uncertain if multifaceted CPW 
intervention reduces hospital costs because the certainty of this evidence is very low. Other 
systematic reviews [138, 139] on this topic are disease-specific and reported mixed results. 





3.9 Authors' conclusions  
3.9.1 Implications for practice  
This review provides evidence based on included primary studies conducted in 13 countries 
(Australia, Canada, Germany, Italy, Spain, Switzerland, United Kingdom, United States, 
Japan, Taiwan, Thailand, New Zealand, Norway). The low certainty of evidence associated 
with the majority of the primary outcomes investigated in this review does not permit robust 
evidence-based conclusions. Although significant variation exists in the direction of effects 
reported by primary studies, this may be due to the differences in health systems, clinical 
conditions and other context-specific factors. However, stand-alone clinical pathways may 
reduce in-hospital complications and hospital cost compared to usual care (low certainty 
evidence). It is uncertain whether stand-alone clinical pathways reduce hospital length of stay 
or improve adherence to recommended practice by healthcare providers because the certainty 
of this evidence is very low.  
Multifaceted clinical pathway interventions implemented in hospitals compared to usual care 
makes little or no difference in hospital readmissions up to six months and length of stay (low 
certainty evidence). It is uncertain if multifaceted clinical pathway interventions reduce 90-
day mortality and hospital costs because the certainty of this evidence is very low.  
Overall, there is an association between stand-alone CPWs and a reduction in hospital 
complications, reduced length of stay, reduced costs and adherence to recommended practice. 
However, there is no association between stand-alone CPWs and mortality and readmissions. 
For Multifaceted CPW interventions implemented in hospitals, there is no association 
between CPW as part of a multifaceted approach and mortality, readmissions, length of stay 
and costs. 
It is worth noting that the review conclusions are limited to the country where the included 
studies are carried out. The limitations in evidence for effects of clinical pathways in hospital 
care previously mentioned and the heterogeneity in healthcare systems of the primary studies 
suggest careful interpretation and application of the evidence into different hospital 
jurisdictions. Large numbers of adequately powered and rigorous primary studies are 
required to investigate each sector of hospital care adequately. Due to the costs associated 
with the implementation and sustainability of complex interventions such as clinical 
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pathways, a careful prioritization among stakeholders, including patients should be 
considered.  
Also, many studies showed no differences between the pathway group and usual care which 
may suggest a lack of study power in the design of the study, a relatively high level of care 
provided in those settings, or low uptake of the pathway intervention by healthcare 
professionals. Thus, it is imperative for clinical managers to pay close attention to 
implementation strategies that are more likely to lead to successful patient outcomes.  
3.9.2 Implications for research  
Study designs 
Majority of the included studies were randomized patient studies and are prone to the serious 
risk of bias of contamination of healthcare professionals that may distort the certainty of 
evidence. We recommend the use well powered cluster-randomized designs on a hospital 
level to reduce the threats to internal validity posed by patient-RCTs conducted in the same 
institution or ward. Interrupted time series design with sufficient time points and well-
designed controlled before-and-after study design with at least two intervention and two 
control groups can also be considered. However, it is difficult to eliminate contamination 
during the evaluation of social complex interventions such as CPWs. Thus, we recommend 
the use of realist designs which considers contextual factors that modulate patterns of 
outcomes observed at the level of reality. 
Intervention reporting 
The development and implementation of the clinical pathways were poorly reported in most 
studies. This poor reporting hampered our ability to assess implementation and other 
contextual factors that may translate to successful patient and health system outcomes. These 
assessments are imperative and will aid program implementers to utilize scare healthcare 
resources judiciously. It will also enable them to choose the best strategies that are evidence-
informed and tailored to the local context. Based on the evidence generated in this review and 
the findings by Squires et al. (2014) on implementation strategies for complex interventions, 




Clinical pathway definition 
Owing to the lack of consensus for a clinical pathway definition, identification of primary 
studies for thorough evaluation of the effects of clinical pathways remain an on-going 
challenge. We overcame this barrier by refining and pilot testing an operational or working 
definition for clinical pathways that was subsequently applied to identify important studies. 
We recommend future researchers or evaluators to use and refine our working definition as 
they deem fit to their clinical context when synthesizing evidence on this topic. Further 
research such as concept analysis is required to address the variation in the definition of this 
complex intervention. 
Outcome reporting 
The quality of reporting of the study outcomes in many studies was problematic. Primary and 
secondary outcomes alongside their uncertainty measures should be completely assessed and 
reported by authors of primary studies. Complete reporting will enable a thorough analysis of 
the study outcomes, as imputation limits the external validity of the evidence generated. To 
ensure meaningful interpretation of patient-important measures such as hospital length of stay 
or mortality rate, associated measures such as rehospitalization or readmissions should 
likewise be reported. 
Cost evaluations 
There is an urgent need for robust economic analysis and economic evaluations of clinical 
pathway interventions in healthcare. This chasm, if filled, will aid policymakers and clinical 
managers to make evidence-informed decisions to develop, implement and sustain clinical 
pathways in hospitals. Until this evidence is available, it is difficult to ascertain the return on 
investment of healthcare dollars. 
3.10 Author Contribution 
Thomas Rotter (TR) and Leigh Kinsman (LK) conceptualized the study. TR, AL, LK planned 
the review process in consultation with the Australasian Cochrane Centre. Adegboyega 
Lawal (AL) managed the data acquisition process in collaboration with the UK Cochrane 
Centre. AL, TR, LK, Phil Woods (PW), Andreas Machotta (AM) screened records for titles 
and abstracts. AL and Christopher Plishkha (CP) reviewed and extracted data from eligible 
full text articles and TR acted as an arbitrator to resolve any disagreement. AL took the 
 75 
leadership of the review and led the writing, data analysis and final conclusions of the review. 
TR, LK, Ulrich Ronellenfitsch (UR), Shannon Scott (SS), Donna Goodridge (DG), Gary 
Groot (GG) provided comments and approved the final draft of the review to be published. 
3.11 Differences between protocol and review 
In consultation with the Australasian Cochrane centre, the following changes were made to 
the update review since the protocol was published in 2007. 
1.) We refined the working definition for the definition of a clinical pathway (CPW). The 
following four criteria for clinical working definition derived include: 
• the intervention was a structured multidisciplinary plan of care; 
• the intervention was used to translate guidelines or evidence into local structures; 
• the intervention detailed the steps in a course of treatment or care in a plan, pathway, 
algorithm, guideline, protocol or other ‘inventory of actions’ (i.e. the intervention had 
time-frames or criteria-based progression; and 
• the intervention aimed to standardize care for a specific population. 
An intervention meeting all four criteria was considered to be a clinical pathway 
2.) Since the protocol was published in 2007, we split the review into two separate 
reviews; this review focusing on secondary care and the other on primary care. For 
literature searching purposes, we removed the colon and changed the title from 
'Clinical pathways: effects on professional practice, patient outcomes, length of stay, 
and hospital costs' to 'Clinical pathways for secondary care and the effects on 
professional practice, patient outcomes, length of hospital stay and costs'. 
3.) 'Adverse event' was listed as a separate secondary outcome in the protocol. However, 
due to the overlap with another outcome 'in-hospital complications', we recorded 
'adverse events' as a type of in-hospital complication. 
4.) We initially planned a fixed-effect and random-effects meta-analysis, however we 
only conducted random-effects meta-analyses owing to the assumption of the 
variation in the effect estimates across the included studies. 
5.) The first version of this review did not include a 'Summary of findings' table. For this 
update, we incorporated a few changes to ensure the review complies with updated 
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MECIR standards by including two 'Summary of findings' tables with six patient 
relevant outcomes that were defined posthoc. 
6.) To conform with the EPOC taxonomy for outcomes reported in EPOC reviews, we 
changed 'adherence to evidence-based practice' to 'adherence to recommended 
practice'. 
7.) To avoid duplication in outcome reporting, we reported 'inpatient mortality' and 
'mortality at longest follow-up' as '90-day mortality'. 
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TRANSITION FROM CHAPTER 3 TO CHAPTER 4 
The Cochrane systematic review (update) on the effects of clinical pathways in hospitals 
showed that clinical pathways have potentials to reduce hospital length of stay, hospital costs, 
in-hospital complications and improve adherence to recommended practice. Apart from the 
equivocal results on the primary and secondary outcomes from the systematic review update, 
the following gaps were also identified from the review update: 
1. Lack of a coherent theory on how clinical pathways work in hospitals 
2. Limited research on costing studies and economic evaluations on clinical pathways 
utilizations in hospitals 
3. Lack of contextual factors and mechanisms for successful implementation of CPWs in 
hospitals 
To address some of the limitations of the systematic review update and to adequately address 
the research questions asked by this thesis, the next manuscript is a realist review protocol 
that aims to describe a method for developing a realist program theory for clinical pathways 
in hospitals. Using Pawson’s approach for conducting realist reviews and recognizing the role 
of contextual factors, the protocols describes a five-step process to create the first realist 
program theory for clinical pathways in hospitals.  
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Background: Despite the increased utilization of clinical pathways (CPWs) as a strategy to 
improve patient and system outcomes in hospitals, there remain ongoing challenges with their 
conceptualization, implementation and evaluation. Theories that explain how CPWs work in 
hospitals are lacking, making it difficult to identify important factors for sustaining changes 
arising from CPWs implemented in hospitals.  
Methods: This is a protocol for a realist review following the approach proposed by Pawson 
et al. (2005) for realist synthesis and adapted by Molnar et al. (2015).  The review will use a 
six-step iterative process to develop a program theory for CPWs in hospitals. 
Discussion: Overall, the review aims to develop a program theory for CPWs in hospitals and 
to explore how, why, to what extent and in what contexts does the effective implementation 
of CPWs in hospitals contribute to better patient and system outcomes. As a result, the review 
will provide a theoretical evidence base on how CPWs work in hospitals. 
Systematic review registration: CRD42018103220 







In this era of increasingly scarce resources, administrators and healthcare providers are tasked 
continually with the responsibility of providing high-quality patient-centered care [140, 141]. 
Hospitals play a vital role in patient management by providing acute and specialist services, 
which constitutes a core feature of well-functioning health systems [142]. Many health 
systems have turned to new ways of delivering patient care to maximize clinical efficiency 
[143]. Robust quality improvement initiatives to improve quality of patient care has been 
trialed across different health systems to improve the quality of the care delivered [143]. 
Examples of these hospital initiatives include the use of Six Sigma, Lean management and so 
on [143].  Despite the conscientious effort by healthcare systems to enhance patient 
outcomes, the adoption and sustainability of improvement initiatives remain an ongoing 
challenge. Communication and variation of clinical processes have been identified as crucial 
factors that impact patient care in several hospitals [144, 145].  
Clinical pathways (CPWs), also known as care maps, algorithms or protocols are evidence-
based multidisciplinary care plans that detail a stepwise approach to the management of 
patients with a specific disease [40, 146]. CPWs are used to translate universal clinical 
guidelines into local protocols to influence clinical practice [147]. Originating in the United 
States in the 1980s [16], CPWs have been implemented across many health systems and are 
primarily used in hospitals to reduce clinical variation by standardizing care processes, 
promoting interprofessional teamwork, containing costs and improving patient outcomes [21, 
39]. CPWs are commonly implemented as web-based tools to support clinical decision-
making processes.  
Despite the widespread use of CPWs in healthcare settings, evidence on their effectiveness in 
hospital settings has been equivocal [21]. A Cochrane systematic review on effects of clinical 
pathways in hospitals by Rotter et al. (2010) [3] concluded that CPWs have the potential to 
reduce in-hospital complications and improve documentation among healthcare providers, 
although there was no evidence of differences in hospital readmissions or mortality rates [3]. 
Conversely, Doig et al. (2008) and Process et al. (2014) reported increased mortality within a 
period of 90-days after using CPWs to manage stroke and septic shock patients respectively 
[66, 124]. A systematic review by Deneckere et al. (2012) on the effects of CPWs on 
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teamwork found little evidence of improvement in staff knowledge, interprofessional 
documentation, team communication or team-relations [39].  
The conceptualization, implementation and evaluation of CPWs in healthcare settings is an 
on-going challenge for program managers and CPWs researchers [16, 148]. Several problems 
plaguing this area of investigation includes a lack of a unified definition for CPWs in 
healthcare, scarcity of evidence-based strategies for effective implementation and the use of 
weak evaluative designs [16]. One of the common challenges facing CPWs in hospitals is the 
lack of explicit theories on how CPWs work in these practice settings [149]. Hospitals are 
complex healthcare environments with diverse stakeholders and structures interwoven to 
achieve different and common goals [150]. Adoption of interventions with multifaceted 
components (complex interventions), such as CPWs in hospitals, require a broader 
perspective and understanding of the hierarchical layers within the hospital environment [55, 
151]. When poorly implemented, CPWs have been portrayed as “cookbook medicine” with 
little or no adherence by care providers at healthcare facilities including hospitals [41].  
The use of theory in implementing evidence-based interventions is vital to the 
operationalization, adoption and replication of new knowledge in hospitals. Additionally, 
interventions underpinned by theories are more likely to provide meaningful information on 
the sequence of events and how they relate to the intended program outcomes [55]. This 
information can, in turn, be used to improve the overall program or be adapted for a different 
setting or purpose. Similar to other complex interventions, CPWs can have influence at the 
micro (individual), meso (healthcare teams) and macro (policy) levels of the health system 
and a thorough understanding of the relationship between these levels is required for system-
wide success [152]. This protocol focuses on the effects of CPWs at the macro health system 
level, particularly on how effective implementation impacts health-system outcomes.  
Factors such as leadership commitment, healthcare provider engagement, information 
technology, staff empowerment and patient engagement have been identified to influence 
implementation of CPWs in hospitals [153]. However, there is a lack of understanding of 
how these critical factors interact to influence patient care in hospitals [77]. Furthermore, 
unknown critical factors may negatively impact the implementation process and ultimately 
lead to poor outcomes. Hence, it is timely to develop a testable theory that can explain how, 
 82 
why, to what extent and in what contexts effective implementation of CPWs in hospitals 
contributes to better health system outcomes.  
A theoretical lens of how CPWs work in hospitals will uncover the essential determinants of 
effective implementation that can translate to better outcomes. Due to the methodological 
constraints posed by randomized controlled trials and systematic reviews of randomized 
controlled trials to control for contextual factors in CPWs research, it is difficult to unravel 
contextual factors that impact successful adoption of CPWs in healthcare environments. This 
is due to the difficulty in capturing the reality of healthcare professional environment with 
these evaluation designs. Therefore, we intend to conduct a realist review to develop a 
program theory for CPWs in hospital care.  
Realist philosophy acknowledges that the world is “real” and humans interact with reality 
which limits or constructs their interpretation [154]. Thus, realist methodology considers 
multiple layers of interpretations within a social context as a function of reasoning and 
resources provided by the social environment [57]. This notion is important in our review 
because there is a likelihood of variation in the level of understanding or purpose of a CPW 
for different groups of care providers within the same hospital. Furthermore, our rationale for 
adopting a realist approach is due to the equivocal results from the preliminary results of our 
ongoing systematic review update on the effects of CPWs in hospitals [155]. The first version 
of the ongoing systematic review [3] was limited due to inadequate reporting of included 
studies and the methodical approach of conducting systematic reviews with explicit inclusion 
and exclusion criteria. This approach hindered the addition of narrative studies that might 
have been useful for identifying essential elements of implementation that are associated with 
intended outcomes.   
Realist reviews aim to examine “what works for whom under what circumstances, how and 
why?” [60] Originally developed by Ray Pawson, a realist review utilizes multiples sources 
of information and relevant study designs linked to the program theory to explain causal 
relationships between contexts, mechanisms and outcomes with the goal of refining the 
program theory [57]. A program theory is an expression of how of an intervention or its 
components lead to intended outcomes [60]. The program theory seeks to provide decision-
makers with an in-depth understanding of an intervention and how it works or does not work 
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in different contexts, thus making it appropriate for evaluating complex interventions such as 
CPWs.  
While contexts are conditions that an intervention operates in (not necessarily settings),  
mechanisms in simple terms are “what causes things to happen.” [57] Thus realists assert that 
the interaction between the context(s) and mechanisms can shed light on the patterns of 
outcomes observed. This theory based synthesis will utilize a context-mechanism-outcome 
(CMO) configuration to develop a program theory for implementing CPWs in hospitals [57]. 
CMO configurations will permit the formation of testable hypotheses that can be used for 
confirmation or refinement of an initial program theory [60]. For example, the identification 
of a hypothesis for implementing CPWs in hospitals that value “interprofessional 
collaboration” may provide valuable information that can be used to confirm or refute this 
aspect of the program theory. The proposed realist review will permit the development of 
testable hypotheses that can improve our understanding of CPWs in healthcare and how they 
contribute to better health system outcomes.  
4.3 Review objectives and questions  
The objective of this realist review is to develop a final program theory for CPWs in hospitals 
that can be subsequently tested in the real world for further refinement.  
The primary review question is: “How, why, to what extent and in what contexts does the 
effective implementation of clinical pathways in hospitals contribute to better health system 
outcomes?” To ensure a sizeable scope of the review and allow for comparison with our 
ongoing systematic review on the effects on CPWs in hospitals, we will focus on the 
following health system outcomes: length of hospital stay, costs, in-hospital mortality, 
adherence to recommended practice and in-hospital complications. 
The secondary review questions are as follows: 
I. What contexts facilitate or hinder the implementation of clinical pathways in 
hospitals? 




With content and clinical expertise and librarian support, our team will review the CPWs 
literature with the aim of developing a program theory. We will adopt the approach by 
Molnar et al. (2015) [156], developed initially by Pawson for conducting realist review [57], 
to develop a program theory for CPWs in hospitals. The steps involves (1) development of a 
preliminary program theory; (2) search strategy and literature search; (3) study selection and 
appraisal; (4) data extraction; (5) data analysis and synthesis [156]. This review will be 
conducted following the RAMESES quality standard guidelines for realist synthesis [60]. For 
this review, we will adopt the working definition for a CPW originally developed by Rotter et 
al. (2013) and refined by Lawal et al. (2016): (1) the intervention was a structured 
multidisciplinary plan of care; (2) the intervention was used to translate guidelines or 
evidence into local structures; (3) the intervention detailed the steps in a course of treatment 
or care in a plan, pathway, algorithm, guideline, protocol or other ‘inventory of actions’ (i.e., 
the intervention had time-frames or criteria-based progression); and (4) the intervention 
aimed to standardize care for a specific population [146, 157]. An intervention meeting all 
four criteria will be considered to be a CPW.  
4.5 Initial program theory development 
In addition to examining the grey literature, the initial program theory will be derived by 
examining all articles retrieved from the literature search of the on-going systematic review 
update on the effects of CPWs in hospitals [155]. We will identify and group the processes, 
strategies, resources and outcomes resulting from the implementation of CPWs in hospitals 
based on the objective and theoretical accounts of the authors. The review team will construct 
the preliminary program theory by generating hypotheses of “how,” “to what extent” and in 
“what contexts” does the effective implementation of clinical pathways in hospitals 
contribute to better health system outcomes. This process will be carried out in close 
consultation with a realist methodologist, Dr. Gill Westhorp. With support from the 
Saskatchewan Ministry of Health and the Saskatchewan Health Quality Council’s Variations 
and Appropriateness Working Group, we will consult with a group of multidisciplinary 
content experts including physicians, nurses, researchers, project managers and other relevant 
frontline users of CPWs based in Saskatchewan, to provide critical insights to refine the 
preliminary program theory. 
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4.6 Search strategy and literature search 
To develop an initial understanding of how effective implementation of CPWs in hospitals 
translates to better health system outcomes, we will conduct a focused examination of the 
CPWs literature. As recommended by the RAMESES guidelines, our search strategy and 
search terms will be guided by hypotheses developed from the preliminary program theory 
[60]. We will start with the initial search terms identified from the on-going systematic 
review update of CPWs effects in hospitals. Search terms will include: “clinical pathways,” 
“care pathways,” “critical pathways,” “clinical protocol,” “implementation,” “effective,” 
“hospital,” “patient,” “physician(s),” “treatment,” “theory,” “models,” “strategy(s).” The 
review team will examine these search terms in consultation with an information scientist and 
expanded as necessary. The search process will commence with Medline and Google scholar 
and be further expanded to other databases and other sources of information related to our 
review objectives.  
Additionally, we will search grey literature and websites of organizations involved with the 
implementation of CPWs, such as Intermountain Healthcare [158], European Pathway 
Association [159], The National Institute for Health and Care Excellence, [160] etc. We will 
contact authors of included primary articles for other relevant publications. We will use a 
snowball sampling method [161] to examine references of retained articles during the initial 
screening phase. We will follow an iterative approach for searching the literature to refine or 
refute the preliminary program theory. Overall, the initial development and refinement of the 
search strategy and conducting the literature search will follow an iterative process. Since 
CPWs emerged in the 1980s, we will search for studies from 1980 to the present. See 
Appendix 5 for an example of the initial Medline search strategy used for the on-going 
Cochrane systematic review on the effects of CPWs in hospitals. 
4.7 Study selection and appraisal 
Two review members will independently screen all retrieved studies from the search process 
using the following inclusion criteria: (1) intervention meets the following definition for a 
clinical pathway ((i) the intervention was a structured multidisciplinary plan of care; (ii) the 
intervention was used to translate guidelines or evidence into local structures; (iii) the 
intervention detailed the steps in a course of treatment or care in a plan, pathway, algorithm, 
guideline, protocol or other ‘inventory of actions’ (i.e. the intervention had time-frames or 
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criteria-based progression); and (iv) the intervention aimed to standardize care for a specific 
population. An intervention meeting all four criteria will be considered a CPW); (2) study 
was conducted in a hospital; (3) availability of information on implementation strategy(s) 
employed; (4) at least one health system outcome reported - length of hospital stay, costs, in-
hospital mortality, adherence to recommended practice and in-hospital complications. We 
will exclude studies on CPWs that are not focused on hospital interventions. To ensure that 
the credibility and trustworthiness of the review is maintained, we will assess the rigor and 
relevance of each study’s potential contribution to the development of the program theory. 
Iteratively, we will use a two-step process to screen all retrieved studies beginning with the 
abstracts, followed by full-text assessment of the included abstracts. We will manage the 
literature process using Endnote software and code all included and pending studies. Where 
applicable, a third review member will resolve any disagreement during the screening 
process. Following a similar approach, we will assess grey literature and other sources of 
information relevant during the review process.  
4.8 Data extraction 
Two review authors will independently extract data from all included primary studies using a 
piloted draft proposition sheet to extract explanatory accounts propositions (EAPs) about the 
program theory for CPWs implementation in hospitals. The EAPs are explanatory statements 
that may support, refine or refute judgments about an aspect or the program theory in its 
entirety [60]. Areas of data extraction will include:  
• Study characteristics: title, author, publication year, country, participants, study focus 
(hospital interventions) 
• Intervention: relevance to the program theory, implementation strategies 
• Program theory: explanatory accounts in C-M-O configuration, aspect(s) of program 
theory supported, refined or refuted, other notes 
• Methodology: relevance, study rigor  
Relevance and rigor are dimensions of ‘fitness for purpose’ in realist synthesis [53]. EAPs 
will be extracted from primary studies using an adapted format (“If-then-because”)  for 
extracting propositions in realist inquiries [162]. “If-then-because” propositions assume that 
“outcome - y” will occur because “z mechanism” fire in context “x.” We will identify EAPs 
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focused on the implementation and outcomes of CPWs in hospital settings. Subsequently, we 
will attempt to identify the CMOs from the extracted EAPs. Additionally, we will identify 
middle-range theories which are demi-regularities emerging from the data and are observable 
as a testable hypothesis to refine, support or refute the program theory [60]. Where feasible, 
the extracted middle-range theories will be supported by formal theories identified from our 
ongoing systematic review update or additional sectors apart from healthcare, where CPWs 
have been implemented. This step will be supported by the review teams’ theoretical and 
content expertise. All extracted data will be managed using Microsoft Excel. See Appendix 5 
for the draft data extraction sheet to be used for the review.  
4.9 Data analysis and synthesis 
Two review authors will extract the EAPs from the data extraction stage. Where necessary 
the team will consult with a review team to resolve any disagreement to improve the 
consistency and validity of the evidence generated. We will group the EAPs statements based 
on emerging themes, for example, “leadership support” or “staff empowerment.” 
Retroductively, we will identify the emerging CMOs configurations from thematic groupings 
of EAPs. Because the emerging themes from EAPs are not mutually exclusive, EAPs can be 
grouped into more than one thematic category.  Where appropriate, we will juxtapose, 
reconcile, adjudicate, consolidate and situate the evidence created within the framework of 
the program theory.  
We will then identify the CMOs configuration existing within each thematic grouping and 
attempt to form CMOs configurations at middle range theory level. Middle range theories 
explain the regularities of social behavior that can be explored further by hypothesis testing 
[60]. The CMOs at the middle range theory level will be used to revise our initial program 
theory to form the initial revised program theory. All hidden and explicitly stated 
mechanisms [163] will be elicited with the support of content and theoretical expertise within 
the review team. Due to the focused scope of the review, we will only utilize fundamental 
mechanisms in developing and refining the program theory; we will use mechanisms that 
yielded the most substantial impact on the outcomes of interest based on different contexts. 
This approach also makes the breadth and depth of the review manageable and tangible for 
translation and implementation. This process will be conducted in consultation with content 
specialists and other frontline users of CPWs in hospitals to refine the program theory. 
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4.10 Stakeholder consultation and refinement of the program theory 
To ensure the relevance of the program theory, we will consult with a CPW stakeholder 
advisory group comprising of content experts, realist methodologist, patient representative, 
policy makers, program managers, healthcare providers and other CPWs frontline users. Our 
content experts may include authors of primary studies focused on CPW implementation in 
hospitals or researchers who have successfully implemented CPWs in hospital settings. We 
will present the initial revised program theory and other study findings to the advisory group 
for their perspectives and to confirm, refine, or refute the initial revised program theory. The 
stakeholder engagement sessions will be delivered via facilitated discussion in a semi-
structured format comprising of face-to-face and remote sessions to accommodate 
international participants. The engagement sessions will follow the guiding principles 
described by Mazano 2016 for conducting approach for realist inquiry [164]. The goal of the 
engagement sessions is to ensure the appropriateness of all aspects of the program theory and 
to make suggested changes where necessary. This process will further improve our 
understanding of the program theory for CPWs in hospitals and ultimately lead to the 
development of the final revised program theory.  
4.11 Discussion  
Overall, the realist review aims to assess “how, why, to what extent and in what contexts 
does the effective implementation of clinical pathways in hospitals contribute to better health 
system outcomes?” As such, the review will create an evidence-based and theoretical 
framework to support key decision makers involved with the implementation of CPWs in 
hospitals. Building on the contextual attributes, successful implementation factors and key 
mechanisms identified via the program theory, we anticipate an improvement in the uptake of 
CPWs in hospitals. However, it is important to note that the steps described in this protocol 
will be conducted iteratively as opposed to a linear process which does not capture the 
complexities and iterations associated with realist reviews and complex interventions. The 
review will be disseminated via peer-reviewed journals, academic conferences and as part of 
a graduate thesis. Finally, we anticipate an increase in beneficial effects from the future 
implementation of CPWs in hospitals, particularly those focused on the outcomes of interest 
in this review; length of hospital stay, costs, in-hospital mortality, adherence to recommended 
practice and in-hospital complications.  
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7. CHAPTER 5: GENERAL DISCUSSION & CONCLUSIONS 
Clinical pathways (CPWs) have been used across health systems to bridge the evidence-
practice gap, reduce clinical variation, improve patient-centered care and reduce cost [21, 
165]. CPWs are predominantly implemented in hospitals and have evolved in healthcare as 
part of the ongoing effort to improve the quality of healthcare services. Also, CPWs are 
complex interventions that aim to translate the best available evidence to practice for specific 
health conditions [14]. They are multidisciplinary care plans that support the clinical 
decision-making process during the delivery of patient care.  
Traditionally, systematic reviews and more recently, realist reviews have been used to 
synthesize evidence on complex interventions such as CPWs [148, 166]. The aim is to 
translate research findings from several sources into a portable format that is useful for 
clinical practice on time. Despite the upward trend in the use of CPWs in hospitals due to 
their promising potentials to reduce clinical variation, improve patient outcomes, reduce 
associated healthcare cost in healthcare, there still exists issues that affect their effectiveness 
and uptake in hospitals [3]. To date, there is no consensus on the definition of a CPW in 
healthcare and studies evaluating the effects of CPWs have produced variable results [3]. 
Furthermore, there is no theoretical framework on how CPWs work in hospitals and evidence 
on strategies to best implement pathways in hospitals are lacking.  
The primary objective of this thesis was to examine the effects of clinical pathways (CPWs) 
in hospitals specifically on professional practice, patient outcomes, length of hospital stay 
and hospital cost. The secondary objective is to propose and describe a scientific method to 
develop a program theory for CPWs in hospitals as a starting point towards a theoretical 
framework for hospital pathways. The objectives were addressed via three manuscripts that 
form the core of this thesis: 1) a study that describes the process of refining an operational 
definition for CPWs; 2) a systematic review on the effects of CPWs in hospitals, and 3) a 
realist review protocol that describes a scientific approach to develop a program theory for 




The following overarching research questions were addressed: 
1.) What is a clinical pathway (manuscript 1)? 
2.) What are the effects of clinical pathways in hospitals on professional practice, patient 
outcomes, length of stay and hospital costs (manuscript 2)? 
3.) How can we develop a program theory for hospital-based clinical pathways 
(manuscript 3)? 
A brief synopsis and analysis of the three manuscripts will be provided in this chapter. An 
overall discussion that integrates the findings from all manuscripts and how they contribute to 
the current body of evidence, future research considerations, and implications for practice 
and policy will also be provided. 
5.1 Synopsis of Manuscripts 
5.1.1 Manuscript 1: What is a clinical pathway? Refinement of an operational definition to 
identify clinical pathway studies for a Cochrane systematic review   
The first manuscript (chapter 2) was a methods paper that builds on the work of Kinsman et 
al. 2010 [16]where a minimum set of criteria was developed to identify CPW studies in 
hospital settings for appraisal. The five-criteria checklist was used in conducting the first 
Cochrane systematic review on the effects of CPWs in hospitals in 2010 [14].  
However, due to poor reporting of CPWs interventions by authors of primary studies, it was 
problematic in applying the minimum criteria (operational definition) developed by Kinsman 
et al. 2010 to CPWs studies conducted across broader healthcare settings, e.g. primary care 
[157]. Hence, a four-criteria checklist (operational definition) for the definition of a CPWs 
was proposed as a more inclusive definition to capture CPW studies for literature synthesis. 
This thesis began by rigorously testing the refined operational definition for a CPW using 
reliability analysis.   
Twenty randomly selected articles focused on CPWs research were selected and 
independently appraised by two review team members using the four-criteria checklist for the 
definition of a CPW. Reliability analysis for qualitative variables was estimated using the 
kappa statistic. The pilot testing process generated 85% observed and 75% expected 
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agreement respectively with a kappa statistic of 0.99 (P value < 0.001), implying perfect 
agreement between the two reviewers.  
Henceforth a CPW was defined as an intervention that contained all four criteria; 1) a 
structured multidisciplinary care plan (2) used to channel the translation of guidelines or 
evidence into local structures (3) it details the steps in a course of treatment or care in a plan, 
pathway, algorithm, guideline, protocol or other ‘inventory of actions’ (i.e. the intervention 
had time frames or criteria based progression) (4) it aims to standardize care for a specific 
clinical problem, procedure or episode of care in a specific population [15]. The refinement 
and validation of the operational definition for a CPW permitted us to objectively investigate 
the current evidence on the effects of CPWs in hospitals via a Cochrane systematic review 
update. 
5.1.2 Manuscript 2: Clinical pathways for secondary care and their effects on professional 
practice, patient outcomes, length of stay and hospital costs: A Cochrane systematic review 
update 
The systematic review update to assess the current evidence on the effects of CPWs in 
hospitals followed the approach recommended by the Cochrane Effective Practice and 
Organisation of Care group for evaluating complex interventions. Due to the sensitivity of the 
search filters applied to various databases searched from August 7, 2008 to March 1, 2017 
and broad scope of the review, over 8000 search hits were screened with 12 additional 
identified during the updated search. In addition to the previously included 27 studies in the 
first version of the systematic review, the total number of included studies in the review 
update is 39 involving 15,911 participants.  
The review spanned across a broad range of hospital contexts from 13 countries and 
examined several clinical conditions involving diverse patient groups with 28 studies focused 
on non-invasive interventions. Thirty-two studies used a CPW as a single intervention (stand-
alone) to manage patient care while seven studies utilized a CPW as part of a multifaceted 
intervention to deliver patient care. In terms of study designs, four types of study designs 
(randomized controlled trials, non-randomized controlled trials, interrupted time series study 
and controlled before and after study) were considered for analysis. Overall, the direction of 
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effect estimates observed from the individual studies examined range from beneficial to non-
beneficial.  
Length of hospital stay (LOS) was the most frequent outcome reported among the included 
studies. LOS was reported more by studies evaluating stand-alone CPW interventions 
compared to multifaceted CPW interventions. Majority (22 studies) of the individual studies 
reported a reduction in hospital length of stay for patients managed with a CPW. Statistical 
pooling of the estimates from individual studies reporting on the length of hospital stay 
showed an overall reduction in length of stay of 0.83 days (95% CI -1.21 to -0.45) for stand-
alone CPW interventions and there were no differences in the LOS for patients managed with 
multifaceted CPW intervention compared to usual care. See (Table 3-3 and Table 3-4).   
In terms of hospital cost, seven studies reported on a highly diverse set of hospital cost or 
charge measures. All seven studies found lower hospitalization cost/charges or insurance 
points after the use of a stand-alone CPW for managing different clinical conditions. Meta-
analysis showed a cost savings of USD 1171.52 (95% CI -1835.86 to -507.18). There were 
no differences in cost savings for patients managed with multifaceted CPW intervention 
compared to usual care See (Table 3-3 and Table 3-4). 
Concerning patient outcomes, mortality at 90 days was examined by six studies from the 
stand-alone CPW intervention perspective. Meta-analysis revealed no differences between 
the CPW group and usual care group with an odds ratio of 0.83 (95% CI 0.62 to 1.12). For 
multifaceted CPW interventions, only two studies examined the effects of CPWs on mortality 
at 90 days and both studies found no statistical difference between the CPW group and usual 
care. Meta-analysis of seven studies using stand-alone CPW interventions to assess in-
hospital complications showed a significant reduction in in-hospital complications with an 
odds ratio of 0.46 (95% CI 0.33 to 0.65). There were no differences in hospital readmission 
rates up to six months after the use of stand-alone CPW interventions in managing patient 
care. See (Table 3-3 and Table 3-4).  
Adherence to recommended practice particularly documentation was the only professional 
practice outcome identified and examined. We found evidence for an increase in the number 
of documentation by healthcare providers using a CPW for clinical management purposes 
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compared to usual care. The combined odds ratio from two non-randomised studies was 
11.95 (95% CI 4.72 to 30.58). See (Table 3-3 and Table 3-4). 
Due to poor reporting of the primary studies examined we were only able to explore the 
number of implementation strategies used in implementing CPWs in hospitals and limited in 
assessing the degree with which the implementation strategies were effective. Clinician 
involvement was the most frequently reported strategy used by authors of included studies 
during the implementation of a CPW in the hospital (Table 3-2). Overall, the systematic 
review found evidence of improved outcomes when multiple implementation strategies are 
used.  
In terms of the quality of the evidence, all included studies had an inherent risk of bias that 
could have impacted the individual and pooled estimates. Sensitivity analyses of different 
effect estimates of the outcomes assessed by this review revealed equivocal results 
(Appendix 3). Apart from the broad scope of the review, the indefinite results observed from 
most of the outcomes examined may be due to the high-level of statistical and clinical 
heterogeneity. Following the Grading of Recommendations, Assessment, Development and 
Evaluations (GRADE) framework for developing and presenting summaries of evidence, the 
strength of the evidence of the review conclusions range from low certainty to very-low 
certainty (Table 3-3 and Table 3-4).  
The systematic review identified gaps in the literature; lack of a theoretical framework for 
CPWs in hospitals, no consensus on the definition of a CPW, lack of robust costing studies 
and a paucity of studies focused on the implementation process of CPWs in hospitals. These 
gaps allowed us to identify the next step in advancing the evidence base for CPWs in 
hospitals by attempting to describe a scientific process to develop a program theory for 
hospital-based pathways.   
5.1.3 Manuscript 3: Development of a program theory for clinical pathways in hospitals: 
protocol for a realist review 
The lack of a theoretical framework on how CPWs work in hospitals and the shortfall of 
systematic reviews to rigorously examine the relationship between contextual factors and 
observed outcomes has been documented in the literature [167]. A realist review aims to 
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develop a program theory by eliciting the interaction between context and mechanisms that 
can explain the pattern(s) of outcomes; a critical piece for implementing CPWs in hospitals 
[53]. The third manuscript, a realist review protocol describes a six-step process to 
developing a realist program theory for hospital-based CPWs with a focus on “how, why, to 
what extent and in what contexts does the effective implementation of CPWs in hospitals 
contribute to better health system outcomes?”  
Following Pawson’s approach for conducting realist reviews and in a non-iterative manner, 
the review will follow the following steps depicted in the figure below to arrive at the first 














Figure 3-3: Non-iterative steps to conducting realist review. Adapted from Molnar et. al (2015) 
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To our knowledge, the realist review will be first to elicit a program theory for CPWs in 
hospitals considering the influence of contextual factors on desired outcomes. This step can 
fill the void on a theoretical framework for hospital-based pathways and support 
implementation efforts in hospital settings. 
What is a clinical pathway? 
Historically, several definitions have been used to describe a clinical pathway and to date, 
there is still a lack of international consensus on what constitutes a clinical pathway [15]. 
This notion was evidenced via the systematic review on the effects of CPWs in hospitals 
where several terms such as protocols, care maps, algorithms, etc. used to refer to a clinical 
pathway were identified [14]. This finding is not surprising because CPWs are purported as 
complex interventions requiring a collaborative effort between different stakeholders to 
advance patient care. With variation in stakeholder interests especially in a hospital setting, 
CPWs may mean or serve different purposes for different groups of care providers and 
patients. Variation in CPW definition can negatively impact the strength of the evidence base 
for CPWs due to inconsistent and unobjective identification of pathway studies. 
However, this thesis was able to circumvent this problem by empirically testing a working 
(operational) definition for CPWs developed by Kinsman et al. (2010) [16] that is more 
inclusive of other healthcare settings including hospitals [15]. The refined definition 
comprising of four-criteria checklist for a CPW was subsequently used to update the evidence 
base on the effects of CPWs in hospitals via a Cochrane systematic review. A similar 
approach to developing and refining working definitions described in manuscript 1 can be 
adopted by researchers aiming to objectively create a set of criteria to identify studies 
reporting on interventions that lack a standard definition.  
Implementation of clinical pathways in hospitals 
Globally, the prevalence of CPWs in hospitals is on the horizon [36]. CPWs are often 
developed by care teams who adapt clinical guidelines and often supplemented with local 
evidence to suit clinical need or policy purposes. The implementation process is a vital step 
to ensure stakeholders clearly understand intended outcomes and expectations. Single or 
multiple implementation strategies have been reported in the literature [136]. Apart from poor 
reporting, the Cochrane EPOC study designs are quantitative thus making it difficult to assess 
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the relationship between CPW implementation strategies and the outcomes reported by 
primary studies in the systematic review update. This vital piece of the review is probably 
located in qualitative literature that has been excluded from the review thus justifying the use 
of a realist approach for future synthesis. 
All included studies in the review used multifaceted implementation strategies during the 
implementation of a CPW in various hospital context (Table 3-2). Clinician involvement was 
the most frequently used implementation strategy during the implementation process of a 
CPW on a ward, unit or hospital level (Table 3-2). This finding may be due to the key role 
clinicians play in driving pathway usage in hospital settings.  
The systematic review update also found no difference between the use of a single 
implementation strategy and multiple implementation strategies. This finding conforms with 
a recent systematic review by Squires et al. (2014) [136]. It could also imply that CPWs are 
less likely to affect outcomes in high functioning care teams in hospital although we found no 
evidence of this notion in our review. Overall, the evidence base on the best approach to 
implement CPWs to maximize intended outcomes is still weak as most reviews focused on 
the number of strategies as opposed to their influence on outcomes, a pivotal piece to 
successful implementation. 
Effects of clinical pathways in hospitals 
With the surge in the use of CPWs in hospitals and several healthcare systems intending to 
develop more pathways in various areas to address health system needs, it was timely to 
assess the evidence base on the effects of CPWs in hospitals. Equivocal results on the effects 
of CPWs in hospital settings have been documented by several studies in the literature [14]. 
To our knowledge, this systematic review update is the most comprehensive evidence base 
on the effects of hospital-based CPWs. The review builds on the first version of the Cochrane 
systematic review with new insights and findings [14].  
The updated review concluded that there is an association between stand-alone CPWs and a 
reduction in in-hospital complications, reduced length of hospital stay, reduced costs and 
adherence to recommended practice. However, there is no association between stand-alone 
CPWs and mortality and readmissions. For multifaceted CPW interventions implemented in 
hospitals, there is no association between a CPW that is part of a multifaceted approach and 
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mortality, readmissions, length of stay and costs. The strength of the evidence range from low 
certainty to very weak certainty. Due to the small number of studies (39 studies) included in 
the review from 13 countries with a high degree of statistical and clinical heterogeneity, the 
conclusions should be applied with caution. It was problematic in assessing disease-specific 
outcomes that may be more meaningful due to the insufficient studies reporting on similar 
outcomes or group of patients.  
Evaluation of clinical pathways in hospitals 
A key finding from the systematic review update is still the prevalence of weak study designs 
in evaluating the effects of CPWs in hospital contexts. Majority of the studies excluded from 
the review is due to the use of pre-post study designs which are prone to bias e.g. 
confounding bias. The use of randomized trials, non-randomized trials, interrupted time 
series design and controlled before-after designs as suggested by the Cochrane EPOC group 
ensured that only rigorous evaluations were considered for analysis [31]. Majority of the 
meta-analysis conducted in the review showed that weak study designs tend to overestimate 
the effects of CPWs in individual studies (Appendix 3). The use of Cochrane EPOC study 
designs aims to limit bias but are resource intensive and may limit the sample size of 
included studies that might have resulted in different conclusions.  
Despite the use of systematic reviews in providing information in a portable format for 
stakeholders and generating new hypotheses, there still exist gaps when used for complex 
interventions such as CPWs. This notion was evidenced in our systematic review where we 
found it difficult to attribute beneficial outcomes reported from individual studies to any 
aspect of the intervention. Apart from poor reporting in primary studies, the quantitative 
focus of the systematic review might have led to the exclusion of qualitative articles with 
contextual information that can inform us better on how CPWs work in hospitals and what 
pieces contribute to intended outcomes.  
A proposed method to bridge the gaps in the field of evaluation research for CPWs is the use 
of “realist methodology.” Realist reviews aim to utilize multiple sources of information to 
examine “what works for whom under what circumstances, how and why” and with the goal 
of developing or refining a program theory [53]. This thesis proposed a six-step process for 
developing a draft program theory for CPWs in hospitals. Due to the complexities associated 
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with normalizing CPWs in complex environments, it is not surprising there that is variability 
in the effects reported across various hospital contexts.  
Realist methods are more suited than systematic reviews for the evaluation of CPWs because 
they go beyond examining if an intervention “works or not” to “why,” “for whom,” “in what 
context” and “to what extent,” which is vital for success. The realist review will attempt to 
extract all explanatory account statements (EAs) related the initial program theory for 
implementing CPWs in hospitals and using a context-mechanism-outcome configuration 
(CMO). Subsequently, emergent themes, e.g. leadership support, team-work, etc. from the 
EAs will be used to develop key middle-range theories that can be tested at a hypothesis level 
to support, refute or refine the initial program theory. Apart from a better understanding of 
for whom or how CPWs work in hospitals, the realist approach will also help to uncover 
barriers and enablers to CPW implementation in different hospital settings making it a 
suitable choice for policy and practice.  
5.2 Contributions to Research 
This thesis started by statistically assessing the reliability of an operational definition for 
CPWs developed by defined Kinsman et al. (2010) to permit an objective identification of 
CPW studies (Manuscript 1) [146]. To my knowledge, the four-set CPW criteria validated via 
reliability analysis is the first of its kind to be used in appraising the literature for evidence 
synthesis in the field of CPW research. The four-criteria checklist for a CPW can be used to 
advance discussions towards an international consensus on what constitutes a CPW and 
further strengthen the evidence base for CPWs research. 
The Cochrane systematic review update on the effects of CPWs in hospitals represents the 
most comprehensive evidence base on this research topic since the first version of the review 
by Rotter et al. (2010). Other reviews exploring CPW effects in hospitals are limited in scope 
to assessing effects in a hospital unit or on a single clinical condition and do not focus on 
implementation strategies. Also, the Cochrane systematic review update is the first of its kind 
to rank the strength of the evidence which is vital to policymakers, researchers and care 
providers using CPWs. This step is a key addition to the field of evidence synthesis as 
methodological bias inherent in included studies tends to overestimate or underestimate 
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intervention effects and may likely affect policy formulation on hospital-based pathways. The 
updated systematic review will be published in the Cochrane Library.  
Due to resource constraints and scope of my doctoral program, it was not feasible to 
complete the realist review on CPWs in hospitals in this thesis. However, a significant 
strength is that this thesis did not only investigate the effects of clinical pathways in hospitals 
but ended with a comprehensive realist review protocol that lays the foundation for future 
research. The development of a realist program theory for CPWs in hospitals proposed by 
this thesis (Manuscript 3) will be the first attempt to derive a coherent theoretical framework 
on how CPWs work in hospitals. Upon completion of the realist review, the derived program 
theory for CPWs will advance our knowledge and understanding of CPWs in hospitals and 
how they contribute to better health system outcomes. The derived program theory can be 
adapted, refined or refuted with subsequent realist syntheses. To my knowledge, the realist 
review will be the first literature synthesis to develop a generic realist program theory for 
CPWs in hospitals. The nuggets of evidence arising from the realist review will be valuable 
to policymakers, care providers and researchers in optimizing the effects of CPWs in 
hospitals.   
5.3 General Study Limitations 
Although we validated a refined operational definition for CPWs via reliability analysis, there 
is a likelihood that other attributes of a CPW might have been missed by the four-criteria 
checklist used to define a CPW in this thesis. This is an area that can be explored for future 
research via concept analysis [168] with an international perspective. Another study 
limitation is the inherent risk of bias present in the 39 included studies of the systematic 
review update on the effects of CPWs in hospitals (Fig 3-2). Ten studies had an unclear risk 
of bias and two studies had a loss to follow up of more than 20%. The risk of bias in the 
included studies could have impacted the study results reported in the individual studies used 
in the meta-analysis for estimating CPW effects in hospitals.  
The broad scope of the systematic review by attempting to examine CPW effects across all 
hospital contexts might have contributed to the high degree of statistical and clinical 
heterogeneity observed in the majority of the meta-analytic comparisons carried out in the 
review (Appendix 3). Although highly sensitive search filters were used to design the search 
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strategy for the searching studies for the systematic review and other sources were searched, 
it is still unlikely to have captured all relevant CPW studies during this process. Also, 
Imputation techniques were used to account for missing data in some of the included studies 
particularly on missing measures of uncertainties (standard deviations, p-values, confidence 
intervals, etc.). The imputed values could have impacted the review estimates and associated 
meta-analyses in an unknown direction. Statistical summaries generated via systematic 
reviews are mostly based on averages or medians that may not be representative of the 
general population.  
Lastly, the positivist approach (systematic review) used by this thesis to investigate the 
effects of CPWs in hospitals was not able to capture the complexities associated with CPWs. 
Several qualitative studies or methods that could have better inform the current evidence 
were excluded or not considered. This made it difficult to identify and understand how 
important contextual factors and mechanisms for CPW effectiveness interact in hospitals to 
generate intended outcomes. However, this thesis filled this void by proposing an alternative 
method for future inquiries for CPW effects in hospitals following a realist approach. 
5.4 Future Research Recommendations 
Future research should focus on addressing the confusion on what constitutes a CPW. The 
lack of specificity in the definition of a CPW hinders the objective examination of CPW 
effects in healthcare. The four-criteria used to to define a CPW by this thesis operationally 
can be a starting point for international consensus. This task requires a joint effort by 
researchers, methodologist, health providers, patients, healthcare organizations and 
governmental bodies associated with the development, implementation and evaluation of 
CPWs in healthcare.  
The broad scope of the systematic review update on the effects of CPWs in hospitals 
contributed to the clinical and statistical heterogeneity observed in majority of the meta-
analytic summaries included in the review. To limit the impact of these variations in future 
reviews, authors should focus on investigating disease-specific pathways in hospitals. This 
approach may help to increase the number of primary studies available for possible analysis 
with higher statistical power and increased precision in the effect estimates. 
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Based on the complexities associated with normalizing CPWs in hospitals and the limited 
evidence generated by the systematic reviews in evaluating complex interventions, future 
evaluative designs with policy and practice implications should consider using realist 
methods for evidence synthesis. Realist approaches have the potential to elicit “who,” “for 
whom,” “how,” “in what contexts” and “to what extent” are CPWs effective in hospitals. 
Conducting the realist review described by the protocol in this thesis can serve as a starting 
point to form a theoretical framework on how CPWs work in hospitals which can be further 
explored by other researchers.  
With the global rise in the cost of healthcare, it is imperative to fill the void on the economic 
evidence for CPW interventions in hospitals. This issue can be addressed by conducting 
economic evaluations or robust costing studies that can objectively present the cost benefit of 
using CPWs in hospitals. Also, economic studies can provide additional information on the 
resources required for the effective implementation of CPWs. Finally, robust economic 
designs can aid the decision-making process for policy makers and hospital managers 
regarding the key decision to implement a pathway for a clinical condition or not- an 
exploration of value for money.  
5.5 Implications for Practice and Policy 
CPWs are continually developed in hospital settings to bridge evidence-practice gaps and 
support clinical decision making processes to maximize patient and health system outcomes. 
With the reported increase in the global prevalence of CPWs across many health systems, 
more CPWs are likely to be developed in the future for patient management. The information 
presented in this thesis on the effects of CPWs in different hospitals settings can support the 
decision-making process for healthcare providers using CPWs for managing patients with 
different clinical conditions.  
With the conflicting evidence and low confidence associated with the outcomes examined by 
the systematic review conducted in this thesis, it is essential for policymakers and health 
administrators to carefully consider the cost versus quality implications and where possible 
utilize alternative interventions. Additionally, the evidence on implementation strategies for 
CPWs in hospitals generated by this thesis is valuable to health administrators who are 
challenged with the best approach to roll out CPWs in hospital units.  
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5.6 Conclusion 
Globally, health systems are continuously searching for effective ways to provide patient care 
without a comprise of quality and costs. CPWs are quality improvement strategies that can 
reduce variation in care processes during an episode of care thus optimizing patient and health 
system outcomes. This thesis has shown via a Cochrane systematic review on the effects of 
CPWs in hospitals, that stand-alone CPW interventions have the potential to reduce hospital 
length of stay and in-hospital complications, improve documentation by care providers and 
reduce associated healthcare costs for patients. These findings should be interpreted and 
extrapolated with caution due to the low certainty of evidence associated with the review 
conclusions. 
To our knowledge, this is the most comprehensive evidence base for assessing the effects of 
CPWs in hospitals. Due to the study limitations, experience and challenges faced using the 
systematic review methodology to assess CPW effects, we recommend a realist approach for 
future syntheses of complex interventions including CPWs. A realist synthesis helps to identify 
and unpack critical factors within different hospital contexts that may influence the patterns of 
outcomes observed after the implementation of a CPW. These nuggets of information are vital 
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53 (pre-workshop or post-workshop or (before adj3 workshop) or (after adj3 workshop)).ti,ab. 
54 trial.ti. or ((study adj3 aim?) or "our study").ab. 
55 (before adj10 (after or during)).ti,ab. 
56 ("quasi-experiment$" or quasiexperiment$ or "quasi random$" or quasirandom$ or "quasi control$" or quasicontrol$ or ((quasi$ or experimental) adj3 (method$ or study or trial or design$))).ti,ab,hw. 
57 ("time series" adj2 interrupt$).ti,ab,hw. 
58 (time points adj3 (over or multiple or three or four or five or six or seven or eight or nine or ten or eleven or twelve or month$ or hour? or day? or "more than")).ab. 
59 pilot.ti. 
60 Pilot projects/ 
61 (clinical trial or controlled clinical trial or multicenter study).pt. 
62 (multicentre or multicenter or multi-centre or multi-center).ti. 
63 random$.ti,ab. or controlled.ti. 
64 (control adj3 (area or cohort? or compare? or condition or design or group? or intervention? or participant? or study)).ab. not (controlled clinical trial or randomized controlled trial).pt. 
65 evaluation studies as topic/ or prospective studies/ or retrospective studies/ [Added Jan 2013] 
66 (utili?ation or programme or programmes).ti. [Added Jan 2013] 
67 (during adj5 period).ti,ab. [Added Jan 2013] 
68 ((strategy or strategies) adj2 (improv$ or education$)).ti,ab. [Added Jan 2013] 
69 "comment on".cm. or review.pt. or (review not "peer review$").ti. or randomized controlled trial.pt. [Changed Jan 2013] 
70 (rat or rats or cow or cows or chicken? or horse or horses or mice or mouse or bovine or animal?).ti. 
71 exp animals/ not humans.sh. 
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72 (or/48-68) not (or/69-71) [EPOC Methods Filter 2.5-added Evaluation Studies line forward--Jan 20130 Medline] 
73 (or/39-44) and 47 [RCT Results] 
74 (39 and 72) not 73 [EPOC Filter Results Set 1 : Pathways & PC] 
75 (40 and 72) not (or/73-74) [EPOC Filter Set 2: Pathways & Community-Ambulatory Care] 
76 (41 and 72) not (or/73-75) [EPOC Filter Set 3: Focussed GL & PC] 
77 (42 and 72) not (or/73-76) [EPOC Filter Set 4: Focussed GL & Ambultory] 
78 (43 and 72) not (or/73-77) [EPOC Filter Set 5: GL & PC/Amb care] 
79 or/74-78 [EPOC Filter Results] 
80 73 or 79 
81 limit 80 to yr="2015 -Current" 
  
2016 update: 30/08/2016 
No. Search terms 
1 Critical Pathways/ 
2 ((clinical or critical) adj2 (pathway? or path)).ti,ab. 
3 ((care adj2 algorithm?) or clinical algorithm?).ti,ab. 
4 (care adj2 pathway?).ti,ab. 
5 (treatment adj3 algorithm?).ti,ab. 
6 (structured care or intensive management).ti,ab. 
7 (standardi$ adj3 (treatment? or care or patient care or plan$)).ti,ab. 
8 (care adj2 (plan? or map or maps or protocol? or algorithm?)).ti,ab. 
9 (protocol? adj4 (nursing or treatment or management or directed or guided)).ti,ab. 
10 ((local or locally) adj2 adapt$ adj5 guideline?).ti,ab. 
11 (treatment model? adj10 standardi$).ti,ab. 
12 (standardi$ adj3 (template or templates)).ti,ab. 
13 or/1-12 [Pathways] 
14 Clinical protocols/ 
15 Algorithm/ and (di.fs. or (treatment or care or patient?).ti. or diagnos$.ti,ab.) 
16 Practice Guidelines as Topic/ or Guideline Adherence/ or Guidelines as topic/ 
17 ((guideline or guidelines) adj2 (adher$ or implement$)).ti,ab. 
18 (guideline? adj4 (compliance or complying)).ti,ab. 
19 or/16-18 [PGL or GL Adherence] 
20 (adherence or care or compliance or comply$ or implement$ or impact or plan? or standardi?ed or pathway or (treatment adj3 (protocol? or algorithm?))).ti,ab. 
21 19 and 20 [GL ] 
22 *Guidelines as topic/ or *Practice Guidelines as topic/ 
23 *Guideline Adherence/ 
24 or/22-23 [Focussed MeSH Guideline] 
25 Primary health care/ or Primary Care Nursing/ 
26 Family practice/ or General Practice/ 
27 General Practitioners/ or Physicians, Family/ or Physicians, Primary Care/ 
28 ((general or family) adj2 (practice? or practitioner? or physician? or doctor?)).ti,ab. 
29 (primary adj2 (care or health care or healthcare or medical care or patient care)).ti,ab. 
30 (primary care or family medic$ or general practice or family practi$).jn. 
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31 GP.ti. 
32 or/25-31 [Primary Care ] 
33 Ambulatory Care/ or Community medicine/ or community health nursing/ or community health services/ or home care services/ or Community mental health services/ or Community Pharmacy Services/ 
34 Ambulatory Care Facilities/ or Community Health Centers/ 
35 (community or communities).ti,ab,hw. 
36 (((ambulatory or walk-in or neighbo?rhood or community) adj2 (clinic? or care centre or care centres or care center? or health$ centre or health$ centres or health$ center?)) or public clinic?).ti,ab. 
37 ((urban or rural) adj3 health).ti,ab. 
38 or/33-37 [Community Care] 
39 13 and 32 [Pathway terms & PC] 
40 (and/13,38) not 39 [Pathways & Community-Ambulatory Care] 
41 (and/24,32) not (or/39-40) [Focussed GL & PC] 
42 (and/24,38) not (or/39-41) [Focussed GL & Community-Ambulatory Care] 
43 (21 and (or/32,38)) not (or/39-42) [GL & PC/Amb Care] 
44 ((or/14-15) and ((or/26-31,38) or *Primary health care/ or *Primary Care Nursing/)) not (or/39-43) [Clinical Protocols/Algorithms Mesh & PC/Community Care-combine with RCT filter only] 
45 (randomized controlled trial or controlled clinical trial).pt. or randomized.ab. or placebo.ab. or clinical trials as topic.sh. or randomly.ab. or trial.ti. 
46 exp animals/ not humans.sh. 
47 45 not 46 [Cochrane RCT Filter 6.4.d Sens/Precision Maximizing] 
48 
intervention?.ti. or (intervention? adj6 (clinician? or collaborat$ or community or complex or DESIGN$ or 
doctor? or educational or family doctor? or family physician? or family practitioner? or financial or GP or 
general practice? or hospital? or impact? or improv$ or individuali?e? or individuali?ing or interdisciplin$ 
or multicomponent or multi-component or multidisciplin$ or multi-disciplin$ or multifacet$ or multi-
facet$ or multimodal$ or multi-modal$ or personali?e? or personali?ing or pharmacies or pharmacist? or 
pharmacy or physician? or practitioner? or prescrib$ or prescription? or primary care or professional$ or 
provider? or regulatory or regulatory or tailor$ or target$ or team$ or usual care)).ab. 
49 (pre-intervention? or preintervention? or "pre intervention?" or post-intervention? or postintervention? or "post intervention?").ti,ab. [added 2.4] 
50 (hospital$ or patient?).hw. and (study or studies or care or health$ or practitioner? or provider? or physician? or nurse? or nursing or doctor?).ti,hw. 
51 demonstration project?.ti,ab. 
52 (pre-post or "pre test$" or pretest$ or posttest$ or "post test$" or (pre adj5 post)).ti,ab. 
53 (pre-workshop or post-workshop or (before adj3 workshop) or (after adj3 workshop)).ti,ab. 
54 trial.ti. or ((study adj3 aim?) or "our study").ab. 
55 (before adj10 (after or during)).ti,ab. 
56 ("quasi-experiment$" or quasiexperiment$ or "quasi random$" or quasirandom$ or "quasi control$" or quasicontrol$ or ((quasi$ or experimental) adj3 (method$ or study or trial or design$))).ti,ab,hw. 
57 ("time series" adj2 interrupt$).ti,ab,hw. 
58 (time points adj3 (over or multiple or three or four or five or six or seven or eight or nine or ten or eleven or twelve or month$ or hour? or day? or "more than")).ab. 
59 pilot.ti. 
60 Pilot projects/ 
61 (clinical trial or controlled clinical trial or multicenter study).pt. 
62 (multicentre or multicenter or multi-centre or multi-center).ti. 
63 random$.ti,ab. or controlled.ti. 
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64 (control adj3 (area or cohort? or compare? or condition or design or group? or intervention? or participant? or study)).ab. not (controlled clinical trial or randomized controlled trial).pt. 
65 evaluation studies as topic/ or prospective studies/ or retrospective studies/ [Added Jan 2013] 
66 (utili?ation or programme or programmes).ti. [Added Jan 2013] 
67 (during adj5 period).ti,ab. [Added Jan 2013] 
68 ((strategy or strategies) adj2 (improv$ or education$)).ti,ab. [Added Jan 2013] 
69 "comment on".cm. or review.pt. or (review not "peer review$").ti. or randomized controlled trial.pt. [Changed Jan 2013] 
70 (rat or rats or cow or cows or chicken? or horse or horses or mice or mouse or bovine or animal?).ti. 
71 exp animals/ not humans.sh. 
72 (or/48-68) not (or/69-71) [EPOC Methods Filter 2.5-added Evaluation Studies line forward--Jan 20130 Medline] 
73 (or/39-44) and 47 [RCT Results] 
74 (39 and 72) not 73 [EPOC Filter Results Set 1 : Pathways & PC] 
75 (40 and 72) not (or/73-74) [EPOC Filter Set 2: Pathways & Community-Ambulatory Care] 
76 (41 and 72) not (or/73-75) [EPOC Filter Set 3: Focussed GL & PC] 
77 (42 and 72) not (or/73-76) [EPOC Filter Set 4: Focussed GL & Ambultory] 
78 (43 and 72) not (or/73-77) [EPOC Filter Set 5: GL & PC/Amb care] 
79 or/74-78 [EPOC Filter Results] 
80 73 or 79 
81 limit 80 to yr="2015 -Current" 
  
2017 update: 08/02/2017 
No. Search terms 
1 (clinical adj2 pathway?).ti. 
2 critical pathways/ 
3 ((clinical or critical) adj1 (pathway? or path?)).ti,ab. 
4 ((care adj2 algorithm?) or clinical algorithm?).ti,ab. 
5 (care adj1 pathway?).ti,ab. 
6 (treatment adj3 algorithm?).ti,ab. 
7 (management protocol? or treatment protocol?).ti,ab. 
8 (care adj1 (plan? or map?)).ti,ab. 
9 (protocol? adj1 (nursing or directed or guided)).ti,ab. 
10 ((local or locally) adj2 adapt* adj5 guideline?).ti,ab. 
11 (treatment model? adj10 standardi*).ti,ab. 
12 (standardi* adj3 protocol?).ti,ab. 
13 systematic detection.ti,ab. 
14 or/2-13 
15 clinical protocols/ 
16 (treat* or therap*).ti,ab. 
17 15 and 16 
18 practice guidelines as topic/ 
19 (implement* or pathway or protocol?).ti,ab. 
20 18 and 19 
21 (guideline? adj1 (implement* or pathway or protocol?)).ti,ab. 
22 or/20-21 
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23 14 or 17 or 22 
24 (hospital or hospitals or hospitalis* or hospitaliz*).ti,ab. 
25 exp hospital units/ 
26 exp hospitals/ 
27 exp hospital departments/ 
28 hospitalization/ 
29 or/24-28 
30 1 or (23 and 29) 
31 randomized controlled trial.pt. 
32 controlled clinical trial.pt. 
33 multicenter study.pt. 
34 pragmatic clinical trial.pt. 
35 (randomis* or randomiz* or randomly).ti,ab. 
36 groups.ab. 
37 (trial or multicenter or multi center or multicentre or multi centre).ti. 
38 
(intervention? or effect? or impact? or controlled or control group? or (before adj5 after) or (pre adj5 post) 
or ((pretest or pre test) and (posttest or post test)) or quasiexperiment* or quasi experiment* or pseudo 
experiment* or pseudoexperiment* or evaluat* or time series or time point? or repeated measur*).ti,ab. 
39 non-randomized controlled trials as topic/ 
40 interrupted time series analysis/ 
41 controlled before-after studies/ 
42 or/31-41 
43 exp animals/ 
44 humans/ 
45 43 not (43 and 44) 
46 review.pt. 




51 cochrane database of systematic reviews.jn. 
52 comment on.cm. 
53 (systematic review or literature review).ti. 
54 or/45-53 
55 42 not 54 
56 30 and 55 
57 limit 56 to yr="2008 -Current" 
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APPENDIX B 
Table B.1: Costing method and cost/charges for included studies  
Study ID Costs measure Country Costing method Costs/ charges included 
Costs/ charges 
excluded 







& fixed costs 
Dosage, injection, treatment, 
operation and anaesthesia, 
examination, diagnostic, 
room, medical care Not reported 
Falconer 
1993 
Hospital charges to 
proxy costs of 
rehabilitation USA Hospital charges 
Charges for hospital bed days, medical and 
rehabilitation services (including professional fees), 
equipment, drugs and procedures (radiographs, 
laboratory tests, injections) Not reported 
Gomez 
1996 Hospital charges USA Hospital charges 
Room, nursing care, laboratory, 
therapeutic and tests Physician fees 
Johnson 
2000 Hospital charges USA Hospital charges 
Room, medication, laboratory 
tests and respiratory therapy Physician fees 




2003a Hospital costs Japan Variable costs 
Total medical costs including medication and 
examination (physician fees) Fixed costs 
Kollef 
1997 Hospital costs USA Not reported Not reported Physician fees 
Roberts 
1997 Hospital costs USA 
Variable & fixed 








Treatment (antibiotic infusion), laboratory and 
radiography tests Fixed costs 
Verdu 
2009 Hospital charges Spain Hospital charges Cost per day of hospital stay Not reported 
Panella 
2009 Hospital charges Italy 
Activity-based 
costing Cost of hospital care (admission) Not reported 
Comparison 2: Multifaceted intervention including a CPW versus usual care  
Bauer 
2006 Hospital costs USA Variable costs Not reported Not reported 
Kampan 
2006 Hospital costs Thailand 
Remains unclear, 
only "mean costs" 
reported Not reported Not reported 
Philbin 

















Table B.2: Original reported costs / charges data  




period Cost / charges measure 
Original 
currency Pathway E-N (SD) 
Usual 
care C-N (SD) 
(Comparison 1: single CPW intervention versus usual care 
Aizawa 
2002 Japan 2000 hospital charges (insurance points) 
insurance 




1993 USA 87-91 (median) hospital charges bed days US $ 14440 53 14420 68 
Falconer 
1993 USA 87-91 (median) hospital charges services US $ 11249 53 9579 68 
Falconer 
1993 USA 87-91 (median) hospital charges drugs US $ 1130 53 1015 68 
Falconer 
1993 USA 87-91 (median) hospital charges; other charges US $ 2397 53 1871 68 
Gomez 








2000 USA 95-97 hospital room charges US $ 2407 55 (1099) 3116 55 (1099) 
Johnson 
2000 USA 95-97 hospital medication charges US $ 129 55 (107) 153 55 (107) 
Johnson 
2000 USA 95-97 hospital lab tests charges US $ 21 55 (66) 42 55 (66) 
Johnson 
2000 USA 95-97 hospital charges respiratory therapy US $ 42 55 (322) 250 55 (322) 
Kim 2002 USA 2000 
direct variable mean hospital costs 
(excluding professional fees) US $ 870 9 (394) 1706 9 (1512) 
Kiyama 
2003a Japan 2001 
direct variable mean hospital costs 
(including medication and professional 
















1997 USA 1995 
hospital costs (poor reporting: seems to be 






2009 Italy 2004 Cost of hospital care (admission) Euros 2125 214 (534) 2211 215 (580) 
Roberts 
1997 USA 1993 
total hospital costs (doctors & nurse fees 
included) US $ 1528 82 (1012) 2095 83 (2095) 
Usui 2004 Japan 
2002/ 







Usui 2004 Japan 
2002/ 
2003 hospital charges antibiotic infusion 
insurance 
points 3285 30 (2027) 3928 31 (2027) 
Usui 2004 Japan 
2002/ 
2003 hospital charges laboratory costs 
insurance 
points 3220 30 (3097) 5785 31 (3097) 
Usui 2004 Japan 
2002/ 
2003 hospital charges radiology costs 
insurance 




2004 Cost of hospital stay Euros 38998.72 40 60391.9 48 
Comparison 2: Multifaceted intervention including a CPW versus usual care 
Bauer 
2006 USA 2004 
3 years mean intervention costs (direct 










period Cost / charges measure 
Original 
currency Pathway E-N (SD) 
Usual 
care C-N (SD) 
Bauer 
2006 USA 2004 
direct outpatient costs (direct variable 






2006 USA 2004 
hospital inpatient costs (direct variable 






2006 USA 2004 
psychiatric inpatient costs (direct variable 






2006 USA 2004 
medical surgical inpatient costs (direct 






2006 Thailand 2005 
hospital costs (poor reporting: seems to be 
total hospital costs  BAHT 2744 33 (1473) 3687 32 (3111) 
Philbin 





E-N = number of participants in experimental group; C -N = number of participants in control group; (SD) = standard deviation; USA = 




Table B.3: Cost / charges data, standardized to the year 2016 (CCEMG EPPI tool used)  














Comparison 1: single CPW intervention versus usual care 
Aizawa 
2002 
hospital charges (insurance 
points) 2000 NONE 
insurance 
points NON 48424 
32 
(4438) 55366 37 (168) 
Falconer 
1993 










2016 22155.47 53 22124.78 68 
Falconer 
1993 










2016 17259.48 53 14697.18 68 
Falconer 
1993 










2016 1733.77 53 1557.33 68 
Falconer 
1993 










2016 3677.75 53 2870.70 68 
Gomez 














































2016 183.30 55 (112) 217.41 57 (112) 
Johnson 







2016 29.84 55 (70) 59.68 55 (70) 
Johnson 
2000 








2016 59.68 55 (338) 355.24 55 (338) 
Kim 2002 
direct variable mean 
hospital costs (excluding 







2016 1177.73 9 (394) 2382.52 9 (1512) 
Kiyama 
2003a 
direct variable mean 
hospital costs (including 
medication and 



























direct variable mean daily 




2016 507.81 47 (55) 484.05 38 (100) 
Kollef 
1997 
hospital costs (poor 
reporting: seems to be 
direct variable costs 






















total hospital costs (doctors 









(1145) 3214.38 83 (920) 
Usui 
2004 




































































Euros US $ year 2016 38998.72 40 60391.9  
Comparison 2: Multifaceted intervention including a CPW versus usual care 
Bauer 
2006 
3 years mean intervention 






US   year 
2016 76369.27 
157 
(57672)  149 
Bauer 
2006 
direct outpatient costs 









(14457) 24989.98 149 
Bauer 
2006 
hospital inpatient costs 









(49957) 55087.18 149 
Bauer 
2006 
psychiatric inpatient costs 









(37857) 38142.35 149 
Bauer 
2006 
medical surgical inpatient 









(26308) 16820.45 149 
Kampan 
2006 
hospital costs (poor 
reporting: seems to be total 








2016 291.58 33 (82) 391.78 32 
Philbin 









(18593) 512.14 664 
Legend: E-N = number of participants in experimental group; C -N = number of participants in control group; (SD) = standard deviation; 




Table B.4: Continuous primary study results post-intervention measures  




95% CI as 
far as 
reported 
Comparison 1: single CPW intervention versus usual care 
Aizawa 2002 LOS (days) 12.70 2.80 32.00 14.70 5.20 37.00     
Aizawa 2002 Duration of catheterization 4.75 1.10 32.00 5.40 2.10 37.00     
Bernard 2011 Final ED blood glucose (mg/dl) 217 71 87.00 257 89 89.0 <0.01  
Bernard 2011 ED Length of stay (days) 0.23 0.1 87.00 0.2 0.1 89.0 0.06  
Bernard 2011 Number of patients treated with insulin 100  87.00 54  89.0   
Bernard 2011 Admission blood glucose level (mg/dl) 184 70 87.00 224 93 89.0 0.01  
Bernard 2011 Hospital length of stay (days) 2.7 2.0 87.0 3.1 1.9 89.0 0.58  
Bernard 2011 Number of admissions 60   61  89.0   
Bittinger 
1995 Total satisfaction scores 246.80 17.97 15 233.133 25.357 15 0.100  
Bittinger 
1995 Dissatisfaction scores 97.80 11.98 15 90.67 16.39 15 0.184  
Bittinger 
1995 Interpersonal scores 77.60 4.405 15 73.47 5.01 15 0.023  
Bittinger 
1995 Good impression 71.4 4.52 15 69.0 6.79 15 0.266  
Brook 1999 
Duration of mechanical ventilation 
(in hours) 89.10 133.60 162.00 124.00 153.60 159.00     
Brook 1999 LOS ICU stay (days) 5.70 5.90 162.00 7.50 6.50 159.00     
Brook 1999 LOS hospital stay (days) 14.00 17.30 162.00 19.90 24.20 159.00     
Brook 1999 
Number of acquired organ system 
derangements 2.84 1.40 162.00 2.90 1.50 159.00     
Carratala 
2012 length of stay (days) 3.9  200 6.0  201 <0.001  
Carratala 
2012 Adverse drug reaction (%) 4.5  200 15.9  201 <0.001  
Carratala 
2012 Patient satisfaction (%) 94.6  200 94.3  201 0.60  
Carratala 
2012 
Number of subsequent hospital 
admission within 30 days 18  200 15  201 0.59  
Carratala 
2012 
Number of overall case fatality rate 
within 30days 4  200 2  201 0.45  
Carratala 
2012 
Median length of antibiotic IV 
therapy 2.0  200 4  201 <0.001  
Chadha 2000 
Compliance with five 
recommendations for initial hospital 
assessment (urinary incontinence). 3.80 1.52 416.00 3.10 1.52 472.00    (0.5 to 0.9) 
Choong 2000 LOS (days) 6.60 3.35 55.00 8.00 3.35 56.00 0.0300   
Choong 2000 Days to mobilisation (days) 1.60 1.44 55.00 2.20 1.44 56.00 0.0300   
Costantini 
2014 Overall quality of care (scores) 70.5  118 63.0  111 0.12  
Costantini 
2014 informing and making decisions 73.5  117 64.3  110 <0.01  
Costantini 
2014 Respect, dignity and kindness 78.8  115 70.4  109 <0.01  
Costantini 
2014 Family emotional support 46.6  117 38.6  109 0.09  
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2014 Coordination of care 81.4  115 76.8  110 0.04  
Costantini 
2014 Family self-efficacy 48.9  116 44.4  110 0.01  
Cunningham 
2008 
Mean time from arrival at ED to 
achieve oxygen saturation >=94% 
(hrs) 
9.3  136 10.3  115 0.30  
Cunningham 
2008 
Time to achieve 4-hr spacing of 
multidose spacer delivered 
salbutamol (1000mg) in hrs 
23.1  136 23.6  115 0.83  
Cunningham 
2008 Length of stay (days) 37.6  136 40.7  115 0.07  
Cunningham 
2008 Number of additional visits 16  136 19  115 0.27  
Cunningham 
2008 Number of prescribing errors 10.4  136 14.8  115 0.02  
Cunningham 
2008 
Number of medical contacts with 
patient during the first 12 hrs 6  136 5.5  115 0.04  
Cunningham 
2008 Number of nursing contacts 16  136 13.8  115 0.002  
Cunningham 
2008 
Number of clinical contacts with 
patients 22  136 19.2  115 0.0004  
Doig 2008 LOS in hospital (days) 24.2  561 24.3  557 0.97  
Doig 2008 LOS in ICU (days) 9.1  561 9.9  557 0.42  
Doig 2008 Renal dysfunction days/10 patient days 1.54  561 2.12  557 0.04  
Doig 2008 Pulmonary dysfunction days/10 patient days 8.28  561 7.79  557 0.18  
Doig 2008 Hepatic dysfunction days/10 patient days 1.43  561 1.41  557 0.91  
Doig 2008 Coagulation dysfunction days/10 patient-days 1.13  561 0.97  557 0.25  
Doig 2008 Cardiovascular dysfunction days/10 patient days 1.04  561 1.09  557 0.72  
Doig 2008 Multiple organ dysfunction days/ 10 patient days 3.26  561 3.41  557 0.77  
Doig 2008 Organ system dysfunction, no/patient day 1.34  561 1.34  557 0.94  
Doig 2008 Witnessed aspiration/1000 fed pt. days 2.19  561 4.33  557 0.28  
Doig 2008 
Witnessed aspiration and new 
pulmonary infiltrates within 24h, 
events/1000 fed pt. days 
0.83  561 0.93  557 0.84  
Doig 2008 Serum albumin <25g/l, days/10 pt. days 4.58  561 4.31  557 0.22  
Doig 2008 Renal replacement therapy/pt. days 0.75  561 0.91  557 0.29  
Doig 2008 Invasive mechanical ventilation/10 pt. days 7.69  561 7.21  557 0.70  
Doig 2008 Deaths at hospital discharge N (%) 172  561 153  557 0.75  
Doig 2008 Systemic antibiotics/10 pt. days 7.41  561 7.19  557 0.47  
Delaney 2003 
LOS days (primary LOS until 
discharge) 5.20 2.50 31.00 5.80 3.00 33.00     
Delaney 2003 
Total LOS days including time spent 
in readmission 5.40 2.50 31.00 7.10 4.80 33.00     
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95% CI as 
far as 
reported 
Delaney 2003 Pain score at two days’ post-op 3.30 1.90 31.00 3.40 1.50 33.00     
Delaney 2003 QOL at ten days’ post-op 5.60 1.80 31.00 6.30 2.10 33.00     
Delaney 2003 
Satisfaction with hospital stay at 30 
days 8.20 2.20 31.00 8.40 1.60 33.00     
Delaney 2003 Happiness to be discharged 8.00 1.90 31.00 8.00 1.90 33.00     
Dowsey 1999 Los (days) 7.10 3.67 92.00 8.60 3.67 71.00   (1.03-1.30) 
Dowsey 1999 Days to sitting out of bed 1.94 2.80 92.00 3.42 2.80 71.00 0.0010 (1.05-1.95) 
Dowsey 1999 Days to Ambulation 2.19 3.83 92.00 3.61 3.83 71.00 0.0200 (0.94-1.98) 
Falconer 
1993 Los (days) 35.60 15.50 53.00 32.30 15.40 68.00     
Falconer 
1993 Patient satisfaction 7.70 2.60 53.00 8.8 1.70 68.00     
Falconer 
1993 Functional status 40.90 15.80 53.00 40.2 17.40 68.00     
Gomez 1996 LOS (days) 0.64 0.51 53.00 2.28 5.25 68.00     
Gomez 1996 LOS (hours) 15.40 12.20 50.00 54.6 126.00 50.00     
Johnson 2000 LOS (days) 1.68 1.12 50.00 2.24 1.12 50.00     
Johnson 2000 LOS (hours) 40.30 26.80 55.00 53.7 26.80 55.00 0.0100   
Johnson 2000 
Number of nebulizations during 
hospitalisation every 2 hours 4.50 4.44 55.00 6.5 4.44 55.00 0.0200   
Johnson 2000 
Number of nebulizations during 
hospitalisation every 3 hours 3.70 3.64 55.00 5.9 3.64 55.00 0.0020   
Johnson 2000 
Number of nebulizations during 
hospitalisation every 4 hours 3.50 3.09 55.00 4.7 3.09 55.00 0.0440   
Johnson 2000 
Number of nebulizations during 
hospitalisation every 6 hours 1.40 1.60 55.00 2.2 1.60 55.00 0.0100   
Johnson 2000 
Number of nebulizations during 
hospitalisation every 8 hours 0.10 -0.52 55.00 0 -0.52 55.00 0.3200   
Kim 2002 Los (days) 0.25 0.15 9.00 2.1 2.30 9.00     
Kiyama 
2003a 
Los (days) pre-operative hospital 
stay 9.00 3.20 47.00 12.6 6.00 38.00 0.0010   
Kiyama 
2003a 
Los (days) post-operative hospital 
stay 18.10 9.50 47.00 28.2 22.30 38.00 0.0100   
Kollef 1997 
Duration of mechanical ventilation 
(in hours) following commencement 
of weaning 69.40 123.70 179.00 102 169.10 178.00 0.2900   
Marrie 2000 
SF-36 2 weeks after cessation of 
antibiotics 16.00 3.70 716.00 16.50 4.70 1027.00     
Marrie 2000 
SF-36 6 weeks after cessation of 
antibiotics 30.30 1.50 716.00 29.9 1.60 1027.00     
Marrie 2000 
Bed days per patient managed 
(product of average LOS/admission 
rate) surrogate for direct costs 4.4 1.50 716.00 6.1 2.10 1027.00 0.0400   
Marrie 2000 LOS (days) 8.20 1.90 716.00 9.60 2.10 1027.00     
Marrie 2000 
Duration intravenous antibiotics 
(days) 4.60 0.90 716.00 6.30 1.40 1027.00     
Marelich 
2000 
Duration of mechanical ventilation 
(medical ICU) median values 
reported 3.25 11.32 82.00 9.67 11.32 88.00 0.0003   
Marelich 
2000 
Duration of mechanical ventilation 
(combined ICUs) median values 
reported 2.83 5.42 166.00 5.17 5.42 169.00 0.0001   
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95% CI as 
far as 
reported 
Panella 2009 Death (in-hospital mortality) 5.6  214 15.4  215 0.001  
Panella 2009 Transferred to another hospital 0.5  214 1.5  215 0.30  
Panella 2009 Appropriateness of the stay (%) 76.2  214 72.1  215 0.30  
Panella 2009 Rate of unscheduled readmissions 7.9  214 13.9  215 0.053  
Panella 2009 LOS (days) 10.4  214 11.4  215 0.028  
Panella 2009 Cost of admission (Euros) 2125  214 2211  215 0.11  
Panella 2009 Patient satisfaction score 8.5  214 8.14  215 0.50  
ProCess 2014 In hospital death after 60 days, n (%) 21  439 18.9  456 0.83  
ProCess 2014 Death by 90 days 31.9  405 33.7  412 0.66  
ProCess 2014 Cardiovascular failure in the first week (%) 61.3  439 56.1  456 0.06  
ProCess 2014 Respiratory organ failure (%) 38.0  434 32.4  451 0.19  
ProCess 2014 Renal failure (%) 3.1  382 2.8  397 0.04  
ProCess 2014 Duration of cardiovascular support (days) 2.6 1.6 439 2.5 1.6 456 0.52  
ProCess 2014 Respiratory support (days) 6.4 8.4 439 6.9 8.2 456 0.41  
ProCess 2014 Renal support (days) 7.1 10.8 439 8.8 13.7 456 0.92  
ProCess 2014 Admission to ICU (%) 91.3  439 86.2  456 0.01  
ProCess 2014 Stay in ICU among admitted patients (days) 5.1 6.3 439 4.7 5.8 456 0.63  
ProCess 2014 Stay in hospital (days) 11.1 10 439 11.3 10.9 456 0.25  
ProCess 2014 Serious ADR N (%) 5.2  439 8.1  456 0.32  
Roberts 1997 LOS (days) 1.38 1.18 82.00 1.87 1.33 83.00     
Roberts 1997 LOS (hours) 33.10 28.40 82.00 44.8 31.80 83.00     
Rotter 2014 LOS (days) 9.16 0.9 123 9.11 1 131 0.91  
Rotter 2014 Duration of operation (min) 241.99 14.5 123 272.86 28.2 131 0.038  
Rotter 2014 Duration of anaesthesia (min) 323.51 17.89 123 354.06 30.58 131 0.061  
Rotter 2014 No of patients admitted to ICU 4  123 11  131 0.041  
Rotter 2014 Number of patients requiring readmissions within 30 days 23  123 8  131 0.006  
Sulch 2002 LOS (days) 50.00 19.00 76.00 45 23.00 76.00     
Sulch 2002 
Physiotherapy: Mean duration of 
therapy input at 12 weeks 38.00 28.80 76.00 34.8 27.80 76.00     
Sulch 2002 
Physiotherapy: Mean duration of 
therapy input at 26 weeks 42.80 41.20 76.00 39.4 36.40 76.00     
Sulch 2002  
Physiotherapy: Mean duration of 
therapy per patient day 0.80 0.60 76.00 0.7 0.60 76.00     
Sulch 2002 
Occupational Therapy: Mean 
duration of therapy input at 12 
weeks 8.00 6.00 76.00 7.5 7.00 76.00     
Sulch 2002 
Occupational Therapy: Mean 
duration of therapy input at 26 
weeks 8.50 7.50 76.00 8 705.00 76.00     
Sulch 2002  
Occupational Therapy: Mean 
duration of therapy per patient day 0.20 0.40 76.00 0.2 0.20 76.00     
Trombetti 
2013 
Proportion of nutrition counselling 
requests (%) 43  465 32  229 <0.05  
Trombetti 
2013 
Number of nutritional supplements 
prescribed (%) 38  465 30  229 <0.05  
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Proportion of patients receiving an 
enriched meal (%) 20  465 8  229 0.0001  
Trombetti 
2013 LOS (days) 38 34 465 37 32 229 0.613  
Trombetti 
2013 Functional independence 6.4 18.6 465 7.2 19.6 229 0.756  
Usui 2004 LOS (days) 8.03 4.18 30.00 10.77 4.18 31.00 0.0130   
Usui 2004 
Duration of antibiotic infusion 
(days) surrogate outcome for costs 6.47 3.53 30.00 8.22 3.53 31.00 0.0580   
Verdu 2009 Mean LOS (days) 4.72 3.83 40 6.78 3.83 48 0.014  
Verdu 2009 Degree of implementation (%) 95.3  40   48   
Verdu 2009 Compliance (%) 65  40   48   
Verdu 2009 Cost savings in euros (2004 vs 2002) 38998.72  40 60391.90  48   
Verdu 2009 Patient satisfaction 67  40   48   
Comparison 2: Multifaceted intervention including a CPW versus usual care 
Chen 2004 
Usage rate of the emergency room 
(surrogate outcome for in-hosp. 
complications) 0.15 0.37 20.00 0.59 0.50 22.00     
Cole 2002 LOS days 19.70 17.10 113.00 19.10 16.80 114.00     
Kampan 2006 LOS (days) 3.94 1.03 33.00 6.38 4.04 32.00     
Kampan 2006 
Number of capillary blood glucose 
tests 10.03 5.04 33.00 12.34 5.96 32.00     
Philbin 2000 LOS (days) all hospitals pooled -1.80 17.69 840.00 -0.70 17.69 664.00   (-2.9 - 0.7) 
E = experimental; C = control; E-N = number of participants in experimental group; C -N = number of participants in control group; E-mean 
= mean off outcome in the experimental group; C-mean = mean of outcome in the control group; E-SD = standard deviation in the 
experimental group; C-SD = standard deviation in the control group 
 
 
Table B.5: Continuous primary study results (pre-intervention) baseline measures  
STUDY 













Comparison 1: single CPW intervention versus usual care 
Chadha 
2000 
Compliance with five recommendations 
for initial hospital assessment 
(menorrhagia). 3.7   472 3.4   416 
Chadha 
2000 
Compliance with five recommendations 
for initial hospital assessment (urinary 
incontinence). 3.1   416 3.0   472 
Smith 
2004 LOS days (no values reported)     505     216 
Smith 
2004 Readmission rate per 100 participant days 0.59     0.56    
Smith 
2004 Deaths per 100 patient days 0.20     0.19    
Sulch 
2002  Barthel index   5 
152 (total 
both groups)   6 
152 (total 
both groups) 
Comparison 2: Multifaceted intervention including a CPW versus usual care 
Philbin 
2000 LOS (days) all hospitals pooled 8.0   762 7.7   640 
E = experimental; C = control; E-N baseline= number of participants in experimental group at baseline; C -N baseline = number of 
participants in control group at baseline; 
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Table B.6: Continuous primary study outcome (more than two study groups/ hospitals): 















change P value 
Comparison 1: single CPW intervention versus usual care 
Philbin 
2000 Hospital A LOS (days) 18 9.2 Hospital A LOS (days) 37 5.8  P= 0.42 
Philbin 
2000 Hospital B LOS (days) 243 9.1 Hospital B LOS (days) 217 6.9  P= 0.02 
Philbin 
2000 Hospital C LOS (days) 159 7.2 Hospital C LOS (days) 126 5.2   P= 0.01 
Philbin 
2000 Hospital D LOS (days) 168 9.0 Hospital D LOS (days) 225 7.5  P= 0.07 
Philbin 




Symptoms assessed 20 7.6 
Palliative ward 
Symptoms assessed 55 10.2 2.6 P<0.001 
Bookbinder 
2005 
Oncology & geriatric 
wards Symptoms 
assessed 41 6 
Oncology & geriatric 
wards Symptoms 





Symptoms identified 20 4.8 
Palliative ward 
Problematic 
Symptoms identified 55 3.7 1.1 P=0.014 
Bookbinder 
2005 
Oncology & geriatric 
wards Problematic 
Symptoms identified 41 3.5 
Oncology & geriatric 
wards Problematic 





Interventions 20 5.1 
Palliative ward 
Number of 
Interventions 55 4.1 1 P=0.021 
Bookbinder 
2005 
Oncology & geriatric 
wards Number of 
interventions 41 4.1 
Oncology & geriatric 
wards Number of 





consultations 20 1.6 
Palliative ward 
Number inpatient 
consultations 55 2.2 0.6 P=0.062 
Bookbinder 
2005 
Oncology & geriatric 
wards Number 
inpatient consultations 41 4 
Oncology & geriatric 
wards Number 










32 78 2 P=0.960 
Kinsman 
2012 
Mean door -to-needle 
time (mins) 25 46.6 
Mean door -to-needle 









within 30 mins 




time (mins) 25 6.4 
Mean door-to-ECG 








ECG within 10 
minutes 
32 72 1 P=0.980 
E = experimental; C = control; E-N = number of participants in experimental group; C -N = number of participants in control group; ECG = 





Table B.7: Continuous primary study outcome (more than two study groups/ hospitals): 
















change P value 
Comparison 1: single CPW intervention versus usual care 
Philbin 2000 
Hospital F LOS 
(days) 152 5.7 
Hospital F LOS 
(days) 134 5.2   P= 0.48 
Philbin 2000 
Hospital G LOS 
(days) 117 8.0 
Hospital G LOS 
(days) 152 7.3   P= 0.34 
Philbin 2000 
Hospital H LOS 
(days) 125 9.4 
Hospital H LOS 




Hospital I LOS 
(days) 25 6.5 
Hospital I LOS 
(days) 5 6.8   P= 0.08 
Philbin 2000 
Hospital J LOS 
(days) 221 8.9 
Hospital J LOS 





assessed 50 7.9 
General Medical 
Wards Symptoms 





Symptoms identified 50 3.4 
General Medical 
Wards Problematic 




Wards Number of 
interventions 50 3.9 
General Medical 
Wards Number of 




















25 84 12 0.191 
Kinsman 
2012 
Mean door -to-needle 
time (mins) 26 43.8 
Mean door -to-needle 









within 30 mins 




time (mins) 26 7.0 
Mean door-to-ECG 








ECG within 10 
minutes 
25 83 -6 0.571 
E = experimental; C = control; E-N = number of participants in experimental group; C -N = number of participants in control group; ECG = 














Table B.8: Dichotomous primary study outcomes (pre-intervention) baseline  









Comparison 1: single CPW intervention versus usual care 
Chadha 2000 Appropriate use of hospital investigations (menorrhagia) 208 472 44% 175 416 42% 
Chadha 2000 
Appropriate use of hospital investigations (urinary 
incontinence) 92 416 22% 212 472 45% 
Chadha 2000 Inappropriate use of hospital investigations (menorrhagia) 127 472 27% 125 416 30% 
Chadha 2000 
Inappropriate use of hospital investigations (urinary 
incontinence) 116 416 28% 38 472 8% 
Chadha 2000 Appropriate first-line treatments (menorrhagia) 382 472 81% 345 416 83% 
Chadha 2000 Appropriate first-line treatments (urinary incontinence) 262 416 63% 340 472 72% 
Chadha 2000 Appropriate pre-surgery assessment (menorrhagia) 90 472 19% 62 416 15% 
Chadha 2000 Appropriate pre-surgery assessment (urinary incontinence) 29 416 7% 99 472 21% 
Doherty 
2006a Assessment of severity of asthma 4 52 8% 5 46 11% 
Doherty 
2006a Use of spirometry 6 52 12% 1 46 2% 
Doherty 
2006a Overuse of ipratropium for mild asthma 16 36 44% 15 31 48% 
Doherty 
2006a Use of systemic steroids 31 51 61% 22 46 48% 
Doherty 
2006a Use of STAMP (Short-term Asthma Management Plan) 4 44 9% 0 32 0% 
Doherty 
2006a Inappropriate use of antibiotics 9 43 21% 11 41 27% 
Doherty 
2006a Aggregate measures 99 278 36% 74 242 31% 
























Table B.9: Dichotomous primary study results post-intervention measures  
Study ID Dichotomous outcome post-intervention E-events E-N % C-events C-N % 
Comparison 1: single CPW intervention versus usual care 
Aizawa 2002 In-hospital complications 1 32 3% 2 37 5% 
Aizawa 2002 Rehospitalisation within 6 months 1 32 3% 0 37 0% 
Brook 1999 In-hospital mortality 49 162 30% 57 159 36% 
Chadha 2000 Appropriate use of hospital investigations (menorrhagia) 217 472 46% 233 416 56% 
Chadha 2000 Appropriate use of hospital investigations (urinary incontinence) 179 416 43% 179 472 38% 
Chadha 2000 Inappropriate use of hospital investigations (menorrhagia) 99 472 21% 75 416 18% 
Chadha 2000 Inappropriate use of hospital investigations (urinary incontinence) 58 416 14% 64 427 15% 
Chadha 2000 Appropriate first-line treatments (menorrhagia) 378 472 80% 324 416 78% 
Chadha 2000 Appropriate first-line treatments (urinary incontinence) 241 416 58% 359 472 76% 
Chadha 2000 Appropriate pre-surgery assessment (menorrhagia) 203 472 43% 46 416 11% 
Chadha 2000 Appropriate pre-surgery assessment (urinary incontinence) 133 416 32% 127 472 27% 
Choong 2000 Confusional status (yes-no) 23 55 42% 31 56 55% 
Choong 2000 In-hospital complications 10 55 18% 14 56 25% 
Choong 2000 Post-discharge complications 3 55 5% 6 56 11% 
Choong 2000 Readmission rates (28 days) 2 55 4% 6 56 11% 
Costantini 2014 Overall control of pain 100 119 70.7% 89 113 65% 
Costantini 2014 Overall control of breathlessness 108 119 54.4% 97 113 36.9% 
Costantini 2014 Overall control of nausea or vomiting 102 119 83.9% 91 113 77.2% 
Delaney 2003 Hospital readmissions within 30 days 3 31 10% 6 33 18% 
Delaney 2003 In-hospital complications 7 31 23% 10 33 30% 
Doherty 2006a Assessment of severity of asthma 29 47 62% 6 42 14% 
Doherty 2006a Use of spirometry 29 47 62% 3 42 7% 
Doherty 2006a Overuse of ipratropium for mild asthma 9 30 30% 13 42 31% 
Doherty 2006a Use of systemic steroids 33 46 72% 8 38 21% 
Doherty 2006a Use of STAMP (Short-term Asthma Management Plan) 10 38 26% 1 38 3% 
Doherty 2006a Inappropriate use of antibiotics 9 42 21% 5 39 13% 
Doherty 2006a Aggregate measures 155 250 62% 71 231 31% 
Dowsey 1999 Match/ planned discharge destination 64 92 70% 43 71 61% 
Dowsey 1999 hospital readmission at 3 month follow up 4 92 4% 9 71 13% 
Dowsey 1999 complication until 3 month 10 92 11% 20 71 28% 
Gomez 1996 Rehospitalisation within 30 days 3 50 6% 3 50 6% 
Johnson 2000 Number of unplanned interventions within 2 weeks of discharge 1 55 2% 4 55 7% 
Kiyama 2003a Morbidity rate in hospital 3 47 6% 5 38 13% 
Kiyama 2003a In-hospital complications until discharge 3 47 6% 5 38 13% 
Kiyama 2003a Target achievements day 1 41 47 87% 21 38 54% 
Kiyama 2003a Target achievements day 4 46 47 98% 30 38 78% 
Kiyama 2003a Target achievements day 7 43 47 91% 26 38 68% 
Kiyama 2003a Target achievements day 14 43 47 91% 19 38 50% 
Kollef 1997 Hospital mortality 40 179 22% 42 178 24% 
Marelich 2000 Rate of ventilator assisted pneumonia (medical ICU) 6 82 7% 8 88 9% 
Marelich 2000 Rate of ventilator assisted pneumonia (surgical ICU) 5 84 6% 12 81 15% 
Marelich 2000 Rate of ventilator assisted pneumonia (combined ICUs) 11 166 7% 20 169 12% 
Roberts 1997 Hospital admission rate 37 82 45% 83 83 100% 
Roberts 1997 Rehospitalisation after 8 weeks 5 82 6% 4 83 5% 
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Study ID Dichotomous outcome post-intervention E-events E-N % C-events C-N % 
Smith 2004 Hospital mortality 49 334 15% 30 175 17% 
Sulch 2002 Mortality at 26 weeks 10 76 13% 6 76 8% 
Sulch 2002 Discharge to home 56 76 74% 54 76 71% 
Sulch 2002aa Process of care (nutritional assessment) 49 66 74% 14 64 22% 
Sulch 2002aa Process of care (documentation of goals) 75 76 99% 56 76 74% 
Sulch 2002aa Process of care (documented death / follow-up) 68 76 89% 53 76 70% 
Sulch 2002aa Process of care (communication with GP) 61 76 80% 34 76 45% 
Usui 2004 Treatment success rate 27 30 90% 28 31 90% 
Comparison 2: Multifaceted intervention including a CPW versus usual care 
Cole 2002 Mortality at 8 weeks 25 113 0.22 22 114 19% 
Cole 2002 Discharged at 8 weeks 65 113 0.58 77 114 68% 
Cole 2002 Less dependent at 8 weeks 4 65 0.06 6 77 8% 
Kampan 2006 Readmissions with hypoglycaemia within 3 months 2 33 6% 11 32 34% 
Philbin 2000 In-hospital mortality 44 840 5% 25 664 4% 
Philbin 2000 Quality of life (QOL) following discharge 7 840 1% 7 664 1% 
Philbin 2000 QOL (functional) 2 840 0% 2 664 0% 
Philbin 2000 Heart failure mortality (6 months) 105 840 13% 84 664 13% 
Philbin 2000 All-cause mortality (6 months) 183 840 22% 139 664 21% 
Philbin 2000 Readmission for heart failure (6 months) 169 840 20% 141 664 21% 
Philbin 2000 Readmission - all causes (6 month) 363 840 43% 293 664 44% 
Philbin 2000 Process of care - evaluation 638 840 76% 485 664 73% 
Philbin 2000 Process of care - documentation 529 840 63% 511 664 77% 
Philbin 2000 Process of care - diet counselling 613 840 73% 518 664 78% 
Philbin 2000 ACE inhibitor use at discharge 529 840 63% 438 664 66% 
Trombetti 2013 In-hospital mortality 28 465 6% 20.6 229 9% 
E = experimental; C = control; E-N = number of participants in experimental group; C -N = number of participants in control group; ICU = 




Table B.10: ITS studies data  
Study ID Tilden, VP (Tilden 1987) 
Brattebo, G 
(Brattebø 2002) Rotter, T (Rotter 2014) 
Outcome measure 
Documented identification by nurses of 
female victims of domestic violence 
Ventilation patient 
days per month 
Number of admissions, number of 
readmissions, LOS, number of re-operations, 
N-baseline 447 147 123 
N-post-intervention 445 138 131 
Number of 
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Table C.1: Stand-alone clinical pathway versus usual care  
Outcome or Subgroup Studies Participants Statistical Method Effect Estimate 
1.1 90-day mortality 7  Odds Ratio (M-H, Random, 95% CI) Subtotals only 
  1.1.1 90-day mortality 7 4341 Odds Ratio (M-H, Random, 95% CI) 0.84 [0.65, 1.08] 
  1.1.2 90-day mortality: sensitivity 
analysis 
4 2705 Odds Ratio (M-H, Random, 95% CI) 1.04 [0.87, 1.24] 
1.2 Hospital readmission (up to 6 
months) 
8 1647 Odds Ratio (M-H, Random, 95% CI) 0.76 [0.51, 1.12] 
1.3 In-hospital complications 8 2123 Odds Ratio (M-H, Random, 95% CI) 0.48 [0.35, 0.65] 
1.4 Length of hospital stay 25  Mean Difference (IV, Random, 95% 
CI) 
Subtotals only 
  1.4.1 Length of hospital stay 22 5931 Mean Difference (IV, Random, 95% 
CI) 
-0.94 [-1.32, -0.55] 
  1.4.2 Length of hospital stay: non-
randomised studies 
3 260 Mean Difference (IV, Random, 95% 
CI) 
-1.85 [-2.74, -0.95] 
  1.4.3 Length of hospital stay: 
Randomised 
22 7351 Mean Difference (IV, Random, 95% 
CI) 
-0.84 [-1.21, -0.47] 
  1.4.4 Length of hospital stay 
(country): Japan 
3 215 Mean Difference (IV, Random, 95% 
CI) 
-3.01 [-5.35, -0.67] 
  1.4.5 Length of hospital stay 
(country): Spain 
2 489 Mean Difference (IV, Random, 95% 
CI) 
-2.09 [-3.06, -1.11] 
  1.4.6 Length of hospital stay 
(country): Australia 
3 1393 Mean Difference (IV, Random, 95% 
CI) 
-1.29 [-2.02, -0.56] 
  1.4.7 Length of hospital stay 
(country): USA 
9 1981 Mean Difference (IV, Random, 95% 
CI) 
-0.60 [-1.08, -0.11] 
  1.4.8 Length of hospital stay 
(country): UK 
2 403 Mean Difference (IV, Random, 95% 
CI) 
1.29 [-3.22, 5.81] 
  1.4.9 Length of hospital stay (hospital 
area): emergency department 
7 2117 Mean Difference (IV, Random, 95% 
CI) 
-0.66 [-1.12, -0.20] 
  1.4.10 Length of hospital stay 
(hospital area): acute care 
11 2132 Mean Difference (IV, Random, 95% 
CI) 
-1.37 [-1.87, -0.87] 
  1.4.11 Length of hospital stay 
(hospital area): extended care 
3 337 Mean Difference (IV, Random, 95% 
CI) 
1.46 [-2.14, 5.05] 
  1.4.12 Length of hospital stay 
(hospital area): intensive care unit 
2 1440 Mean Difference (IV, Random, 95% 
CI) 
-2.86 [-7.77, 2.04] 
  1.4.13 Length of hospital stay 
(hospital area): surgical unit 
2 154 Mean Difference (IV, Random, 95% 
CI) 
-5.18 [-12.94, 2.57] 
  1.4.14 Length of hospital stay: study 
year 
22 5815 Mean Difference (IV, Random, 95% 
CI) 
-0.98 [-1.35, -0.60] 
  1.4.15 Length of hospital stay (clinical 
condition): paediatric asthma 
2 351 Mean Difference (IV, Random, 95% 
CI) 
-0.31 [-0.72, 0.09] 
  1.4.16 Length of hospital stay (clinical 
condition): stroke rehabilitation 
2 273 Mean Difference (IV, Random, 95% 
CI) 
3.99 [-0.29, 8.27] 
  1.4.17 Length of hospital stay (clinical 
condition): pneumonia 
3 673 Mean Difference (IV, Random, 95% 
CI) 
-1.64 [-2.24, -1.05] 
  1.4.18 Length of hospital stay (clinical 
condition): malnutrition 
2 1813 Mean Difference (IV, Random, 95% 
CI) 
-0.67 [-2.07, 0.74] 
  1.4.19 Length of hospital stay (clinical 
condition): suspected myocardial 
infarction 
2 286 Mean Difference (IV, Random, 95% 
CI) 
-0.90 [-1.98, 0.18] 
 136 
  1.4.20 Length of hospital stay 
(procedure type): invasive 
8 1099 Mean Difference (IV, Random, 95% 
CI) 
-1.39 [-2.17, -0.60] 
  1.4.21 Length of hospital stay 
(procedure type): non-invasive 
14 4716 Mean Difference (IV, Random, 95% 
CI) 
-0.81 [-1.25, -0.37] 
  1.4.22 Length of hospital stay 
(implementation): low 
7 2555 Mean Difference (IV, Random, 95% 
CI) 
-1.42 [-2.40, -0.43] 
  1.4.23 Length of hospital stay 
(implementation): low - sensitivity 
analysis 
2 1216 Mean Difference (IV, Random, 95% 
CI) 
-2.61 [-8.13, 2.91] 
  1.4.24 Length of hospital stay 
(implementation) moderate 
12 1889 Mean Difference (IV, Random, 95% 
CI) 
-0.96 [-1.46, -0.47] 
  1.4.25 Length of hospital stay 
(implementation): high 
2 252 Mean Difference (IV, Random, 95% 
CI) 
1.17 [-3.87, 6.22] 
1.5 Hospital cost and charges 7  Mean Difference (IV, Random, 95% 
CI) 
Subtotals only 












1.6 Adherence to recommended 
practice 




Table C.2: Multifaceted intervention (including clinical pathway) versus usual care  
 
Outcome or Subgroup Studies Participants Statistical Method Effect Estimate 
2.1 Length of hospital stay 3 1796 Mean Difference (IV, Random, 95% 
CI) 
-0.71 [-1.84, 0.42] 
2.2 Hospital cost and charges 3  Mean Difference (IV, Random, 95% 
CI) 
Subtotals only 
  2.2.1 Hospital cost and charges 3 1875 Mean Difference (IV, Random, 95% 
CI) 
-53.77 [-120.08, 12.54] 




  2.2.3 Hospital costs 2 371 Mean Difference (IV, Random, 95% 
CI) 








3 Forest plots for meta-analysis summaries 
 
Figure C.1: Analysis 1.1.1 and 1.1.2 90-day mortality 
 
 











Figure C.4: Analysis 1.4.1 Length of hospital stay                    Favours CPW      Favours UC 
 
 












Figure C.7: Analysis 1.4.4 Length of hospital stay (country): Japan                   Favours CPW        Favours UC 
 
 




Figure C.9: Analysis 1.4.6 Length of hospital stay (country): Australia             Favours CPW        Favours UC 
 
 
Figure C.10: Analysis 1.4.7 Length of hospital stay (country): USA                   Favours CPW        Favours UC 
 
 
Figure C.11: Analysis 1.4.8 Length of hospital stay (country): UK                      Favours CPW        Favours UC 
 
  
Figure C.12: Analysis 1.4.9 Length of hospital stay (hospital area): ED              Favours CPW        Favours UC 
 










Figure C.14: Analysis 1.4.11 Length of hospital stay (hospital area): EC           Favours CPW        Favours UC 
 
 
EC = extended care 
 
Figure C.15: Analysis 1.4.12 Length of hospital stay (hospital area): ICU           Favours CPW        Favours UC 
 
ICU = intensive care unit 
 
Figure C.16: Analysis 1.4.13 Length of hospital stay (hospital area): SU            Favours CPW        Favours UC 
 























Figure C.18: Analysis 1.4.15 Length of hospital stay (clinical condition): PA   Favours CPW        Favours UC 
 
PA = paediatric asthma 
 
 
Figure C.19: Analysis 1.4.16 Length of hospital stay (clinical condition): SR     Favours CPW        Favours UC 
 
SR = stroke rehabilitation 
 
 
Figure C.20: Analysis 1.4.17 Length of hospital stay (clinical condition): PN     Favours CPW        Favours UC 
 
 










Figure C.21: Analysis 1.4.18 Length of hospital stay (clinical condition): MN   Favours CPW        Favours UC 
 
MN = malnutrition 
 
 
Figure C.22: Analysis 1.4.19 Length of hospital stay (clinical condition): MI    Favours CPW        Favours UC 
 
MI = myocardial infarction 
 
 




Figure C.24: Analysis 1.4.21 Length of hospital stay (procedure type): NI          Favours CPW        Favours UC 
 
NI = non-invasive 
 





Figure C.26: Analysis 1.4.23 Length of hospital stay (implementation): low-SA Favours CPW        Favours UC 
 
 
SA = sensitivity analysis 
 
 




Figure C.28: Analysis 1.4.25 Length of hospital stay (implementation): high     Favours CPW        Favours UC 
 
 






DATA EXTRACTION SHEET FOR MANUSCRIPT 2 and 3 
 
Data Collection Form  
Study ID number ………………… 
STUDY STATUS 
Pending = Pend 
Included = In 
Excluded = Ex 
Did both reviewers agree on inclusion / exclusion? No 
Notes, including source(s) of disagreement. 
Primary Author Email Address for correspondence: Email address  
DATA EXTRACTION FORM: 
Clinical Pathways: Effects on Professional Practice, Patient Outcomes, 
Length of Stay and Hospital Costs. 
Name of Reviewer: 
MINIMUM CRITERIA FOR A CLINICAL PATHWAY 








3. Does it detail the steps in a course of treatment or care in a plan, pathway, algorithm, guideline, 












Source of information for minimum criteria for a clinical pathway (CPW) (page numbers): 
Eligibility:  
All 4 Criteria – must be “yes” 
Eligibility: EXCLUDE / CONTINUE 
STUDY DESIGN 
Type of study (using EPOC criteria): 
RCT: participants randomly allocated, has a control group 
NRCTs: participants quasi-randomly allocated, has a control group 
CBA: participants non-randomly allocated, has a control group 
ITS: no control group. Must have 3 data points before and after intervention 





For RCTs, NRCTs or CBA:  
Level of randomisation/allocation? 
Was randomisation at the level of individual participant (e.g. patient) or were groups randomly 





Level of analysis 





Contemporaneous data collection? 
The timing of data collection pre-and post-intervention must be the same both study and 
control sites. 
DONE = dates mentioned  
NOT CLEAR = dates not mentioned - STOP DATA EXTRACTION UNTIL CONFIRMED 
NOT DONE = STOP DATA EXTRACTION 
Done  
Not clear  
Not done  
Appropriate choice of control sites AND at least two control sites? 
Control and study sites need to be comparable on issues such as reimbursement system, level 
of care, setting, academic status 
NOT CLEAR = can’t tell if sites are comparable - STOP DATA EXTRACTION UNTIL 
CONFIRMED 
NOT DONE = STOP DATA EXTRACTION 
Done  
Not clear  
Not done  
If ITS: 
Clearly defined point in time when the intervention occurred? 
Intervention must have occurred at a clearly defined point in time. 
NOT CLEAR = not reported in paper STOP DATA EXTRACTION UNTIL CONFIRMED 
NOT DONE = STOP DATA EXTRACTION 
Done  
Not clear  
Not done  
At least three data points before and after the intervention? 
NOT CLEAR = e.g. number of discrete data points not mentioned in table or text - STOP 
DATA EXTRACTION UNTIL CONFIRMED 
NOT DONE = STOP DATA EXTRACTION 
Done  
Not clear  
Not done  
Source of information for study design (page numbers): 
Eligibility: If not above design, or have selected NOT DONE then EXCLUDE 
Reason for exclusion: _______________________ or CONTINUE 
SETTING & PARTICIPANTS 
Geographic location of the hospital 





Not clear  
Country 
Where was the study conducted? 
Not clear if information is not available 
Not clear  
Specify 
_______________ 
Description of health professionals targeted 
Which health professionals were expected to utilise the CPW? 








Not clear ⁯ 
Number of health professionals targeted 
How many health professionals were involved (include both intervention 
and control sites) 
n =  
not stated 
Demographic characteristics of health professionals 
Was a description of the health care professionals who were the target of 
the CPW provided? 
Gender (% male): 
Gender (% female): 
Age range:  
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Not stated 
Section of hospital where intervention took place 









Not clear  
Description of patients 
What were the characteristics of the patients? 
Outpatients  
Presenting to ED  
Hospitalised  
Other (specify)  
_____________ 
Inclusion criteria for patients 
Were the inclusion criteria for patients clearly stated and appropriate? 
Inclusion criteria for cluster? 
For cluster trials, were the inclusion criteria for clusters (e.g. hospitals, 
wards) clearly stated and appropriate? 
Done  
Not clear  
Not done  
Done  
Not clear  
Not done  
Not applicable  
Number of patients included 
How many patients were included in the study? 
How many in intervention and control groups? 
Number of groups 
Intervention  
Control  
Number of participants 
Intervention n = 
Control n = 
Total number of 
participants 
n =  
Characteristics of patients included. 
What were the demographic characteristics of the patients who were 
recruited? 
Gender (% male): 





Was a power calculation explicitly stated? 
Record specific power calculation here: 
(page no.) 
For cluster trials, did power calculation allow for effects of 
clustering?  
e.g. do they mention intraclass correlation co-efficient? 
Done  
Not clear  
Not done  
Yes  
No  
Not applicable  
ELIGIBILITY: If setting is not a hospital or patients are not hospitalised then EXCLUDE 
Reason for exclusion: -_______________________ or CONTINUE 
CLINICAL PATHWAY CHARACTERISTICS 
Type of intervention: 
Was the CPW combined with any other type of intervention (e.g. 
electronic medical records, academic detailing) or was it a stand-alone 
intervention? 
CPW vs usual care  
Intervention including CPW vs 
intervention without CPW  
Intervention including CPW vs 




Description of intervention:  
(page no.) 
Invasive or non-invasive intervention targeted? 
INVASIVE examples = CPW for gastrectomy; PTCA; laparoscopic 
cholecystectomy; hip and knee arthroplasty  
NON-INVASIVE examples = CPW for stroke; pneumonia; asthma 
Invasive  
Non-invasive  
Specify intervention or diagnosis targeted: 
What was the purpose of the CPW? 
What did the authors state as the main reason the CPW was 
developed/introduced? 
Appropriate mgmt.  
Cost containment  
Other (specify) 
_____________ 
Not clear  
Was there a multi-faceted implementation process? 
Was the process of development of the CPW described? 
Short description of the collaborative process:  
(page no.) 
Done  
Not clear  
Not done  
Was content of the CPW evidence based? 
DONE = content of CPW based on a systematic review or ≥ one RCT or 
best practice guidelines 
NOT CLEAR = not stated 
NOT DONE = content clearly not evidence-based 
Done  
Not clear  
Not done  
What was the format of the CPW? 






Not clear  
Was the CPW adapted for local use? 
DONE = format of CPW adapted in collaboration with users / clinicians 
NOT CLEAR = not stated 
NOT DONE = no collaboration with users / clinicians on format of CPW 
Done  
Not clear  
Not done  
Was there clinician involvement in development of CPW? 
DONE = clearly stated that clinicians were involved in content of CPW 
Done  
Not clear  
Not done  
Was there an implementation team? Done  
Not clear  
Not done  
Were evidence-practice gaps identified prior to implementation of the 
CPW? 
DONE = gaps identified by local audit 
NOT CLEAR = anecdotal or evidence not local 
NOT DONE = no audit or identifying of evidence-practice gaps 
Done  
Not clear  
Not done  
Were barriers to change identified? 
DONE = barriers clearly stated 
NOT CLEAR = barriers may have been identified 
NOT DONE = barriers to change not stated 
Done  
Not clear  
Not done  
Were reminder systems incorporated into implementation? 
DONE = formal reminder system described e.g. posters, computer 
reminders 
NOT CLEAR = reminder system may have been used 
Done  
Not clear  
Not done  
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NOT DONE = reminder system not described 
Was audit and feedback incorporated into implementation? 
DONE = audit and feedback process clearly stated 
NOT CLEAR = audit and feedback may have been used 
NOT DONE = no description of audit and feedback provided 
Done  
Not clear  
Not done  
Were education sessions used to implement CPW? 
DONE = education sessions attended by majority of users / clinicians 
NOT CLEAR = education sessions may have been provided and may have 
been attended by users / clinicians 
NOT DONE = no education sessions provided or attended by users / 
clinicians 
Done  
Not clear  
Not done  
Were local opinions leaders used to implement CPW? 
DONE = clear identification and utilisation of local opinion leaders 
NOT CLEAR = local opinion leaders may have been involved 
NOT DONE = no evidence of utilisation of local opinion leaders 
Done  
Not clear  
Not done  
Evidence-based implementation strategy: 
A = 7-10 criteria checked as “Done” 
B = 2-6 criteria checked as “Done” 
C = 0-1 criteria checked as “Done” 
A (high)  
B (moderate)  
C (low)  
What was the source of funding for the study? 




Health service  





Not clear  
Eligibility: If intervention does not clearly include a CPW then EXCLUDE 
Reason for exclusion: -_______________________ or CONTINUE 
OUTCOME MEASURE(S): 
NB: Primary outcomes are those that correspond to the primary hypothesis or question as defined by the 
authors. Other outcomes may be incorporated if they are relevant to patient outcomes and professional 
practice, and meet the EPOC quality criteria. 







Was compliance or adherence to CPW measured and reported? Yes (specify)  
__________ 
No  
What was the length of post–intervention follow-up? 
Was there a possible ceiling effect? (i.e. little room for improved outcomes) 
Ceiling effect identified by investigator: Yes (specify)  
__________ 
No  
Not relevant  
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Ceiling effect identified by reviewer: Yes (specify)  
__________ 
No  
Not relevant  
Were outcomes measured in a clinical (i.e. not test) situation? Done  
Not clear  
Not done 
Are the results relevant and interpretable? Done  
Not clear  
Not done 
Eligibility: If outcomes are not relevant to our stated review aims then EXCLUDE 
Reason for exclusion: _______________________ or CONTINUE 
 
Did both reviewers agree on inclusion / exclusion and study 
quality? 
Yes / No 
If no, what was the source(s) of disagreement? 
 
3 Working definition for a clinical pathway  
MINIMUM CRITERIA FOR A CLINICAL PATHWAY 








3. Does it detail the steps in a course of treatment or care in a plan, pathway, algorithm, guideline, 












Source of information for minimum criteria for a clinical pathway (CPW) (page numbers): 
Eligibility:  
All 4 Criteria – must be “yes” 




APPENDIX E  
Medline Search Strategy.  








Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations and Ovid 
MEDLINE(R) 1946 to Present 
 
30-8-2016 Epub Ahead of Print, In-Process & Other Non-Indexed Citations, Ovid 




8-2-2017 Ovid MEDLINE(R) Epub Ahead of Print, In-Process & Other Non-
Indexed Citations, Ovid MEDLINE(R) Daily and Ovid MEDLINE(R) 




   
 Date searched (if different to summary sheet):  
   
No. Search terms Results 
1 Critical Pathways/ 5140 
2 ((clinical or critical) adj2 (pathway? or path)).ti,ab. 7456 
3 ((care adj2 algorithm?) or clinical algorithm?).ti,ab. 1176 
4 (care adj2 pathway?).ti,ab. 2616 
5 (treatment adj3 algorithm?).ti,ab. 5539 
6 (structured care or intensive management).ti,ab. 862 
7 (standardi$ adj3 (treatment? or care or patient care or plan$)).ti,ab. 5862 
8 (care adj2 (plan? or map or maps or protocol? or algorithm?)).ti,ab. 10333 
9 (protocol? adj4 (nursing or treatment or management or directed or 
guided)).ti,ab. 
25010 
10 ((local or locally) adj2 adapt$ adj5 guideline?).ti,ab. 79 
11 (treatment model? adj10 standardi$).ti,ab. 9 
12 (standardi$ adj3 (template or templates)).ti,ab. 257 
13 or/1-12 [Pathways] 59310 
14 Clinical protocols/ 21974 
15 Algorithm/ and (di.fs. or (treatment or care or patient?).ti. or 
diagnos$.ti,ab.) 
44551 
16 Practice Guidelines as Topic/ or Guideline Adherence/ or Guidelines as 
topic/ 
136358 
17 ((guideline or guidelines) adj2 (adher$ or implement$)).ti,ab. 5602 
18 (guideline? adj4 (compliance or complying)).ti,ab. 2931 
19 or/16-18 [PGL or GL Adherence] 139909 
20 (adherence or care or compliance or comply$ or implement$ or impact or 
plan? or standardi?ed or pathway or (treatment adj3 (protocol? or 
algorithm?))).ti,ab. 
2800181 
21 19 and 20 [GL ] 53817 
22 *Guidelines as topic/ or *Practice Guidelines as topic/ 39468 
23 *Guideline Adherence/ 11167 
24 or/22-23 [Focussed MeSH Guideline] 47530 
25 Primary health care/ or Primary Care Nursing/ 59553 
26 Family practice/ or General Practice/ 66773 
27 General Practitioners/ or Physicians, Family/ or Physicians, Primary Care/ 19441 
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28 ((general or family) adj2 (practice? or practitioner? or physician? or 
doctor?)).ti,ab. 
97661 
29 (primary adj2 (care or health care or healthcare or medical care or patient 
care)).ti,ab. 
98355 
30 (primary care or family medic$ or general practice or family practi$).jn. 8571 
31 GP.ti. 3489 
32 or/25-31 [Primary Care ] 232583 
33 Ambulatory Care/ or Community medicine/ or community health nursing/ 
or community health services/ or home care services/ or Community 
mental health services/ or Community Pharmacy Services/ 
127407 
34 Ambulatory Care Facilities/ or Community Health Centers/ 19109 
35 (community or communities).ti,ab,hw. 441147 
36 (((ambulatory or walk-in or neighbo?rhood or community) adj2 (clinic? or 
care centre or care centres or care center? or health$ centre or health$ 
centres or health$ center?)) or public clinic?).ti,ab. 
10485 
37 ((urban or rural) adj3 health).ti,ab. 11119 
38 or/33-37 [Community Care] 515822 
39 13 and 32 [Pathway terms & PC] 3083 
40 (and/13,38) not 39 [Pathways & Community-Ambulatory Care] 3399 
41 (and/24,32) not (or/39-40) [Focussed GL & PC] 3395 
42 (and/24,38) not (or/39-41) [Focussed GL & Community-Ambulatory Care] 2247 
43 (21 and (or/32,38)) not (or/39-42) [GL & PC/Amb Care] 6871 
44 ((or/14-15) and ((or/26-31,38) or *Primary health care/ or *Primary Care 
Nursing/)) not (or/39-43) [Clinical Protocols/Algorithms Mesh & 
PC/Community Care-combine with RCT filter only] 
3511 
45 (randomized controlled trial or controlled clinical trial).pt. or 
randomized.ab. or placebo.ab. or clinical trials as topic.sh. or randomly.ab. 
or trial.ti. 
1013198 
46 exp animals/ not humans.sh. 4152952 
47 45 not 46 [Cochrane RCT Filter 6.4.d Sens/Precision Maximizing] 934229 
48 intervention?.ti. or (intervention? adj6 (clinician? or collaborat$ or 
community or complex or DESIGN$ or doctor? or educational or family 
doctor? or family physician? or family practitioner? or financial or GP or 
general practice? or hospital? or impact? or improv$ or individuali?e? or 
individuali?ing or interdisciplin$ or multicomponent or multi-component 
or multidisciplin$ or multi-disciplin$ or multifacet$ or multi-facet$ or 
multimodal$ or multi-modal$ or personali?e? or personali?ing or 
pharmacies or pharmacist? or pharmacy or physician? or practitioner? or 
prescrib$ or prescription? or primary care or professional$ or provider? or 
regulatory or regulatory or tailor$ or target$ or team$ or usual care)).ab. 
194948 
49 (pre-intervention? or preintervention? or "pre intervention?" or post-
intervention? or postintervention? or "post intervention?").ti,ab. [added 
2.4] 
13033 
50 (hospital$ or patient?).hw. and (study or studies or care or health$ or 
practitioner? or provider? or physician? or nurse? or nursing or 
doctor?).ti,hw. 
781323 
51 demonstration project?.ti,ab. 2122 
52 (pre-post or "pre test$" or pretest$ or posttest$ or "post test$" or (pre adj5 
post)).ti,ab. 
77801 
53 (pre-workshop or post-workshop or (before adj3 workshop) or (after adj3 
workshop)).ti,ab. 
726 
54 trial.ti. or ((study adj3 aim?) or "our study").ab. 760357 
55 (before adj10 (after or during)).ti,ab. 394692 
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56 ("quasi-experiment$" or quasiexperiment$ or "quasi random$" or 
quasirandom$ or "quasi control$" or quasicontrol$ or ((quasi$ or 
experimental) adj3 (method$ or study or trial or design$))).ti,ab,hw. 
114170 
57 ("time series" adj2 interrupt$).ti,ab,hw. 1399 
58 (time points adj3 (over or multiple or three or four or five or six or seven or 
eight or nine or ten or eleven or twelve or month$ or hour? or day? or 
"more than")).ab. 
11310 
59 pilot.ti. 46690 
60 Pilot projects/ 92166 
61 (clinical trial or controlled clinical trial or multicenter study).pt. 674918 
62 (multicentre or multicenter or multi-centre or multi-center).ti. 34245 
63 random$.ti,ab. or controlled.ti. 866032 
64 (control adj3 (area or cohort? or compare? or condition or design or group? 
or intervention? or participant? or study)).ab. not (controlled clinical trial 
or randomized controlled trial).pt. 
470246 
65 evaluation studies as topic/ or prospective studies/ or retrospective studies/ 
[Added Jan 2013] 
1079015 
66 (utili?ation or programme or programmes).ti. [Added Jan 2013] 60368 
67 (during adj5 period).ti,ab. [Added Jan 2013] 328905 
68 ((strategy or strategies) adj2 (improv$ or education$)).ti,ab. [Added Jan 
2013] 
22433 
69 "comment on".cm. or review.pt. or (review not "peer review$").ti. or 
randomized controlled trial.pt. [Changed Jan 2013] 
3269864 
70 (rat or rats or cow or cows or chicken? or horse or horses or mice or mouse 
or bovine or animal?).ti. 
1420258 
71 exp animals/ not humans.sh. 4152952 
72 (or/48-68) not (or/69-71) [EPOC Methods Filter 2.5-added Evaluation 
Studies line forward--Jan 20130 Medline] 
3177316 
73 (or/39-44) and 47 [RCT Results] 3063 
74 (39 and 72) not 73 [EPOC Filter Results Set 1 : Pathways & PC] 1293 
75 (40 and 72) not (or/73-74) [EPOC Filter Set 2: Pathways & Community-
Ambulatory Care] 
1565 
76 (41 and 72) not (or/73-75) [EPOC Filter Set 3: Focussed GL & PC] 1099 
77 (42 and 72) not (or/73-76) [EPOC Filter Set 4: Focussed GL & Ambultory] 847 
78 (43 and 72) not (or/73-77) [EPOC Filter Set 5: GL & PC/Amb care] 2586 
79 or/74-78 [EPOC Filter Results] 7390 
80 73 or 79 10453 
81 limit 80 to yr="2015 -Current" 1257 
   
   
2016 update: 30/08/2016  
   
No. Search terms Results 
1 Critical Pathways/ 5420 
2 ((clinical or critical) adj2 (pathway? or path)).ti,ab. 8083 
3 ((care adj2 algorithm?) or clinical algorithm?).ti,ab. 1275 
4 (care adj2 pathway?).ti,ab. 3099 
5 (treatment adj3 algorithm?).ti,ab. 6141 
6 (structured care or intensive management).ti,ab. 927 
7 (standardi$ adj3 (treatment? or care or patient care or plan$)).ti,ab. 6438 
8 (care adj2 (plan? or map or maps or protocol? or algorithm?)).ti,ab. 11126 
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9 (protocol? adj4 (nursing or treatment or management or directed or 
guided)).ti,ab. 
26862 
10 ((local or locally) adj2 adapt$ adj5 guideline?).ti,ab. 81 
11 (treatment model? adj10 standardi$).ti,ab. 11 
12 (standardi$ adj3 (template or templates)).ti,ab. 292 
13 or/1-12 [Pathways] 64309 
14 Clinical protocols/ 23218 
15 Algorithm/ and (di.fs. or (treatment or care or patient?).ti. or 
diagnos$.ti,ab.) 
46262 
16 Practice Guidelines as Topic/ or Guideline Adherence/ or Guidelines as 
topic/ 
142398 
17 ((guideline or guidelines) adj2 (adher$ or implement$)).ti,ab. 6225 
18 (guideline? adj4 (compliance or complying)).ti,ab. 3159 
19 or/16-18 [PGL or GL Adherence] 146461 
20 (adherence or care or compliance or comply$ or implement$ or impact or 
plan? or standardi?ed or pathway or (treatment adj3 (protocol? or 
algorithm?))).ti,ab. 
3037238 
21 19 and 20 [GL ] 56974 
22 *Guidelines as topic/ or *Practice Guidelines as topic/ 41843 
23 *Guideline Adherence/ 11918 
24 or/22-23 [Focussed MeSH Guideline] 50500 
25 Primary health care/ or Primary Care Nursing/ 62173 
26 Family practice/ or General Practice/ 69506 
27 General Practitioners/ or Physicians, Family/ or Physicians, Primary Care/ 22382 
28 ((general or family) adj2 (practice? or practitioner? or physician? or 
doctor?)).ti,ab. 
101817 
29 (primary adj2 (care or health care or healthcare or medical care or patient 
care)).ti,ab. 
106166 
30 (primary care or family medic$ or general practice or family practi$).jn. 8827 
31 GP.ti. 3764 
32 or/25-31 [Primary Care ] 244482 
33 Ambulatory Care/ or Community medicine/ or community health nursing/ 
or community health services/ or home care services/ or Community 
mental health services/ or Community Pharmacy Services/ 
130322 
34 Ambulatory Care Facilities/ or Community Health Centers/ 22206 
35 (community or communities).ti,ab,hw. 476877 
36 (((ambulatory or walk-in or neighbo?rhood or community) adj2 (clinic? or 
care centre or care centres or care center? or health$ centre or health$ 
centres or health$ center?)) or public clinic?).ti,ab. 
11292 
37 ((urban or rural) adj3 health).ti,ab. 12016 
38 or/33-37 [Community Care] 556500 
39 13 and 32 [Pathway terms & PC] 3382 
40 (and/13,38) not 39 [Pathways & Community-Ambulatory Care] 3691 
41 (and/24,32) not (or/39-40) [Focussed GL & PC] 3562 
42 (and/24,38) not (or/39-41) [Focussed GL & Community-Ambulatory Care] 2399 
43 (21 and (or/32,38)) not (or/39-42) [GL & PC/Amb Care] 7218 
44 ((or/14-15) and ((or/26-31,38) or *Primary health care/ or *Primary Care 
Nursing/)) not (or/39-43) [Clinical Protocols/Algorithms Mesh & 
PC/Community Care-combine with RCT filter only] 
3722 
45 (randomized controlled trial or controlled clinical trial).pt. or 




46 exp animals/ not humans.sh. 4304227 
47 45 not 46 [Cochrane RCT Filter 6.4.d Sens/Precision Maximizing] 980712 
48 intervention?.ti. or (intervention? adj6 (clinician? or collaborat$ or 
community or complex or DESIGN$ or doctor? or educational or family 
doctor? or family physician? or family practitioner? or financial or GP or 
general practice? or hospital? or impact? or improv$ or individuali?e? or 
individuali?ing or interdisciplin$ or multicomponent or multi-component 
or multidisciplin$ or multi-disciplin$ or multifacet$ or multi-facet$ or 
multimodal$ or multi-modal$ or personali?e? or personali?ing or 
pharmacies or pharmacist? or pharmacy or physician? or practitioner? or 
prescrib$ or prescription? or primary care or professional$ or provider? or 
regulatory or regulatory or tailor$ or target$ or team$ or usual care)).ab. 
218683 
49 (pre-intervention? or preintervention? or "pre intervention?" or post-
intervention? or postintervention? or "post intervention?").ti,ab. [added 
2.4] 
15304 
50 (hospital$ or patient?).hw. and (study or studies or care or health$ or 
practitioner? or provider? or physician? or nurse? or nursing or 
doctor?).ti,hw. 
810807 
51 demonstration project?.ti,ab. 2216 
52 (pre-post or "pre test$" or pretest$ or posttest$ or "post test$" or (pre adj5 
post)).ti,ab. 
86771 
53 (pre-workshop or post-workshop or (before adj3 workshop) or (after adj3 
workshop)).ti,ab. 
820 
54 trial.ti. or ((study adj3 aim?) or "our study").ab. 842176 
55 (before adj10 (after or during)).ti,ab. 416033 
56 ("quasi-experiment$" or quasiexperiment$ or "quasi random$" or 
quasirandom$ or "quasi control$" or quasicontrol$ or ((quasi$ or 
experimental) adj3 (method$ or study or trial or design$))).ti,ab,hw. 
124033 
57 ("time series" adj2 interrupt$).ti,ab,hw. 1728 
58 (time points adj3 (over or multiple or three or four or five or six or seven or 
eight or nine or ten or eleven or twelve or month$ or hour? or day? or 
"more than")).ab. 
12735 
59 pilot.ti. 51666 
60 Pilot projects/ 96615 
61 (clinical trial or controlled clinical trial or multicenter study).pt. 682423 
62 (multicentre or multicenter or multi-centre or multi-center).ti. 37580 
63 random$.ti,ab. or controlled.ti. 934497 
64 (control adj3 (area or cohort? or compare? or condition or design or group? 
or intervention? or participant? or study)).ab. not (controlled clinical trial 
or randomized controlled trial).pt. 
507163 
65 evaluation studies as topic/ or prospective studies/ or retrospective studies/ 
[Added Jan 2013] 
1127398 
66 (utili?ation or programme or programmes).ti. [Added Jan 2013] 64495 
67 (during adj5 period).ti,ab. [Added Jan 2013] 345785 
68 ((strategy or strategies) adj2 (improv$ or education$)).ti,ab. [Added Jan 
2013] 
25129 
69 "comment on".cm. or review.pt. or (review not "peer review$").ti. or 
randomized controlled trial.pt. [Changed Jan 2013] 
3408192 
70 (rat or rats or cow or cows or chicken? or horse or horses or mice or mouse 
or bovine or animal?).ti. 
1476130 
71 exp animals/ not humans.sh. 4304227 
72 (or/48-68) not (or/69-71) [EPOC Methods Filter 2.5-added Evaluation 
Studies line forward--Jan 20130 Medline] 
3387408 
73 (or/39-44) and 47 [RCT Results] 3303 
 155 
74 (39 and 72) not 73 [EPOC Filter Results Set 1 : Pathways & PC] 1418 
75 (40 and 72) not (or/73-74) [EPOC Filter Set 2: Pathways & Community-
Ambulatory Care] 
1681 
76 (41 and 72) not (or/73-75) [EPOC Filter Set 3: Focussed GL & PC] 1167 
77 (42 and 72) not (or/73-76) [EPOC Filter Set 4: Focussed GL & Ambultory] 902 
78 (43 and 72) not (or/73-77) [EPOC Filter Set 5: GL & PC/Amb care] 2716 
79 or/74-78 [EPOC Filter Results] 7884 
80 73 or 79 11187 
81 limit 80 to yr="2015 -Current" 1138 
   
2017 update: 08/02/2017  
   
   
No. Search terms Results 
1 (clinical adj2 pathway?).ti. 1285 
2 critical pathways/ 5562 
3 ((clinical or critical) adj1 (pathway? or path?)).ti,ab. 5259 
4 ((care adj2 algorithm?) or clinical algorithm?).ti,ab. 1315 
5 (care adj1 pathway?).ti,ab. 2703 
6 (treatment adj3 algorithm?).ti,ab. 6455 
7 (management protocol? or treatment protocol?).ti,ab. 17810 
8 (care adj1 (plan? or map?)).ti,ab. 7232 
9 (protocol? adj1 (nursing or directed or guided)).ti,ab. 547 
10 ((local or locally) adj2 adapt* adj5 guideline?).ti,ab. 85 
11 (treatment model? adj10 standardi*).ti,ab. 11 
12 (standardi* adj3 protocol?).ti,ab. 9894 
13 systematic detection.ti,ab. 271 
14 or/2-13 53386 
15 clinical protocols/ 24668 
16 (treat* or therap*).ti,ab. 5628132 
17 15 and 16 12241 
18 practice guidelines as topic/ 97006 
19 (implement* or pathway or protocol?).ti,ab. 1185547 
20 18 and 19 12971 
21 (guideline? adj1 (implement* or pathway or protocol?)).ti,ab. 2112 
22 or/20-21 14130 
23 14 or 17 or 22 76751 
24 (hospital or hospitals or hospitalis* or hospitaliz*).ti,ab. 1022715 
25 exp hospital units/ 90944 
26 exp hospitals/ 241004 
27 exp hospital departments/ 161398 
28 hospitalization/ 85875 
29 or/24-28 1287170 
30 1 or (23 and 29) 18164 
31 randomized controlled trial.pt. 447592 
32 controlled clinical trial.pt. 91833 
33 multicenter study.pt. 218061 
34 pragmatic clinical trial.pt. 521 
35 (randomis* or randomiz* or randomly).ti,ab. 723337 
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36 groups.ab. 1672872 
37 (trial or multicenter or multi center or multicentre or multi centre).ti. 204098 
38 (intervention? or effect? or impact? or controlled or control group? or 
(before adj5 after) or (pre adj5 post) or ((pretest or pre test) and (posttest or 
post test)) or quasiexperiment* or quasi experiment* or pseudo 
experiment* or pseudoexperiment* or evaluat* or time series or time 
point? or repeated measur*).ti,ab. 
7883302 
39 non-randomized controlled trials as topic/ 122 
40 interrupted time series analysis/ 239 
41 controlled before-after studies/ 214 
42 or/31-41 8810908 
43 exp animals/ 20711674 
44 humans/ 16396415 
45 43 not (43 and 44) 4315259 
46 review.pt. 2223092 
47 meta analysis.pt. 73858 
48 news.pt. 180989 
49 comment.pt. 678358 
50 editorial.pt. 425203 
51 cochrane database of systematic reviews.jn. 12923 
52 comment on.cm. 678357 
53 (systematic review or literature review).ti. 90278 
54 or/45-53 7523264 
55 42 not 54 6145029 
56 30 and 55 10214 
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For what aspect(s) of program theory does this study provide evidence (i.e. evidence ‘to 
support, refute or refine elements of theory)?  (Include a summary of the nature of the 
evidence and quotes/ page numbers if possible). 
CMO Table (Or elements of CMOs) (Add extra lines if required). Include quotes or page 
no’s  
Context  Mechanism Outcome  
   
   
   
  
  
    
What amendments to program theory might you propose based on this study? 
  
  
Comments or questions on rigour/methodology  
   
  
Priority for in-depth review:    Please rank as High / Medium / Low.   
Why? 
 
Other notes/comments  
  
  
  
